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1 Introduction 
1.1 Lipoxygenase pathway 
Lipoxygenases (LOX) are widely spread in higher organisms and were found in fungi (Tsitsigiannis and 
Keller, 2007), mammals (Funk, 2001) and flowering plants (Liavonchanka and Feussner, 2006). They 
were also found in bacteria (Iny et al., 1993, Porta and Rocha-Sosa, 2001, Lang et al., 2008) and in 
non-flowering plants like the moss Physcomitrella patens(Senger et al., 2005). 
LOXs catalyze the first committed step in the biosynthesis of oxylipins which function as signaling 
molecules. In fungi LOX-derived oxylipins are involved in the regulation of developmental stages and 
pathogenesis (Noverr et al., 2003), whereas in mammals the LOX-derived oxylipins (e. g. 
leukotrienes) are involved in the regulation of inflammatory processes (Funk, 2001). In plants they 
are involved in developmental processes, in wound response and in pathogen defense reactions 
(Stumpe et al., 2005, Howe and Jander, 2008,Wasternack, 2007). In non-flowering plants oxylipins 
are involved in developmental processes (Stumpe et al., 2010).The biological function in prokaryotes 
is still scarce (Andreou et al., 2009). 
LOXs belong to the dioxygenase family and contain a non-heme iron in its active site. They catalyze 
the formation of (1Z,3E)-hydroperoxy fatty acids by insertion of molecular oxygen in the (1Z,4Z)-
pentadiene system of polyunsaturated fatty acids (PUFAs). Plants use the C18 fatty acids linoleic acid 
(LA, 18:2∆9Z,12Z) and α-linolenic acid (α-LeA, 18:3∆9Z,12Z,15Z) as substrates. Whereas algae and animals 
use additionally to the C18 fatty acids the C20 fatty acids arachidonic acid (ARA, 20:4
∆5Z,8Z,11Z,14Z) and 
eicosapentaenoic acid (EPA, 20:5∆5Z,8Z,11Z,14Z,17Z) (Wichard et al., 2005, Andreou et al., 2009). 
Considering LA or α-LeA as substrates for LOX, introduction of the hydroperoxide group can occur 
either at position C9 (9-LOX) or at position C13 (13-LOX) of the C18 fatty acid, therefore LOXs can be 
divided into 9-LOX and 13-LOX. 9-LOX leads to the (9S)-hydroperoxide derivatives (9S,10E,12Z)-9-
hydroperoxy-10,12-octadecadienoic acid (9-HPOD) or (9S,10E,12Z,15Z)-9-hydroperoxy-10,12,15-
octadecatrienoic acid (9-HPOT), respectively, and 13-LOX to (13S)-hydroperoxide derivatives 
(9Z,11E,13S)-13-hydroperoxy-9,11-octadecadienoic acid (13-HPOD) or (9Z,11E,13S,15Z)-13-
hydroperoxy-9,11,15-octadecatrienoic acid (13-HPOT), respectively (Liavonchanka and Feussner, 
2006, Feussner and Wasternack, 2002). 
In Figure 1.1 the conversion of C18 fatty acid linoleic acid (LA) by 9- and 13-LOX to 9-HPOD and 13-
HPOD, respectively, is shown. 
Introduction    2 
 
Figure 1.1: Synthesis of hydroperoxides derived from LA by 9-LOX or 13-LOX (adapted from (Stumpe and 
Feussner, 2006)). LOX introduce molecular oxygen into the fatty acid either at position C9 or position C13 to 
generate hydroperoxy fatty acids. 
LOX (Figure 1.2) generated fatty acid hydroperoxides can subsequently be metabolized by further 
enzymes, like the allene oxide synthase (AOS), hydroperoxide lyase (HPL), divinyl ether synthase 
(DES), epoxy alcohol synthase (EAS), peroxygenase (PXG), and by LOX itself and lead to various 
products known as oxylipins (Hughes et al., 2009). Oxylipins are fatty acid hydroperoxides, hydroxy-, 
epoxy-, keto- and oxo-fatty acids, epoxy alcohols, divinyl ethers, volatile alcohols and aldehydes, 
jasmonic acid and their derivatives (Mosblech et al., 2009). 
AOS, HPL, DES and EAS contribute to a special enzyme family which is described later in this chapter 
(see 1.3). PXG converts the hydroperoxides to epoxy-, epoxyhydroxy-, dihydroxy- and polyhydroxy 
fatty acids (Feussner and Wasternack, 1998). Reduction of hydroperoxy fatty acids to hydroxyl 
derivatives can occur in addition via a non-enzymatical or chemical process. Under anaerobic 
condition homolytic cleavage of the oxygen binding occurs through the LOX itself, which leads to the 
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Figure 1.2: Formation of oxylipins in plants (adapted from (Göbel et al., 2001)). The insertion of molecular 
oxygen into polyunsaturated fatty acids (PUFAs) like linoleic (LA) or linolenic acid (LeA) by lipoxygenases (LOXs) 
generates hydroperoxy fatty acids which can be further metabolized to oxylipins by various enzymes. 
Abbreviations: HPO(D/T): hydroperoxy octadecadienoic/octadecatrienoic acid, EAS: epoxy alcohol synthase, 
HO(D/T): hydroxyl octadecadienoic/octadecatrienoic acid, PXG: peroxygenase, KO(D/T): keto 
octadecadienoic/octadecatrienoic acid, HPL: hydroperoxide lyase, AOS: allene oxide synthase, DES: divinyl 
ether synthase, AOC: allene oxide cyclase. 
1.2 P450-enzymes 
Cytochrome P450-enzymes (CYP) build one of the largest super families of enzymes. They are found 
in all biological organisms and catalyze a variety of chemical reactions in mammals and plants 
(Denisov et al., 2005). 
P450-enzymes are heme containing enzymes and the prosthetic heme iron is bound to a cysteine 
residue as fifth ligand to the heme iron(Werck-Reichhart and Feyereisen, 2000). 
Their name originates from the observation that in complex with carbon monoxide P450-enzymes 
have a characteristic absorption maximum at 450 nm (Denisov et al., 2005, Marnett, 2008). Enzymes 
of the CYP74-family also belong to the CYPs (see 1.3). 
Most P450-enzymes act as monooxygenases, they need molecular oxygen and a NAD(P)H-dependent 



























aldehyde ω-oxo fatty acid
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1.3 CYP74-enzymes 
CYP74-enzymes build a subgroup of the CYP-superfamily described before (see 1.2). AOS, HPL, DES, 
and EAS belong to the cytochrome P450 subfamily. In contrast to most P450-enzymes the CYP74-
enzymes are not functioning as monooxygenases but rather as hydroperoxide isomerases (HPL) or 
dehydratases (AOS and DES) (Stumpe and Feussner, 2006, Lee et al., 2008,Toporkova et al., 2008). 
CYP74-enzymes do not need molecular oxygen or NAD(P)H-dependent reductase as cofactors. They 
use acylhydroperoxides both as substrate and as oxygen donor to generate new carbon bonds by 
isomerization reactions (Noordermeer et al., 2001a, Andreou et al., 2009). Therefore the catalytic 
centers of CYP74s are very active (Hughes et al., 2006a). A further difference to the classical P450-
enzymes is that in the center of CYP74-enzymes heme-binding loop an additional nine amino acid 
residue insertion is found instead of the conserved threonine found in all other P450s(Marnett, 
2008). 
Functional differences of CYP74- and P450-catalysis is reflected by the different active site 
architectures of the enzymes which was demonstrated by 3D-structures of AOSs from Arabidopsis 
and guayule, which preclude monooxygenase-activity from unusual P450s (Lee et al., 2008, Li et al., 
2008). Mechanic aspects of the relationship between structure and function are still not fully 
understood (Brash, 2009). 
Based on sequence similarity and substrate specificity CYP74-enzymes are further divided into four 
subfamilies (see Figure 1.3). Within a subfamily the amino acid sequence has an identity of more 
than 55 % to each other (Howe and Schilmiller, 2002). 
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Figure 1.3: Phylogenetic analysis of different CYP74 enzymes from different plant species (taken from (Scholz 
et al., 2012)). The phylogenetic tree was calculated using the ClustalX software package employing default 
parameters. Allium sativum (As); Arabidopsis thaliana (At); Citrus sinensis (Ci); Cucumis melo (Cm); Cucumis 
sativum (Cs); Hordeum vulgare (Hv); Lycopersicum esculentum (Le); Musa ascuminata (Ma); Medicago sativum 
(Ms); Medicago truncatula (Mt); Nicotiana attentuata (Na); Nicotiana tabacum (Nt); Oryzae sativum (Os); 
Parthenium argentatum (Pa); Prunus dulcis (Pd); Psidium guajava (Pg); Physcomitrella patens (Pp); Solanum 
tuberosum (St); Zea mays (Zm). AtAOS, CAA63266; AsDES, AJ867809; AtHPL, AAC69871; CiAOS, AA072741; 
CmAOS, AAM66138; CmHPL, AAK54282; CsHPL1, AAF64041; CsHPL2, AF229812; HvAOS1, CAB86384; HvAOS2, 
CAB86383; HvHPL, CAC82980; LeAOS1, CAB88032; LeAOS2, AAF67141; LeAOS3, AAN76867; LeCYPc4, 
AAL86702; LeDES, AAG42261; LeHPL, AAF67142; LuAOS, AAA03353; MaHPL,CAB39331; MsHPL1, CAB54847; 
MsHPL2, CAB54848; MsHPL3, CAB54849; MtAOS, CAC86897; MtHPL2, CAC86899; MtHPL1,CAC86898; NaAOS, 
CAC82911; NtDES, AAL40900; OsAOS1, AY055775; OsAOS2, AAL38184; PaAOS, CAA55025; PdHPL, CAE18065; 
PgHPL, AAK15070; PpAOS1,CAC86919; PpAOS2, XP_001759629; PpHPL, CAC86920; StAOS1,CAD29735; StAOS2, 
CAD29736; StAOS3, CAI30876; StDES, CAC28152; StHPL, CAC44040; ZmHPL, AAS47027. 
To CYP74A-subfamily belongs AOS with a preference for 13-hydroperoxides as substrate. 13-HPL and 
13-DES build subfamily CYP74B. HPL with a preference for 9- and 13-hydroperoxides as substrate, 
and HPL which use only 9-hydroperoxides as substrate, form the CYP74C-family. 9/13- and a 9-AOS 
also belong to this family. Enzymes with 9-DES activity are found in the CYP74D-family(Stumpe and 
Feussner, 2006, Gogolev et al., 2011). 
While the cDNAs of the CYP74-enzymes AOS, DES and HPL were identified in plants over the last ten 
years, in 2008 a fourth CYP74-enzyme EAS was isolated from an animal (Lee et al., 2008). 
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1.3.1 Allene oxide synthase 
The first described CYP74-enzyme was the AOS from flax (Linum usitatissimum) (Song and Brash, 
1991). AOS is a key-enzyme in the biosynthesis of the phytohormone jasmonic acid (JA) and is 
therefore involved in signal and defense responses in higher plants and algae (Andreou et al., 2009). 
It was first described as hydroperoxide isomerase or hydroperoxide dehydratase (Hamberg and 
Gardner, 1992). The AOS-branch of the oxylipin pathway takes place in the plastid. AOS catalyzes the 
conversion of a fatty acid hydroperoxide into a highly unstable allene oxide with a life time of about 
30 s, which then is subsequently hydrolyzed into α-ketol and γ-ketol as well as into cyclopentenone 
derivatives (Brash et al., 1988, Hamberg, 1997, Hamberg, 1987). In Figure 1.4 the reaction for the 
conversion of 13-HPOT by AOS is shown. The 13-HPOT is dehydrated to the unstable allene oxide 
(9Z,11E,13S,15Z)-12,13-epoxy-9,11,15-octadecatrienoic acid (12,13S-EOT). The 12,13S-EOT is than 
hydrolyzed into α-ketol (9Z,15Z)-12-oxo-13-hydroxy-9,15-octadecadienoic acid and γ-ketol (10E,15Z)-
12-oxo-9-hydroxy-10,15-octadecadienoic acid or cyclized to racemic (9S,10Z,13S,15Z)-12-oxo-10,15-
phytodienoic acid (12-OPDA) (Brash et al., 1988). Chemical cyclization leads to the formation of 
racemic OPDA, whereas cyclization by allene oxide cyclase (AOC) arises optically pure (9S,13S)-12-
OPDA (Hamberg and Fahlstadius, 1990). The reduction of (9S,13S)-12-OPDA by OPDA reductase 
isoform 3 (OPR3) and three cycles of β-oxidation leads to the formation of JA and takes place in the 
peroxisome (Ziegler et al., 1999, Grechkin et al., 2008, Vick and Zimmerman, 1984, Itoh et al., 2002). 
The active form of JA, its isoleucine conjugate, regulates developmental processes as well as defense 
responses (Howe and Jander, 2008, Wasternack, 2007). 
All purified AOS are membrane bound. There were each one AOS described for Arabidopsis 
(Arabidopsis thaliana), flax, guayule (Partheniumargentatum) and alfalfa (Medicagotruncatula), two 
were found in barley (Hordeum vulgare) and three have been described for tomato (Lycopersicum 
esculentum) and potato (Solanum tuberosum) (Andreou et al., 2009, Stumpe and Feussner, 2006, 
Mosblech et al., 2009). 
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Figure 1.4: AOS pathway for the conversion of 13-HPOT (adapted from (Stumpe and Feussner, 2006)). The fatty 
acid hydroperoxide is converted by AOS into an unstable allene oxide, which is further hydrolyzed into α-ketol 
and γ-ketol. Chemical cyclization leads to the formation of racemic 12-OPDA. Cyclization by AOC arise 
enantiomeric pure 12-OPDA. The reduction by OPR3 and three cycles of β-oxidation leads to the formation of 
jasmonic acid. Abbreviations: 13-HPOT: 13-hydroperoxy octadecatrienoic acid, AOS: allene oxide synthase, 
AOC: allene oxide cyclase, 12-OPDA: (9S,10Z,13S,15Z)-12-oxo-10,15-phytodienoic acid, OPR3: OPDA reductase. 
1.3.2 Hydroperoxide lyase 
HPL catalyzes homolytic cleavage of fatty acid hydroperoxides in ω-oxo fatty acids and short chain 
aldehydes (Andreou et al., 2009). HPL was first described as hydroperoxide isomerase and only 
recently its hemiacetal hydroperoxide lyase activity was unveiled (Grechkin and Hamberg, 2004). 
In Figure 1.5 exemplarily the HPL pathway for 9- and 13-LOX derived fatty acid hydroperoxides from 
α-LeA is shown. HPL converts the fatty acid hydroperoxide into an unstable hemiacetal, which 
spontaneously dissociates into short chain alkenals (Grechkin and Hamberg, 2004). The alkenals 
generated by 13-HPL can be enzymatically isomerized from (3Z)- to (2E)-enol formation and be 
reduced by alcohol dehydrogenase (ADH) to alcohols. The ω-oxo fatty acids such as (9Z)-12-oxo-9-
dodecenoic acid can be isomerized to the wound hormone traumatin ((10E)-12-oxo-10-dodecenoic 
acid) which spontaneously can oxidize to traumatic acid (Noordermeer et al., 2000). 
Green leaf volatiles (aldehydes and alcohols) derived from 13-LOX pathway have a chain length of six 
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Oxylipins generated by HPL seem to be involved in plant defense processes (Howe and Jander, 2008) 
and in wound healing (Matsui et al., 2006). 
HPL was isolated from A. thaliana, maize (Zea mays), barley, guava (Psidium guajava), bell pepper 
(Casicum anuum), melon (Citrullus lanatus), potato, and tomato (Matsui, 2006, Stumpe and 
Feussner, 2006, Mosblech et al., 2009, Matsui et al., 2006). Most HPLs have a preference for 13-
hydroperoxides as substrate, while HPL from melon and cucumber (Cucumis sativus) uses both 9- 
and 13-hydroperoxides (Grechkin, 2002). 
 
Figure 1.5: HPL pathway for the conversion of α-LeA (adapted from (Stumpe and Feussner, 2006)). 9-HPOT and 
13-HPOT derived from α-LeA are converted by HPL into alkenals and ω-oxo fatty acids. The alkenals can 
enzymatically be isomerized to enols and reduced to alcohols by ADH as shown for the C6 isomers. The C12 ω-
oxo fatty acid can isomerize to traumatin which can be oxidized to traumatic acid. Abbreviations: 9-LOX: 9-
lipoxygenase, 13-LOX: 13-lipoxygenase, 9-HPOT: 9-hydroperoxy octadecatrienoic acid, 13-HPOT: 13-
hydroperoxy octadecatrienoic acid, ADH: alcohol dehydrogenase. 
1.3.3 Divinyl ether synthase 
DES catalyzes the conversion of a fatty acid hydroperoxide derivative into divinyl ether (Stumpe 
et al., 2008). The conjugated divinyl ether fatty acid has molecular oxygen within its carbon chain 
(Itoh and Howe, 2001). 
The divinyl ether colneleic acid (CA, 9-[(1‘E),3‘Z,8E)-nonadienyloxy]-8-nonenoic acid) and colnelenic 
acid (CnA, 9-[(1‘E),3‘Z,6‘Z,8E)-nonatrienyloxy]-8-nonenoic acid) were generated by conversions of 9-
hydroperoxides derived from LA and α-LeA, while etheroleic acid (EA, 12-[(1‘E,9Z,11E)-hexenyloxy]-
9,11-dodecadienoic acid) and etherolenic acid (EnA, 12-[(1‘E,3‘Z,9Z,11E)-hexadienyloxy]-9,11-
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Figure 1.6 the DES pathway for the conversion of 9- and 13-hydroperoxides derived from α-LeA is 
shown. 
In tomato, tobacco (Nicotiana tabacum) and potato 9-hydroperoxide specific cDNAs were isolated 
(Fammartino et al., 2007, Stumpe et al., 2001,Itoh and Howe, 2001). In garlic (Allium sativum) DES 
with preference for both 9- and 13-hydroperoxides (9/13-DES) was isolated (Stumpe et al., 2008, 
Chechetkin et al., 2008). DES activity was detected in Lily-of-the-Valley (Convallaria majalis) and in 
flax (Stumpe et al., 2008, Chechetkin et al., 2008, Ogorodnikova et al., 2008) as well as in marine 
algae (Gerwick, 1994). 
Divinyl ethers are involved in plant defense. In tobacco and potato accumulated CA and CnA was 
detected after treatment with pathogens (Weber et al., 1999, Göbel et al., 2002). However, only in 
defined host-pathogen-interactions the function of divinyl ethers in plant defense was demonstrated 
(Fammartino et al., 2007). 
 
Figure 1.6: DES pathway for the conversion of α-LeA (adapted from (Hamberg, 2004)). 9- and 13-LOX catalyze 
the introduction of molecular oxygen into fatty acid hydroperoxides to form divinyl ethers. CnA derives from 9-
HPOT and EnA from 13-HPOT. Abbreviations: 9-LOX: 9-lipoxygenase, 13-LOX: 13-lipoxygenase, 9-HPOT: 9-
hydroperoxy octadecatrienoic acid, 13-HPOT: 13-hydroperoxy octadecatrienoic acid, CnA: colnelenic acid, EnA: 
etherolenic acid. 
1.3.4 Epoxy alcohol synthase 
The epoxy alcohol synthase (EAS) is the fourth member of the CYP74-enzymes. The first cDNA of EAS 
was found in a marine invertebrate, the lancelet Branchiostoma floridae, and identified as CYP74-
enzyme (Andreou et al., 2009, Lee et al., 2008). In plants only trihydroxy products that might arise 
from the EAS pathway, have been found in Solanaceae like potatoes and in rice upon pathogen 
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The synthesis of epoxyhydroxy fatty acids by intramolecular rearrangement of molecular oxygen of 
the hydroperoxy fatty acid is catalyzed by EAS. The conversion of 9-and 13-hydroperoxides derived 
from α-LeA by EAS is shown in Figure 1.7. The resulting oxylipins seem to be involved in pathogen 
defense reactions (Blée, 1998b, Feussner and Wasternack, 2002). 
As shown in Figure 1.2 epoxy alcohols can also be generated by PXG. It should be emphasized at this 
point, that this reaction is entirely unrelated to CYP74-catalysis and the stereochemistry of this 
substances is different. PXG catalyzes inter- and intramolecular transfer of oxygen from the 
hydroperoxides to generate epoxy alcohols as well as fatty acid epoxides, respectively (Blée, 1998a, 
Hanano et al., 2006). 
 
Figure 1.7: EAS pathway for the conversion of α-LeA. Epoxyhydroxy fatty acids were generated by 
intramolecular rearrangement of molecular oxygen of the hydroperoxy fatty acids. Abbreviations: 9-LOX: 9-
lipoxygenase, 13-LOX: 13-lipoxygenase, 9-HPOT: 9-hydroperoxy octadecatrienoic acid, 13-HPOT: 13-
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1.3.5 Proposed reaction mechanisms of CYP74-enzymes 
CYP74-enzymes have high similarities in their amino acid sequences as well as in their substrate 
specificities (1.3). Kuroda and coworkers showed that AOS, HPL and DES of the CYP74-family have 
common reaction mechanisms because of using the same substrates and formation of a common 
intermediate, an epoxy allylic carbocation, which arises from the fatty acid hydroperoxide (Kuroda 
et al., 2005). After solving the structures of AOS from Arabidopsis (AtAOS) and guayule (PaAOS) as 
well as after site-directed mutagenesis analysis reaction mechanisms for CYP74-enzyme catalysis 
were proposed. Several conserved amino acids were identified to play important roles in catalysis 
(Lee et al., 2008, Li et al., 2008, Toporkova et al., 2008, Schaller and Stintzi, 2009,Brash, 2009). 
In Figure 1.8the proposed reaction mechanism for the CYP74-enzymes AOS and HPL is 
shown(Schaller and Stintzi, 2009). In the active site of the enzyme the heme iron is bound to the 
terminal oxygen of the hydroperoxyl group at position C13 in the hydroperoxide substrate and the 
second oxygen of the hydroperoxide is bound to an asparagine residue (Asn321 in AtAOS (Figure 
1.8)) of the AOS enzyme. Homolytic cleavage of the oxygen bond (O-O bond) leads to an alkoxyl 
radical (RO•) and an iron-oxo complex (Fe(IV)-OH). The alkoxyl radical interacts with the double bond 
between C11 and C12 and forms an epoxide at C12 and C13 and a radical (C
•) at C11. This radical is the 
common intermediate in the proposed AOS and HPL reaction mechanisms. In AOS sequences is a 
highly conserved phenylalanine residue (Phe137 in AtAOS (Figure 1.8)). Oxidation of the C11 radical by 
the iron-oxo complex yields carbocation (C+) at C11. The Phe residue may be essential for AOS activity 
by stabilizing the intermediately formed carbon-centred substrate radical. Proton abstraction leads 
to formation of allene oxide. In HPL sequences is at this particular position instead of the Phe a 
leucine residue (Leu). This Leu is unable to stabilize the reactive product intermediate and thus leads 
to the formation of an unstable hemiacetal. The hemiacetal spontaneously dissociates into short 
chain aldehydes (Lee et al., 2008, Li et al., 2008, Toporkova et al., 2008, Schaller and Stintzi, 
2009,Brash, 2009). 
This concept was analyzed by Lee and coworkers by site-directed mutagenesis in AtAOS. Substitution 
of Phe137 into Leu137 led to alteration of enzyme catalysis (Lee et al., 2008). 
Overall the epoxy allylic radical is the branching point in catalysis. As proposed by Brash (Brash, 2009) 
this radical is the intermediate for the synthesis of allene oxides (AOS), hemiacetals and aldehydes 
(HPL), divinyl ethers (DES) as well as for epoxy alcohols (EAS). 
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Figure 1.8: Proposed reaction mechanisms for CYP74-enzymes (adapted from (Schaller and Stintzi, 2009)). 
Oxygen of hydroperoxide substrate binds to the heme iron and to Asn321 of the enzyme. Homolytic cleavage 
leads to the formation of an epoxy allylic radical as intermediate for both AOS- and HPL-catalysis. AOS catalyzes 
the oxidation by the iron-oxo complex and the formation of a carbocation, which is encouraged by Phe137. 
Proton abstraction leads to an allene oxide. HPL catalyzes the formation of a hemiacetal, which decomposes to 
short chain aldehydes. Amino acid residues are numbered according to the solved structure of Arabidopsis AOS 
(Lee et al., 2008). Abbreviations: 13(S)-HPOT: 13-hydroperoxy octadecatrienoic acid, Asn321: asparagine 321, 
Phe137: phenylalanine 137, Leu137: leucine137, AOS: allene oxide synthase, HPL: hydroperoxide lyase. 
From the epoxy allylic radical further reaction can be by radical (blue) or ionic (red) routes (Figure 1.9) 
(Brash, 2009). Catalysis of allene oxides and divinyl ethers occurs through ionic pathway where the 
radical intermediate is first converted into an epoxy allylic carbocation. Proton loss leads to the 
formation of allene oxides by AOS. Cleavage of the epoxy carbon double bond leads to the formation 
of a vinyl ether cation which can be converted to divinyl ethers by DES through proton loss. 
Brash proposed that HPL products can be synthesized through the radical as well as through the ionic 
route (Figure 1.9) (Brash, 2009). In the ionic route OH- attacks the vinyl ether cation and yield the 
hemiacetal which spontaneously dissociates to short chain aldehydes. Whereas in the radical route 
the carbon double bond of the epoxy allylic radical is cleaved and led to the formation of the vinyl 
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aldehydes. Synthesis of epoxy alcohols can also be through the radical as well as through the ionic 
route. 
 
Figure 1.9: Proposed potential intermediates in radical and ionic pathways to CYP74 products (adapted from 
(Brash, 2009)). Homolytic cleavage of the fatty acid hydroperoxide leads to the formation of an alkoxyl radical 
and than cyclization to epoxy allylic radical occurs. This radical produces via the radical route the short-lived 
hemiacetal which spontaneously decomposes to short chain aldehydes (blue). The epoxyallylic radical can be 
converted to an epoxy allylic cation (black box). The carbocation can be metabolized via the ionic route to 
allene oxides and divinyl ethers. Hemiacetal and short chain aldehydes can also generated by the ionic route 
(red). Epoxy alcohols can also be synthesized via either the radical or ionic route (not shown). 
Thus Brash proposed that synthesis of products by CYP74-enzymes can occur through either radical 
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1.4 Aim 
Aim of this study was to contribute to the characterization of enzymes of the CYP74-family. With the 
purified enzymes biochemical studies should be performed. By UV/vis and CD spectroscopy the 
heme-environment should be analyzed. Additionally the biochemical parameters of the enzyme 
should be determined. The substrate specificity against different hydroperoxides derived from LA, α-
LeA, γ-LeA and ARA and the optimal pH should be determined. In addition the products of the 
enzymatic reactions should be identified by radio-RP-HPLC and RP-HPLC/MS2. 
A further aim of the study is the analysis and comparison of the reaction mechanism of the CYP74-
enzymes. Therefore conserved amino acids should be identified and their role in the reaction 
mechanism should be analyzed by site-directed mutagenesis. 
It has been established that the catalytic trajectories of the different CYP74-enzymes are closely 
related (Brash, 2009) and that AOS and HPL seem to use a closely related mechanism and produce 
similar reaction intermediates in the different reactions. It was shown by single point mutagenesis 
that it is possible to convert the activity of the 13-hydroperoxide specific AOS from Arabidopsis into 
HPLactivity (Lee et al., 2008, Toporkova et al., 2008). In this study site-directed mutagenesis should 
be carried out in order to analyze if it is analogously possible to convert a possible unspecific AOS 
into HPL, DES or EAS. On the other hand, it will be investigated if a HPL can be converted into AOS, 
DES or EAS. 
A fourth CYP74-enzyme EAS was discovered in marine invertebrates (Lee et al., 2008). For 
comparison with the other three CYP74s the EAS from Branchiostoma floridae should be 
characterized. Therefore the biochemical parameters as well as the reaction products were analyzed. 
In addition site-directed mutagenesis should be carried out in order to investigate if the concept 
established for AOS- and HPLactivity can also be applied on EAS. 
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2 Material and Methods 
The molecular and microbiological experiments were done as described in Current Protocols in 
Molecular Biology (Ausubel et al., 1993). The glassware was heat sterilized (8 h at 180 °C) and sterile 
plastic articles were used. Furthermore double distilled water (ddH2O) was used. 
2.1 Materials 
2.1.1 Chemicals 
All chemicals used in this study were purchased from Sigma-Aldrich (Steinheim, Germany) or from 
Carl Roth & Co. (Karlsruhe, Germany) unless stated otherwise. Agarose was obtained from Biozym 
Scientific GmbH (Hess. Oldendorf, Germany), while the fatty acids were acquired from Cayman 
Chemicals (Ann Harbor, MI, USA) as well as from Enzo Life Sciences GmbH (Lörrach, Germany) and 
the restriction enzymes from MBI Fermentas (St. Leon-Rot, Germany). 
2.1.2 Molecular biology reagents 
Molecular biology kits 
Nucleo Spin®Plasmid Kit    Macherey-Nagel (Düren, Germany) 
Big Dye®Terminator v3.1 Cycle Sequencing Kit Applied Biosystems (Darmstadt, Germany) 
 
DNA-Ladder 
Gene Ruler™1kb DNA-Ladder MBI Fermentas (St. Leon-Rot, Germany) 
 
Protein Marker 
Protein Molecular Weight Marker MBI Fermentas (St. Leon-Rot, Germany) 
 
Enzymes 
Phusion™DNA Polymerase  Finnzyme New England Biolabs GmbH 
(Frankfurt am Main, Germany) 
Pfu Polymerase™ MBI Fermentas (St. Leon-Rot, Germany) 
Tfl DNA Polymerase™  Biozym Scientific GmbH (Hess. Oldendorf, 
Germany) 
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DNA 
The cDNA of PpAOS1, PpHPL, StDES and AsDES was kindly provided by Dr. Michael Stumpe (Georg-
August-University, Göttingen, Germany), and the cDNA of PpAOS2 was kindly provided by Dr. Ellen 
Hornung (Georg-August-University, Göttingen, Germany). 
The synthetic cDNA of BfEAS was ordered from GENEWIZ (South Plainfield, NJ, USA). 
2.1.3 Media 
Bacterial media(Ausubel et al., 1993) 
Luria Bertani (LB)-medium: Peptone  10 g/L; 0.1 % (w/v) 
Yeast extract  5 g/L; 0.05 % (w/v) 
NaCl   10 g/L; 0.1 % (w/v) 
in ddH2O and autoclaved for 20 min at 120 °C 
 
2x YT medium:   Peptone  30 g/L; 0.3 % (w/v) 
Yeast extract  20 g/L; 0.2 % (w/v) 
NaCl   5 g/L; 0.05 % (w/v) 
in ddH2O and autoclaved for 20 min at 120 °C 
 
LB agar plates:   1.5 % (w/v) agar was added to the LB-medium 
 
Antibiotics:  For selection of plasmid containing colony antibiotics were added to 
the medium: 
- Carbenicillin:  100 µg/ml 
- Kanamycin:  25 µg/ml 
 
Bacterial strains 
Table 2.1: Bacterial strains used. 















































et al., 1981) 
Qiagen (Hilden, 
Germany) 
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2.1.4 Vectors 
Table 2.2: Vectors used. 
vector selection marker source 
pET24b Kanamycin Novagen/Merck Chemicals (Darmstadt, Germany) 
pET28a Kanamycin Novagen/Merck Chemicals (Darmstadt, Germany) 
pQE30 Carbenicillin, Kanamycin Qiagen (Hilden, Germany) 
2.2 Technical equipment 
Sterile bench Prettl® Telstar Bio II A  Telstar (Terrassa, Spain) 
Thermocycler 
Mastercycler personal   Eppendorf AG (Hamburg, Germany) 
 Mastercycler gradient   Eppendorf AG (Hamburg, Germany) 
Centrifuge 5415D   Eppendorf AG (Hamburg, Germany) 
Centrifuge 5417R   Eppendorf AG (Hamburg, Germany) 
Centrifuge 5810R   Eppendorf AG (Hamburg, Germany) 
Avanti™ J-25 Centrifuge   Beckman Coulter (Krefeld, Germany) 
Mini-PROTEAN Tetra System III   Bio-Rad Laboratories (Hercules, A, USA) 
Raytest IDA gel documentation system  Herolab (Wiesloch, Germany) 
Sonifier® Cell Disruptor B15Branson(Dietzenbach-Steinberg, Germany) 
Corning® Spin-X® UF Concentrators  Life Sciences (Lowell, MA, USA)  
ÄKTAprime™ plus    GE Healthcare (Munich, Germany) 
Ultrospec 1100 pro Photometer  GE Healthcare (Munich, Germany) 
CARY 100 Bio UV-vis Spectrophotometer Varian(Darmstadt, Germany) 
Chirascan™ CD SpectrometerAppliedPhotophysicsLtd.(Leatherhead, 
                                                                                     United Kingdom) 
1100 series HPLC systemAgilent Technologies (Waldbronn, Germany) 
LCQ Ion trap mass spectrometer Thermo Finnigan (San Jose, CA, USA) 
Surveyor HPLC system Thermo Finnigan (San Jose, CA, USA) 
Radio detector Raytest (Straubenhardt, Germany) 
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2.3 Methods 
2.3.1 Amplification of specific DNA fragments by polymerase 
chainreaction (PCR) 
Polymerase chain reaction (PCR) (Mullis et al., 1986) allows the exponential amplification of a specific 
DNA fragment. The PCR reaction mixture contains the template DNA, a heat stable polymerase, the 
four desoxyribonucleotides adenine, cytosine, guanine, and thymine, and two sequence specific 
primers. The PCR is performed in several steps with different temperatures. In the first step 
(denaturation) the double stranded DNA is separated into single strands (92-98 °C). In the second 
step (annealing) the sequence specific primers bind to the single stranded DNA (55-60 °C), and in the 
third step (elongation) DNA strands complementary to the template DNA are synthesized (68-74 °C). 
2.3.1.1 Site-directed mutagenesis 
Site-directed mutagenesis in the amino acid sequence of PpHPL, PpAOS1, StDES, AsDES and BfEAS 
were done with the Phusion™High-Fidelity PCR system (Finnzyme New England Biolabs GmbH, 
Frankfurt am Main, Germany) or Pfu™ DNA polymerase. For this oligonucleotide primers which 
contained the desired mutation and were complementary to each other were used. Primers contain 
additionally desired recognition sites for analysis by DNA restriction with restriction endonucleases. 
Using these primers and the Phusion™DNA polymerase or Pfu™ DNA polymerase the plasmid with 
the desired point mutation was amplified. Subsequently the template DNA was digested with DpnI. 
 
Reaction mixture for Phusion™High-Fidelity PCR system (Vol = 50 µl): 
10 µl  5x Phusion™HF reaction buffer 
1 µl  10 mM dNTP-Mix 
  2 µl  10 µM 3’ Primer 
  2 µl  10 µM 5’ Primer 
0.5 µl  Phusion™ DNA polymerase 
  1 µl  50 ng DNA 
  filled up with ddH2O to 50 µl 
 
PCR program: 
1. Denaturation:   2 min at 98 °C 
2. Denaturation:   30 s at 98 °C 
3. Annealing:    30 s at 55 °C 
4. Elongation:    30 s/kb at 72 °C 
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Repeat step 2 through 4: 16 times for single amino acid changes and 18 times for multiple 
amino acid deletions 
 
Reaction mixture for Pfu™ DNA polymerase (Vol= 50 µl): 
5 µl  10x Pfu™ reaction buffer with MgCl2 
  1 µl  10 mM dNTP-Mix 
  2 µl  10 µM 3’ Primer 
  2 µl  10 µM 5’ Primer 
1 µl  Pfu™ DNA polymerase 
  1 µl  50 ng DNA 
  filled up with ddH2O to 50 µl 
 
PCR program: 
1. Denaturation:   2 min at 95 °C 
2. Denaturation:   30 s at 95 °C 
3. Annealing:    30 s at 55 °C 
4. Elongation:    2 min/kb at 72 °C 
Repeat step 2 through 4: 16 times for single amino acid changes and 18 times for multiple 
amino acid deletions 
 
Restriction of the maternal DNA: 
For the digestion of the template DNA 1 µl DpnI was added and incubated for 1 h at 37 °C. 
2.3.1.2 Colony PCR 
Colony PCR was applied for the identification of positive transformants. Therefore each bacterial 
colony was picked with a toothpick, transferred into a PCR tube containing 10 µl H2O, and used as 
template for the PCR. Furthermore the colonies were streaked in parallel on a selection plate and 
incubated over night at 37 °C. 
 
Reaction mixture (Vol = 25 µl): 1.25 µl  20xTfl DNA polymerase™ reaction 
   buffer 
     0.5 µl  10 mM dNTP-Mix 
     1.5 µl  10 µM 3’ Primer 
     1.5 µl  10 µM 5’ Primer 
     0.25 µl  Tfl polymerase™ 
     2.5 µl  25 mM MgCl2 
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     10 µl  ddH2O with bacterial colony as template 
     filled up with ddH2O to 25 µl 
 
PCR Program: 
1. Denaturation:   2 min at 94 °C 
2. Denaturation:   30 s at 94 °C 
3. Annealing:    30 s at 55 °C 
4. Elongation:    1 min/kb at 72 °C 
Repeat step 2 through 4: 10 times 
5. Denaturation:   30 s at 94 °C 
6. Annealing:    30 s at 55 °C 
7. Elongation:    1 min/kb at 72 °C + 5 s time increment 
Repeat step 5 through 7: 15 times 
8. Elongation:    5 min at 72 °C 
2.3.1.3 DNA precipitation 
For precipitation of amplified DNA fragments (2.3.1) 1/10 volume of 3 M NaAc and 2.5 time the 
volume of 98 % EtOH was added to the reaction mix, gently mixed, and incubated for 30 min at-
20 °C. Then the mixture was centrifuged for 15 min at 20.000 x g at 4 °C. After centrifugation the 
supernatant was removed and the precipitate was washed with 25 µl 70 % EtOH and centrifuged 
again for 5 min at 20.000 x g at 4 °C. Finally the supernatant was removed again, the precipitated 
DNA was dried for 5-10 min at 65 °C, dissolved in 10 µl ddH2O and stored at -20 °C. 
2.3.1.4 DNA restriction 
To verify the presence of the correct mutation in the plasmid the DNA was analyzed by restriction 
analysis. Therefore the double stranded DNA was incubated with restriction endonucleases overnight 
at 37 °C. Restriction endonucelases cleave double stranded DNA sequence specifically by hydrolysis 
of covalent bonds. 
 
Restriction mixture (Vol = 20 µl): 15 µl  of the colony PCR mixture 
     2 µl  10x reaction buffer 
     1 µl  Restriction enzyme 
     2 µl   H2O 
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2.3.2 Sequencing 
To determine the correct nucleotide sequences of the plasmids sequencing analysis according to 
Sanger (Sanger et al., 1977) were done. Therefore the Big Dye®Terminator v3.1 Cycle Sequencing Kit 
(Applied Biosystems, Darmstadt, Germany) was used as described below. For DNA precipitation 1 µl 
125 mM EDTA, 1 µl 3 M NaAc and 50 µl 98 % EtOH was added, gently mixed and incubated for 5 min 
at 4 °C. Afterwards the DNA was precipitated by centrifugation for 15 min at 20.000 x g at 4 °C. The 
resulting pellet was washed with 70 µl 70 % EtOH and centrifuged again for 5 min 20.000 g x at 4 °C. 
Subsequently the supernatant was removed and the precipitate was dried for 1 min at 65 °C, taken 
up in 15 µl formamide and stored at -20 °C. 
 
Reaction mixture (Vol = 10 µl):  1 µl   200-400 ng template DNA 
     1 µl  8 pmol Primer 
     1.5 µl  Sequencing mix 
     1.5 µl  Sequencing reaction buffer 
     filled up with ddH2O to 10 µl 
 
Temperature profile of sequencing reaction: 
1. Denaturation:    1 min at 96 °C 
2. Denaturation:    10 s at 96 °C 
3. Annealing:    15 s at 55 °C 
4. Elongation:    4 min at 60 °C 
Repeat step 2 through 4: 25 times 
2.3.3 Agarose gel electrophoresis 
2.3.3.1 Separation of DNA fragments by agarose gel electrophoresis 
The separation and size determination of DNA fragments was performed by agarose gel 
electrophoresis. For this 1 % (w/v) agarose gel was used and prepared with 1x TAE buffer. Before 
application 1/10 of the volume DNA loading buffer was added to the samples. As DNA standard 
GeneRuler 1kb DNA-Ladder (MBI Fermentas, St. Leon-Rot, Germany) was used. The electrophoresis 
was performed for 20-30 min at 120 V in 1x TAE buffer. Afterwards the agarose gels were incubated 
in an ethidium bromide solution(2 µg/L) for 10-15 min and briefly destained in water. Ethidium 
bromide can intercalate between the bases of the DNA and emits fluorescence under UV light. The 
DNA bands were visualized under UV light and documented with the raytest IDA gel documentation 
system (Herolab, Wiesloch, Germany). 
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TAE buffer (50x):   2 M  Tris/HCl, pH 8.0 
     1 M  Acetic acid 
     0.05 M  EDTA 
 
DNA sample buffer:   100 mM EDTA, pH 8.0 
     0.1 % (w/v) SDS 
     40 % (v/v) Glycerol 
     0.25 % (w/v) Bromphenol 
     0.25 % (w/v) Xylene cyanol 
2.3.4 Cultivation of E. coli 
The E. coli strains used in this work were cultivated on solid or in liquid medium. The precultures 
were cultivated in liquid LB medium shaking at 200 rpm at 37 °C. The expression cultures were 
incubated in liquid 2x YT shaking at 200 rpm at various temperatures (11 °C for 1 d, 28 °C for 1 d or 
16 °C for 3 d). To select plasmid containing bacterial cells antibiotics were added. For selection of 
pET24b and pET28a clones kanamycin was added to the medium. The pQE30 clones were selected by 
adding both carbenicillin and kanamycin. 
2.3.5 Transformation ofE. coli 
2.3.5.1 Transformation 
For the transformation of plasmids frozen chemically competent E. coli cells were thawed on ice. 
Then 100 µl of the cell suspension were added to 1 µl of plasmid DNA or 10 µl of precipitated 
mutated DNA (2.3.1.3) and incubated for at least 20 min on ice. Subsequently the cells were shocked 
for 45 s at 42 °C in a water bath. After incubation for 5 min on ice 900 µl LB medium was added and 
then the mixture was incubated for 1.5 h shaking at 200 rpm at 37 °C. Afterwards the cells were spun 
down for 1 min at 800 x g and the supernatant was discarded. The cell precipitate was resuspended 
in the remaining medium and then spread on selective LB agar plates and incubated over night at 
37 °C. 
To analyze the transformed cells colony PCR was used (see 2.3.1.2). 
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2.3.5.2 Isolation of plasmid DNA fromE. coli 
For isolation of plasmid DNA the E. coli strain XL1-Blue was used. 5 ml of LB medium were inoculated 
with cells from a selected bacterial colony and the appropriate antibiotics and were grown over night 
shaking at 200 rpm at 37 °C. After harvesting the cells by centrifugation the isolation of the plasmid 
DNA was done according to the manual of the Nucleo Spin®Plasmid Kit (Macherey-Nagel, Düren, 
Germany). This method is based on alkaline lysis according to Birnboim and Doly (Birnboim and Doly, 
1979). 
DNA was eluted from the column with 50 µl ddH2O and then stored at -20 °C. 
2.3.6 Heterologous expression of recombinant proteins in E. coli 
For expression of recombinant proteins the E. coli strain BL21 Star was used. First a preculture of the 
expression clones in LB medium with the appropriate antibiotics was prepared and grown over night 
shaking at 200 rpm at 37 °C. The expression culture was inoculated with 1/20 volume of the 
preculture consisting of 2x YT medium which contained the appropriate antibiotics. The cells were 
incubated at 200 rpm at 37 °C until they reached an OD600 of 0.6-0.8. To ensure strong heme 
production 80 mg/Lδ-amino levulinoic acid was added and 150 µM 0.1 mM ammonium ferric citrate. 
After an incubation of 15 min shaking at 200 rpm at 30 °C expression of recombinant protein was 
induced by the addition of IPTG to a final concentration of 0.1 mM. Then the cells were either 
incubated for 3 d shaking at 200 rpm at 16°C or for 1 d at 11 °C or for 1 d at 28 °C. Cells were 
harvested for 20 min at 3.000 x g at 4 °C. 
2.3.7 Cell disruption of E. coli expression cultures (adapted from 
(Richardson et al., 1993)) 
The harvested cells were lysed in accordance to (Richardson et al., 1993), with some modifications. 
Cells from 1 L culture were dissolved in 150 ml Tris buffer. Lysozyme was added up to a final 
concentration of 0.2 mg/ml and the cells were incubated for 30 min while gently stirred at 4 °C. Then 
the solution was centrifuged for 10 min at 3.000 x g at 4 °C. The sedimented spheroblasts were 
dissolved in 50 ml sodium phosphate buffer and frozen over night at -80 °C. 
While thawing the frozen cells protease inhibitor phenylmethylsulfonyl fluoride (PMSF) was added to 
a final concentration of 0.5 mM. Subsequently the cells were further lysed by using a sonifier cell 
disrupter (B15) from Branson (5x 1 min at 40 % power and 40 % pulse) on ice. Afterwards the cell 
debris was removed by centrifugation for 20 min at 50.000 x g. The resulting supernatant was used 
for further analysis. 
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Tris buffer:    100 mM Tris/HCl, pH 7.8 
     20 % (v/v) Glycerol 
 
Sodium phosphate buffer:  10 mM  Sodium phosphate, pH 8.0 
     14 mM  MgAc 
     60 mM  KAc 
     0.1 mM  DTT 
2.3.8 Purification of recombinant expressed proteins 
2.3.8.1 ImmobilizedMetal Ion Affinity Chromatography IMAC 
For the purification of recombinant proteins which have a polyhistidine sequence at the N- or C-
terminal end the immobilized metal ion affinity chromatography (IMAC) is used. In this 
chromatographic separation method the matrix of the column consists of immobilized metal ion 
groups, such as nickel, copper or cobalt. The polyhistidine residues of the recombinant proteins bind 
on the immobilized metal ions. Proteins can be eluted from the column by imidazole which replaces 
the polyhistidine residues at the metal ions. 
For the IMAC a cell culture was harvested and lysed as described in 2.3.6 and 2.3.7. Afterwards the 
supernatant was applied to a 1 ml-HisTrap™ HP-column (GE Healthcare, Munich, Germany) which 
was connected to an ÄKTAprime™ plus system (GE Healthcare, Munich, Germany). The column was 
washed with 10-20 ml of binding buffer. Then unspecific bound proteins were eluted with 10-20 ml 
of 5 % (v/v) elution buffer. Finally protein was eluted from the column with a gradient from 5 %-
100 % elution buffer within 20 min and a flow rate of 1 ml/min. Meanwhile 2 ml fractions were 
collected. 
 
Binding buffer:    50 mM  Sodium phosphate, pH 8.0 
1 M  NaCl 
500 mM  Urea 
 
Elution buffer:    50 mM  Sodium phosphate, pH 8.0 
     1 M  NaCl 
     500 mM Urea 
     300 mM Imidazole 
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2.3.9  Sodium Dodecyl Sulfate PolyAcrylamide Gel 
Electrophoresis (SDS-PAGE) 
To verify protein expression in E.coli and purity of recombinant protein SDS-PAGE according to 
Laemmli (Laemmli, 1970)was performed. In this method proteins are separated according to their 
molecular weight. 
For this purpose 30 µl of purified proteins were treated with 30 µl of 2x SDS sample buffer and gently 
mixed. Afterwards the samples were denaturated for 5 min at 95 °C. 
The Laemmli system consists of a separation gel, whose acrylamide concentration depends on the 
desired separation area and of a stacking gel, which overlays the polymerized separation gel. The 
separation gel was poured in unpolymerized condition between two glass plates and was 
immediately overlaid with ethanol. After polymerization of the separation gel the ethanol was 
removed with water from the separation gel surface. Subsequently the stacking gel was poured in 
and the sample comb was inserted. After polymerization the sample comb was removed carefully. 
5-15 µl of the denaturated samples were loaded per well. Gels were run with 30 mA per gel for 1-
1.5 h. Afterwards the SDS-polyacrylamide gels were stained by Coomassie Brilliant Blue G250 and 
destained in destaining solution to decolorize the background of the gel. 
 
Stacking gel (4.8 %):   375 µl  0.5 mM Tris/HCl, pH 6.8; 0.4 % (w/v) 
       SDS 
     240 µl  30 % (w/v) Acrylamide/Bisacrylamide 
     3 µl  25 % (w/v) APS 
     6 µl  TEMED 
     885 µl  ddH2O 
 
Separating gel (10 %):   1 ml  1.5 M Tris/HCl, pH 8.8; 0.4 % (w/v) SDS 
     1.33 ml  30 % (w/v) Acrylamide/Bisacrylamide 
     3.1 µl  25 % (w/v) APS 
     6.1 µl  TEMED 
     1.67 ml  ddH2O 
 
SDS-PAGE buffer:   25 mM  Tris/HCl, pH 8.0 
     20 mM  Glycine 
     0.1 % (w/v) SDS 
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SDS sample buffer (2x):   20 mM  Tris/HCl, pH 6.5 
     4 % (w/v) SDS 
     40 % (v/v) Glycerol 
     10 % (v/v) ß-Mercaptoethanol 
     0.002 % (w/v) Bromophenol blue 
 
Coomassie staining solution:  0.002 % (w/v) Coomassie brilliant Blue R250 
     40 % (v/v) Methanol 
     5 % (v/v) Acetic acid 
 
Destaining solution:   30 % (v/v) Ethanol 
     5 % (v/v) Acetic acid 
     65 % (v/v) ddH2O 
2.3.10  Substrate preparation and purification 
2.3.10.1 Preparation of 9-hydroperoxy fatty acids 
For the preparation of 9-hydroperoxy fatty acids recombinant StLOX and AtLOX1 were used as 
described before (Stumpe et al., 2006a, Stumpe and Feussner, 2006). 2.5 mg LA was added to a 10 ml 
reaction mix and incubated in open tubes shaking for 30 min at RT. 
For the protonation of the fatty acids 1/10 of volume acetic acid was added. The isolation of the 
hydrophilic substances was done by extraction with diethyl ether. For the separation of the two 
phases the solution was centrifuged for 5 min at 3.220 x g at 4 °C. The upper ether phase was 
removed and transferred into another tube and the extraction step was repeated. The diethyl ether 
was evaporized under streaming nitrogen. Subsequently the product was resolved in methanol, 
vortexed, and transferred into a new tube for storage at -20 °C. 
 
Incubation buffer:   50 mM  Tris/HCl, pH 7.5 
     500 mM NaCl 
     10 % /v/v) Glycerol 
     0.1 % (v/v) Tween 20 
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2.3.10.2 Preparation of 12-hydroperoxy fatty acids 
For the preparation of 12-hydroperoxy fatty acids cell pellets of recombinant PpLOX was 
resuspended in lysis buffer and subsequently digested as described in 2.3.10.1. Then 1 mg ARA was 
added to the supernatant and incubated in open tubes shaking for 30 min at RT. 
The extraction of the hydrophilic substances was performed as described in 2.3.10.1. 
2.3.10.3 Preparation of 13- and 17-hydroperoxy fatty acids 
For the preparation of 13- and 17-hydroperoxy fatty acids 100 mM borate buffer, pH 10.4 was 
incubated with purified recombinant GmLOX1. 2.5 mg α-LeA or 2.5 mg γ-LeA or 2.5 mg LA were 
added for the generation of 13-hydroperoxides, whereas docosahexaenoic acid (DHA) was added for 
17-hydroperoxides. The incubation and extraction was done as described in 2.3.10.1. 
2.3.10.4 Preparation of radio-labeled 9-and 13-hydroperoxy fatty acids 
For the preparation of radio-labeled hydroperoxy fatty acids, [1-14C]-labeled substrates were used 
and prepared similar to the method described above in 2.3.10.1. To ensure high amounts of 
substrates, unlabeled fatty acids were additionally added. 
2.3.10.5 Purification of fatty acid 
It was necessary to purify DHA prior to using it as substrate due to autoperoxidation products. This 
was done by using a high performance liquid chromatography (HPLC). This method is for the 
separation and analysis of liquid mixtures of substances. The separation takes place on a column 
between a stationary and a mobile phase. The stationary phase is a fixed, inert, and highly porous 
column material like silica gel. The mobile phase is the substance which is dissolved in solvent and 
which should be analyzed. The mobile phase is pressed through the column under high pressure. 
Via RP-HPLC (reversed phase) the peroxides can be separated from the fatty acid. By SP-HPLC 
(straight phase) the hydroxides and hydroperoxides as well as their positional isomers can be 
separated(Stumpe et al., 2005). 
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HPLC Parameters: 
RP-HPLC: 
Column: EC 250/4 Nucleosil 120-5 C18 (250 x 4.6 mm, 5 µm particle 
size; Macherey-Nagel, Düren, Germany) 
Eluent:     90 : 10 : 0.1 (v:v:v) Methanol : Water : Acetic acid 
Flow rate:    1 ml/min 
 
SP-HPLC: 
Column: 3 µ LUNA SILICA (50 x 4.6 mm, 3 µm particle size; 
Phenomenex, Aschaffenburg, Germany) 
Eluent: 100 : 1 : 0.02 (v:v:v) n-Hexane : Isopropanol : TFA  
Flow rate: 1 ml/min 
2.3.11  Analyzingenzyme activity 
2.3.11.1 Photometric activity assay 
For the activity analysis it is usefully that the substrates of the CYP74-enzymes, the hydroperoxides 
produced by LOX, possess a conjugated double bound system which absorbs at 234-236 nm and 
therefore can be recorded by a spectrophotometer (Varian, Darmstadt, Germany) under UV light 
(Stumpe et al., 2006b). 
For the analysis a preparation of reaction buffer, substrate, and enzyme was used. First a zero 
adjustment with buffer was done and then the substrate was added. The substrate concentration in 
the reaction mixture was determined. After that the reaction was started by adding the enzyme and 
the absorption curve at 234 nm was recorded. 
The calculation of the substrate concentration was done by using the Lambert-Beer law. For this the 





      
 
  
   
 
The extinction coefficient for hydro(pero)xy fatty acids with a conjugated double bound system is 
23 mM-1cm-1 (= 23 [µmol/ml] -1cm-1) at 234 nm. 
 
Reaction buffer:  50 mM sodium phosphate 
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2.3.12 Determination of protein concentration with Bradford 
The determination of protein concentration was performed with the colorimetric method of 
Bradford (Bradford, 1976). This method is based on the fact that the color brilliant blue G250 shifts 
its absorption maximum from 465 nm to 595 nm in the presence of proteins. 
For the measurement 1 ml Bradford solution and 20 µl protein were incubated for 5 min at RT. The 
absorption was measured with a spectrophotometer (Varian, Darmstadt, Germany) at 595 nm. As 
blank 1 ml Bradford solution with 20 µl buffer was used. 
 
Bradford solution:   425 ml  Water 
     50 ml  Phosphoric acid (85 %, v/v) 
     25 ml  EtOH (96 %, v/v) 
     35 mg  Serva blue G 
     filled up with ddH2O to 1 L 
2.3.13 Analysis of products 
2.3.13.1 RP-HPLC 
For the RP-HPLC analysis samples were evaporated and then dissolved in 80 µl RP-solvent 
(Acetonitrile : Water : Acetic acid 50 : 50 : 0.1, v/v/v). The signals of the products were detected by a 
diode array detector (DAD). 
Table 2.3: Flow diagram for the RP-HPLC separation. 
time [min] % eluent B flow [ml/min] 
0 0 0.2 
25 100 0.2 
30 100 0.2 
32 0 0.2 
35 0 0.2 
 
2.3.13.2 Radio-HPLC 
The radio-RP-HPLC uses additionally to the diode array detector a scintillation detector which detects 
the radioactive radiation. As substrates [1-14C]-labeled hydroperoxides derived from LA and LeA was 
used (2.3.10.4). 
The enzymatic conversions were typically performed in 1 ml 100 mM sodium phosphate buffer, 
pH 6.0 at RT under constant shaking for 30 min. After the incubation remaining substrate and 
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products were extracted twice with 500 µl diethyl ether. The diethyl ether phase was evaporated 
under nitrogen, the residue was resolved in 100 µl methanol and evaporated again under nitrogen 
prior dissolving in 80 µl Acetonitrile : Water : Acetic acid (50 : 50 : 0.1). Samples were then analyzed 




Column: LiChroCART®125-4 LiChrospher®100-RP-18EC (5 µm particle 
size; Merck, Darmstadt, Germany) 
Eluent:     A: 50 : 50 : 0.1 (v:v:v) Acetonitrile : Water : Acetic acid 
     B: 80 : 20 : 0.1 (v:v:v) Acetonitrile : Water : Acetic acid  
Flow rate:    1 ml/min 
Table 2.4: Flow diagram for the radio-RP-HPLC separation. 
time [min] % eluent B flow [ml/min] 
0 0 1 
25 0 1 
26 100 1 
36 100 1 
38 0 1 
 
2.3.13.3 RP-HPLC/MS2 
The coupling of HPLC with mass spectrometry (MS) is described as HPLC/MS2. The separation of the 
sample molecules occurs first by RP-HPLC to which the analysis by mass spectrometry is connected. 
The analytes are transferred and ionized into the vacuum of the mass spectrometer by electrospray 
ionization (ESI). The so formed ions are then analyzed with an ion trap according to their 
mass/charge ratios (m/z). Furthermore it is possible by using an ion trap mass spectrometer that the 
collision induced dissociation fragments the analytes into daughter ion fragments that can be 
analyzed by MS2. 
The enzymatic conversions were performed as described in 2.3.13.2. As substrates unlabeled 
hydroperoxides derived from LA and LeA were used. For the HPLC/MS2 measurements the sample 
were dissolved in 50 µl Acetonitrile : Water : Acetic acid (50 : 50 : 0.1) and analyzed according to 
Brodhun (Brodhun et al., 2009). 
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HPLC Parameters: 
Device: Surveyor HPLC System (Thermo Finnigan, San Jose, CA, USA) 
Column: EC 250/2 Nucleosil 100-5 C-18 (250 x 2.1 mm, 5 µm particle size; 
Macherey-Nagel, Düren, Germany) 
Running time:   45 min 
Eluent:    A: 40 : 60 : 0.1 (v:v:v:) Acetonitrile : Water : Acetic acid 
    B: 100 : 0.1 (v:v) Acetonitrile : Acetic acid 
 
Mass spectrometry parameters: 
Device: LCQ ion trap mass spectrometer (Thermo Finnigan, San Jose, 
CA, USA) 
Ionization:    negative ESI 
Source voltage/collision energy  4 kV/1 V 
Capillary tension and temperature: 27 V and 300 °C 
Mass range:    m/z 50-450 
Table 2.5: Flow diagram for the RP-HPLC/MS
2
 separation. 
time [min] A % B % flow [ml/min] 
0 80 20 0.2 
10 80 20 0.2 
30 0 100 0.2 
35 0 100 0.3 
40 0 100 0.3 
44.5 80 20 0.3 
45 80 20 0.2 
 100 0 0.2 
 
2.3.14 Biochemical characterization 
2.3.14.1 Determination of pH optimum 
For the determination of the pH optimum of the investigated enzymes, the conversion of the 
substrate 13-HPOD to the corresponding products was measured by recording the decrease in 
absorbance at 234 nm with a CARY 100 Bio UV/vis spectrophotometer (Varian, Darmstadt, Germany). 
The reaction and analysis was carried out using various buffers with defined pH (see Table 2.6 and 
Table 2.7) with 30 µM substrate solution and 0.1 nM (PpAOS1) or 1 nM (BfEAS) of enzyme. 
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Table 2.6: Range pH and buffer used for measurements of PpAOS1. 
buffer pH range 
Acetate 4.7-5.5 
Phosphate 5.5-8.0 
Boric Acid-Borax 8.0-10.5 
 
Table 2.7: Range pH and buffer used for measurements of BfEAS. 






2.3.15 Spectroscopic analysis 
2.3.15.1 UV/vis spectroscopy 
UV/vis spectra were performed in 50 mM sodium phosphate buffer, pH 8.0 (PpHPL and BfEAS) or in 
100 mM sodium phosphate buffer, pH 6.0 (PpAOS1 and PpAOS2) at RT in the range of 650 nm to 
250 nm. It was measured with a Varian Cary 100 Bio UV/vis Spectrophotometer (Varian Inc., Palo 
Alto, CA, USA). 
2.3.15.2 CircularDichroism (CD) spectroscopy 
With the CD spectroscopy method the optical activity of chiral molecules in solution can be analyzed. 
The CD spectra shows how circularly polarized light can be absorbed by optically active substances. 
Therefore information about the native folding of a protein can be obtained. 
CD spectra were performed in 50 mM or 100 mM sodium phosphate buffer, pH 8.0 in the range of 
260 nm to 190 nm on a Chirascan™ CD Spectrometer (Applied Photophyscics Ltd., Leatherhead, 
United Kingdom). 
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3 Results 
The aim of the study was the biochemical characterization of the CYP74-enzymes in the moss 
Physcomitrella patens. P. patens is a model organism and a special feature of the moss is that it 
contains additionally to the C18 fatty acids LA and LeA a large amount of the C20 fatty acids ARA and 
EPA (Dembitsky, 1993, Girke et al., 1998) which can also be used as substrates for the oxylipin 
biosynthesis (Wichard et al., 2005). 
In addition to gather insights into CYP74-catalysis and to identify factors determining product 
specificity the EAS of the lancelet Branchiostoma floridae was also characterized. B. floridae contains 
various fatty acids as potential precursors of EAS substrates. Beside the C18 fatty acids it contains the 
C22 fatty acid docosahexaenoic acid (Lee et al., 2008). 
For characterization substrate specificity against hydroperoxides derived from C18- and C22 fatty acids 
were determined. Spectral analysis, pH optima as well kinetic parameters for different substrates 
were determined. Product formation was analyzed by radio-HPLC and RP-HPLC/MS2. Additionally 
site-directed mutagenesis was carried out in order to identify amino acid residues that are essential 
for a distinctive EAS activity. 
In order to compare the CYP74-enzyme EAS with the CYP74-enzymes from Physcomitrella the 
substrate specificity against the hydroperoxides from the C18 fatty acids LA, α-LeA, and γ-LeA, and the 
C20 fatty acid ARA were determined. Furthermore spectral analysis, the pH optima as well the kinetic 
parameters KM and Vmax for the different substrates were determined. The formed products were 
analyzed by radio-HPLC. Also site-directed mutagenesis was carried out and analyzed. 
3.1 Biochemical characterization of CYP74-enzymes from 
P. patens 
3.1.1 Cloning and expression 
The plasmids have previously been constructed as part of former studies (Table 3.1).The two AOS 
genes as well as the two DES genes were cloned with N-terminal hexahistidine peptide, whereas the 
HPL was cloned with a C-terminal hexahistidine peptide. In PpHPL the chloroplastidial signal peptide 
was cut off by truncation of 42 amino acids at the N-terminal. Than an additionally amino acid 
sequence, MAKKTSS (methionine-alanine-lysine-lysine-threonine-serine-serine) was added at the N-
terminal to improve the solubility and the amount of protein. This additional sequence was 
successfully used before for the purification of AtAOS (Lee et al., 2008). 
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Table 3.1: Expression vectors used in this study. 
cDNA vector N- or C-terminal amino acid sequence 
PpAOS1* pQE30 MRGSHHHHHHGSACM 




StDES* pQE30 MRGSHHHHHHGSM 
AsDES* pQE30 MRGSHHHHHHGSM 
*cloned by Dr. Michael Stumpe   
#
cloned by Dr. Ellen Hornung 
The transitions between the C- or N-terminal His-tag and the protein were underlined. 
The genes were amplified by PCR and expressed in the E. coli strain BL21 Star (2.3.1 and 2.3.6). 
Because CYP74-enzymes are heme containing enzymes, 80 mg/L δ-amino levulinoic acid and 150 µM 
0.1 mM ammonium ferric citrate as cofactors were added. The amino levulinoic acid is a precursor in 
the heme biosynthesis-pathway and the ferric citrate serves as iron source for the heme. 
3.1.2 Purification 
The purification of the His-tagged proteins was done according to a previously established 
purification protocol (diploma thesis Scholz, 2009). Cells were prepared according to the membrane 
preparation method reported by Richardson (Richardson et al., 1993) which is used for the isolation 
of P450-enzymes from membranes with some minor modifications (2.3.7). After membrane 
preparation the protein was purified by affinity chromatography. 
Proteins were loaded onto a 1 ml His-trap column and then washed with 20 volumes of binding 
buffer. Non- and unspecifically bound proteins were washed from the column with 20 volumes of 
elution buffer containing 15 mM imidazole. Finally the bound protein was directly eluted with 
300 mM imidazole. Collected fractions were tested for activity (2.3.11.1) and analyzed by SDS-PAGE 
(2.3.9). Figure 3.1 shows the SDS-PAGE of the purification of PpAOS1. The fractions of the eluted 
protein showed a significant enrichment, but were not very pure, because they still showed in 
addition to the strong PpAOS1 band at 55 kDa also further protein bands at 30 kDa, 50 kDa, 66 kDa, 
95 kDa and 105 kDa. 
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Figure 3.1: SDS-PAGE analysis of PpAOS1purification by stepwise elution. PpAOS1 was heterologously 
expressed in BL21 Star. The cells were harvested and disrupted by sonification and the cell debris was removed 
by centrifugation. The purification was done by Ni
2+
-affinity chromatography. First the column was washed 
with binding buffer (50 mM sodium phosphate, pH 8.0, 1 M NaCl, 500 mM urea) and then with buffer which 
contains additionally 15 mM imidazole. The protein was directly eluted from the column with 300 mM 
imidazole. Aliquots of collected fractions of the purification were loaded on a 10 % SDS-PAGE gel. The figure is 
representative for at least three purifications. 
In this work further modifications were done in order to optimize the purification procedure: e. g. the 
elution of the protein was performed by employing a linear gradient with an increasing imidazole 
concentration (15 mM to 300 mM) to elute unspecifically bound proteins. The SDS-PAGE for the 
PpAOS1 purification using this gradient (Figure 3.2) showed that the eluted protein was more 
homogenous after these modifications. Thus the gradual elution led to an optimized purification of 
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Figure 3.2: SDS-PAGE analysis of PpAOS1purification by gradual elution. PpAOS1 was heterologously expressed 
in BL21 Star. The cells were harvested and disrupted by sonification and the cell debris was removed by 
centrifugation. The purification was done by Ni
2+
-affinity chromatography. First the column was washed with 
binding buffer (50 mM sodium phosphate, pH 8.0, 1 M NaCl, 500 mM urea) and then with buffer which 
contains additionally 15 mM imidazole. The protein was eluted from the column by a linear gradient with an 
increasing imidazole concentration (15 mM to 300 mM). Aliquots of collected fractions of the purification were 
loaded on a 10 % SDS-PAGE gel. The figure is representative for at least three purifications. 
In Figure 3.3 the SDS-PAGE analyses of the purification of PpHPL (A and B) and PpAOS2 (C) by 
stepwise elution (A) and by gradual elution (B and C) are shown. Both enzymes were also purified 
more homogenous by elution with an imidazole gradient than by stepwise elution with imidazole. 
By using these modified purification procedures it was possible to obtain approx. between 5-15 mg 
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Figure 3.3: SDS-PAGE analysis of PpHPL (A, B) and PpAOS2 (C) purification.The enzymes were heterologously 
expressed in BL21 Star. The cells were harvested and disrupted by sonification and the cell debris were 
removed by centrifugation. The purification was done by Ni
2+
-affinity chromatography. First the column was 
washed with binding buffer (50 mM sodium phosphate, pH 8.0, 1 M NaCl, 500 mM urea) and then with buffer 
which contains additionally 15 mM imidazole. The protein was directly eluted from the column with 300 mM 
imidazole (A) or it was eluted by a linear gradient with an increasing imidazole concentration (15 mM to 
300 mM) (B, C). Aliquots of collected fractions of the purification were loaded on a 10 % SDS-PAGE gel.The 
figure is representative for at least three purifications. 
By size exclusion chromatography the native molecular weight of the proteins can be determined. In 
this method the proteins were separated according to their size. The protein mix interacts with the 
dextrane matrix of the column, whereas the smaller molecules can be retained longer by the matrix 
than the bigger ones. 
SDS-PAGE analysis of PpHPL showed a molecular weight of 57 kDa (Figure 3.3 A and B) and the 
theoretical calculated mass was of 57 kDa. Analysis by size exclusion chromatography (data not 
shown) showed that PpHPL has under the conditions applied a native molecular weight of 113 kDa 
and was therefore 2-fold higher than the theoretical calculated weight suggesting that PpHPL is a 
homodimeric protein complex. 
PpAOS1 (Figure 3.2) and PpAOS2 (Figure 3.3C) showed on SDS-PAGE analysis molecular weights of 
55 kDa which is in agreement with the theoretical calculated masses of 55 kDa. The analysis by size 
exclusion chromatography showed a native molecular weight of 40 kDa for PpAOS1 which was 
similar to the theoretical mass and therefore PpAOS1 is a monomer (data not shown). The native 
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weight of PpAOS2 was determined to be 240 kDa and therefore about 4.5-fold higher than the 
theoretical weight indicating that PpAOS2 might be a tetrameric or pentameric protein complex. 
3.1.3 Spectroscopic analysis 
3.1.3.1 UV/vis analysis 
The protein fractions obtained by affinity chromatography showed reddish (PpHPL and PpAOS1) and 
yellowish (PpAOS2) colours, which indicated the presence of a heme cofactor. To prove and 
determine the heme content UV/vis spectra of the purified enzymes were recorded in 50 mM 
sodium phosphate buffer, pH 8.0 (PpHPL) and in 100 mM sodium phosphate buffer, pH 6.0 (PpAOS1 
and PpAOS2), respectively, at RT in the range of 650 nm to 250 nm (2.3.15.1). 
Heme containing proteins absorb in visible light and have characteristic absorption maxima 
(Lottspeich, 2006). The UV/vis spectrum of PpAOS1 in Figure 3.4 A showed these characteristic 
maxima. The Soret-band had an absorption maximum at 415 nm. Further maxima were at 280 nm (γ-
band) and 535 nm (β-band). 
The spectrum of PpAOS2 (Figure 3.4 B) is similar to that of PpAOS1 with a Soret-band at 411 nm, γ-
band at 280 nm, and the β-band at 529 nm. 
PpHPL (Figure 3.4 C) showed absorption maxima at 415 nm (Soret-band) and 280 nm (γ-band), and 
smaller maxima at 540 nm (β-band), 360 nm (δ-band), and 570 nm (α-band). 
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Figure 3.4: UV/vis spectra of purified PpAOS1 (A), PpAOS2 (B) and PpHPL (C). They were measuredin 
100 mMsodium phosphate buffer, pH 6.0 (A and B) or 50 mMsodium phosphate buffer, pH 8.0 (C), respectively. 
Note that spectrum A and B were adapted from a former study (diploma thesis Scholz, 2009) and are shown for 
reasons of comparison.The spectra are representative for at least two experiments. 
The heme content of those enzymes varies significantly: Based on theoretical molar extinction 
coefficients (calculated with the Protparam-software tool (http://web.expasy.org/protparam/)) at 
280 nm (ε280(PpAOS1) ≈ 62.000 M
-1 cm-1 and ε280(PpAOS2) ≈ 57.000 M
-1 cm-1) and an excepted molar 
extinction coefficient for the Soret-band of εsoret≈ 100.000 M
-1 cm-1, the calculated heme content of 
PpAOS1 is of approx. 30 % and of PpAOS2 only 4 %. PpHPL (ε280(PpHPL) ≈ 71.000 M
-1 cm-1) had a 
calculated heme content of 46 %. 
All spectra did not show signals at 630 nm, which are characteristic for high-spin iron-III-complexes. 
Therefore the hemeiron in the active site is apparently in its low-spin state, which is characteristic for 
P450 ezymes. 
3.1.3.2 CD spectroscopy 
To analyze the native protein folding of the proteins CD spectra were measured. The spectra were 
recorded in 50 mM or 100 mM sodium phosphate buffer, pH 8.0, respectively, in the range of 260 nm 
to 190 nm (2.3.15.2). In Figure 3.5 the spectrum of purified PpHPL is shown, there were negative 
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peaks at 215 nm and 220 nm, and a positive peak at 195 nm. These peaks are typical for proteins 
with a mainly α-helical fold (Panagakou et al., 2012). 
 
Figure 3.5: CD spectrum of purified PpHPL. It was measured in 100 mM sodium phosphate buffer, pH 8.0, on a 
Chirascan™ CD Spectrometer (Applied Photophysics Ltd., Leatherhead, United Kingdom). The spectrum was 
recorded in the range of 260 nm to 190 nm.The figure shows the spectrum of oneexperiment. 
PpAOS1 showed negative peaks at 215 nm and 222 nm, and a positive peak at 193 nm (Figure 3.6). 
 
Figure 3.6: CD spectrum of purified PpAOS1. It was measured in 50 mM sodium phosphate buffer, pH 8.0 on a 
Chirascan™ CD Spectrometer (Applied Photophysics Ltd., Leatherhead, United Kingdom). The spectrum was 
recorded in the range of 260 nm to 190 nm.The figure shows the spectrum of one experiment. 
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3.1.4 Analysis of products 
3.1.4.1 Radio-HPLC 
Reaction products formed by incubations of different [1-14C]-hydroperoxy fatty acid derivatives with 
PpAOS1, PpAOS2 and PpHPL were analyzed by means of radio-HPLC. In this method the different 
products were separated via RP-HPLC (2.3.13.1) and detected by using a scintillation detector which 
was connected to the chromatographic system. The enzymatic conversions were performed with 
purified PpAOS1 and PpHPL with 9- and 13-hydroperoxides derived from [1-14C]-labeled LA and α-LeA 
as substrates (2.3.10.4). The reaction mix was incubated and the products were extracted with 
diethyl ether as described (2.3.13). 
Exemplarily shown in Figure 3.7 are the radio-RP-HPLC analyses of products formed by incubation of 
PpAOS1 and PpHPL, respectively, with 9-HPOD. In analogy, the respective analysis of products 
formed from incubation of 13-HPOT with PpAOS1 and PpHPL is exemplarily shown in Figure 3.8. 
The reaction of PpAOS1 with [1-14C]-labeled 9-HPOD led to the formation of various products. These 
products were identified as α- (RT 7.5 min; main product) and γ-ketol (RT 5 min), and as 9-oxo 
nonanoic acid (RT 2 min). The ketols arise from the non-enzymatically hydrolysis of the unstable 
allene oxide. The detected 9-oxo nonanoic acid is a distinctive HPLproduct. The main product of the 
conversion of 9-HPOD by PpHPL was 9-oxo nonanoic (RT 2 min) but also different side products as α- 
and γ-ketols (RT 7.5 min and RT 5 min) were formed. As control buffer was incubated with substrate. 
The chromatograms for the conversions of 9α-HPOT (see appendixFigure 9.1 A) were similar to that 
of 9-HPOD. 
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Figure 3.7: Product analysis of PpAOS1 and PpHPL with [1-
14
C]-9-HPOD. The purified enzymes as well as only 
buffer (control) were incubated with the radio-labeled substrate for approx. 30 min at RT. After extraction with 
diethyl ether the products were analyzed by RP-HPLC coupled to a radio-detector. The chromatograms are 
representative for three experiments. 
In Figure 3.8 the chromatograms for the reactions of radio-labeled 13α-HPOT are shown. The 
conversion of 13α-HPOT by PpHPL yielded (9Z)-12-oxo-9-dodecenoic acid (RT 2.5 min) as main 
product. As for the conversion of the respective 9-hydroperoxy fatty acids also incubation of PpAOS1 
with 13α-HPOT yielded a considerable amount of this HPLproduct. However, the main product was 
α-ketol (RT 5.5 min). In addition small amounts of the respective γ-ketol (RT 3.5 min) and 
cyclopentenone (RT 7.5 min) derivatives were detected. The latter product is known to arise from the 
non-enzymatical cyclization of the allene oxide (Hamberg et al., 1988). The peak at about 11 min 
could not be identified. The reactions of PpHPL with 13-HPOD as substrate (see appendix Figure 9.1B) 
gave a similar product pattern as observed with 13α-HPOT as substrate. 
The occurrences of both catalytic activities were consistent with a close interconnection of the 
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Figure 3.8: Product analysis of PpAOS1 and PpHPL with [1-
14
C]-13α-HPOT. The purified enzymes as well as only 
buffer (control) were incubated with the radio-labeled substrate for approx. 30 min at RT. After extraction with 
diethyl ether the products were analyzed by RP-HPLC coupled to a radio-detector. The chromatograms are 
representative for five experiments. 
Table 3.2 gives a semi quantitative summary of the products formed by incubations of PpAOS1 and 
PpHPL with radio-labeled 9- and 13-hydroperoxides derived from LA and α-LeA. 
Table 3.2: Product specificities of PpHPL and PpAOS1. Affinity purified enzymes were incubated with [1-
14
C]-
labeled hydroperoxy fatty acids for approx. 30 min at RT. After extraction with diethyl ether the isolated 
products were analyzed by RP-HPLC that was coupled to a radio-detectorand quantified by integration of the 
respective peak area. The relative amounts of each product is indicated by the number of “+”. 
substrate enzyme 
ω-oxo fatty acids 
(= HPL activity) 
ketols 
(= AOS activity) 
cyclopentenone 
(= AO cyclization) 
9-HPOD HPL ++++ + n. d. 
 AOS1 + ++++ n. d. 
9α-HPOT HPL ++++ + n. d. 
 AOS1 + ++++ n. d. 
13-HPOD HPL ++++ + n. d. 
 AOS1 + ++++ n. d. 
13α-HPOT HPL ++++ + n. d. 
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The product analysis of PpAOS1 and PpHPL showed that in both enzymes both catalytic activities 
(AOS and HPL) occurred. This suggests that the branches of both CYP74-enzymes were closely 
interconnected. To analyze if the DES-branch is also closely interconnected to the AOS- and HPL-
branches product analysis of StDES and AsDES were performed. The conversion of [1-14C]-9α-HPOT 
by StDES yielded the divinyl ether colnelenic acid (RT 28 min) as main product. Also some of the 
HPLproduct 9-oxo nonanoic acid (RT 2 min) was detected (Figure 3.9). The reaction of AsDES with 
13α-HPOT yielded etherolenic acid as main substrate and also less amounts of (9Z)-12-oxo-9-
dodecenoic acid as side product (data not shown). Product analysis with 9- and 13-hydroperoxides 
derived from LA was not performed. Product analysis of DES-enzymes showed that the DES-branch is 
also closely interconnected to the HPL-branch, because both enzyme catalytic activities occurred in 
DES. 
 
Figure 3.9: Product analysis of StDES with [1-
14
C]-9α-HPOT. The purified enzyme wasas well as only buffer 
(control) were incubated with the radio-labeled substrate for approx. 30 min at RT. After extraction with 
diethyl ether the products were analyzed by RP-HPLC coupled to a radio-detector. The chromatograms are 
representative for three experiments. 
3.1.4.2 RP-HPLC/MS2 
Next the different products were also analyzed by RP-HPLC/MS2. With the radio-HPLC method the 
different products were solely identified by comparison of the retention times with authentic 
standards. This method is very sensitive and therefore various sideproducts can be detected. RP-
HPLC/MS2 analysis on the other hand gives structural information about the different products. The 
purified enzymes were incubated with hydroperoxides derived from LA and α-LeA, extracted and 
analyzed as described in 2.3.13.3. The products were first separated by RP-HPLC and subsequently 
analyzed by ESI-MS. 
control
StDES
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In the following figures the extracted ion chromatograms and their associated tandem mass spectra 
and potential fragment patterns of products from conversion of PpAOS1 with 13α-HPOT are shown. 
For analysis of the products formed by the incubation of PpAOS1 with fatty acid hydroperoxide the 
respective products were pre-isolated by RP-HPLC/DAD and then analyzed by RP-HPLC/MS2. The 
extracted ion chromatogram (m/z 309) and the associated tandem mass spectrum (Figure 3.10) of 




-analysis of products formed by incubation of PpAOS1 with 13α-HPOT(γ-ketol). 
Shown are the extracted m/z 309ion chromatogram (A) and the associated tandem mass spectrum (B) of 
thecollected γ-ketolfraction of the RP-HPLC/DAD analysis. 
RP-HPLC/MS2 analysis of the collected main product fraction (α-ketol) of the RP-HPLC/DAD analysis 




-analysis of products formed by incubation of PpAOS1 with 13α-HPOT (α-ketol). 
Shown are the extracted m/z 309ion chromatogram (A) and the associated tandem mass spectrum (B) of the 
collectedα-ketolfraction of the RP-HPLC/DAD analysis. 
The m/z 291 chromatogram (A) and the tandem mass spectrum (B) shown in Figure 3.12 confirmed 
the collected cyclopentenone peak of RP-HPLC/DAD analysis as OPDA. 
RT: 0.00 - 44.99 SM: 7B





































































30 #608-816 RT: 8.79-11.55 AV: 105 NL: 2.03E6
F: - c ESI d Full ms2 309.20@40.00 [ 75.00-320.00]















































RT: 0.00 - 44.99 SM: 7B





































































32 #874-1028 RT: 13.16-14.98 AV: 77 NL: 1.61E7
F: - c ESI d Full ms2 309.20@40.00 [ 75.00-320.00]


















































-analysis of products formed by incubation of PpAOS1 with 13α-HPOT 
(cyclopentenone). Shown are the extracted m/z 291 ion chromatogram (A) and the associated tandem mass 
spectrum (B)of the collected cyclopentenonefraction of the RP-HPLC/DAD analysis. 
The analysis of incubation of PpHPL with 13α-HPOT identified collected product fractions from RP-
HPLC/DAD analysis asα- (Figure 3.13 A and B)and γ-ketol (Figure 3.13 C and D). The extracted ion 
chromatograms m/z 309 as well as the tandem mass spectra of the collected products in Figure 
3.13were similar to that of PpAOS1 conversions (Figure 3.10 and Figure 3.11). 
 
33 #1105-1155 RT: 17.45-18.07 AV: 26 NL: 3.27E6
F: - c ESI d Full ms2 291.35@40.00 [ 70.00-305.00]























































RT: 0.00 - 44.99 SM: 7B





















































RT: 0.00 - 45.00 SM: 7B

























































18 #874-935 RT: 13.49-14.54 AV: 29 NL: 3.80E5
F: - c ESI d Full ms2 309.30@40.00 [ 75.00-320.00]


































































RT: 0.00 - 45.00 SM: 7B

























































16 #622-810 RT: 9.00-11.38 AV: 94 NL: 2.38E6
F: - c ESI d Full ms2 309.21@40.00 [ 75.00-320.00]
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Figure 3.13: RP-HPLC/MS
2
-analysis of products formed by incubation of PpHPL with 13α-HPOT (α- and γ-ketol). 
Shown are the extracted ion chromatograms (m/z 309) and the associated tandem mass spectra of the 
collected α- (A and B) and γ-ketol (C and D) fractions from the RP-HPLC/DAD analysis. 
3.1.5 Kinetic analysis 
The moss Physcomitrella patens contains C18- and C20 fatty acids. Analysis of kinetic parameters of 
conversions of PpAOS1 with different fatty acid hydroperoxides derived from LA, α-LeA and ARA 
should determine which substrate is preferred. 
Kinetic measurements were done by photometrically approaches as described in 2.3.11.1. 
3.1.5.1 pH optimum 
The determination of the pH optimum was performed with 0.1 nM PpAOS1 and 30 µM 13-HPOD as 
described in 2.3.14.1. Therefore the initial velocity for the conversion of the fatty acid hydroperoxide 
at 234 nm was measured in different buffers. An acetate buffer was used for the pH range 4.7 to 5.5 
and a phosphate buffer for the range from 5.5 to 8.0. 
In Figure 3.14 the initial velocity in dependence on different pH values is shown. The optimal pH for 
PpAOS1 is at pH 6.5. 
 
Figure 3.14: The pH optimum of PpAOS1 with 13-HPOD. Measurements of the initial velocity in dependence of 
different pH values were carried out with 0.1 nM PpAOS1 and 30 µM of 13-HPOD at RT.Each data point 
represents the mean value of three measurements. 
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3.1.5.2 Kinetic parameters 
For the determination of the various specificities of PpAOS1 for different substrates the kinetic 
parameters were measured. Based on the kinetic parameters the different specificities of PpAOS1 
and PpAOS2 can be elucidated and compared. Therefore the kinetic parameters KM and Vmax for the 
reaction of PpAOS1 with various hydroperoxides were determined by measuring the initial time-
dependent substrate consumption at 234 nm at different substrate concentrations (2.3.11.1). The 
reactions were performed in sodium phosphate buffer (50 mM, pH 8.0) at RT and were started by 
the addition of PpAOS1. 9- and 13-hydroperoxides derivatives of LA, α-LeA, and γ-LeA, and 12-
hydroperoxide derivative of ARA were used as substrates. For the measurements of 9- and 13-HPOD, 
9α- and 13α-HPOT, and 12-HPETE 0.1 nM PpAOS1 and for the measurements of 9γ- and 13γ-HPOT 
0.05 nM PpAOS1 was added. In Figure 3.15 the Michaelis-Menten diagram for the reactions of 
PpAOS1 with 9- and 13-hydroperoxides derived from the above mentioned C18 fatty acid are shown. 
It should be noted at this point, that substrate concentration higher than 100 µM resulted in an 
absorption approaching the saturation of the photometer. In order to circumvent this problem the 
maximal substrate concentration used in standard experiments (with substrates yielding 
KM < 100 µM) was 100 µM. However,for some substrates, yielding KM > 100 µM, the maximal 
substrate concentration was 150 µM. Although this value gives an absorbance higher than the 
detection limit, it was possible to derive reasonable data from these experiments, since, due to the 
experimental setup and the resulting dead-time, the substrate was already consumed to some 
extend when we started to record the absorption after enzyme addition. This normally results in 
“starting- absorbance” below 3 AU. 
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Figure 3.15: Kinetic analyses of PpAOS1 with different hydroperoxides from C18 fatty acids as substrates. The 
reactions wereperformed in 50 mM sodium phosphate buffer, pH 8.0 at RT and started by addition of 0.1 nM 
(A, B, C, D) or 0.05 nM (E, F) PpAOS1. The initial time-dependent changes at 234 nm were measured. A-F shows 
Michaelis-Menten diagrams for the conversions of PpAOS1 with A: 9-HPOD, B:13-HPOD, C: 9α-HPOT, D: 13α-
HPOT,E: 9γ-HPOT and F: 13γ-HPOT.For each data point the substrate concentration was measured again. 
Figure 3.16 shows the Michaelis-Menten diagram for the reaction of PpAOS1 with the C20 fatty acid 
derived hydroperoxide 12-HPETE. 
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Figure 3.16: Kinetic analysis of PpAOS1 with 12-HPETE. The Michaelis-Menten diagram is shown. The reaction 
was performed in 50 mM sodium phosphate buffer, pH 8.0 at RT and was started by addition of 0.1 nm 
PpAOS1.The initial time-dependent changes at 234 nm were measured. For each data point the substrate 
concentration was measured again. 
The measured data points were plotted to the Michaelis-Menten equation and the derived 
parameters are summarized in Table 3.3. The values for kcat were calculated by considering heme 
occupancy of approx. 30 %. The values for kcat/KM show that the PpAOS1 isomerized both 9- and 13-
hydroperoxides derived from LA, α-LeA, and γ-LeA with a similar specificity as 12-HPETE. 
Table 3.3: Kineticparameters for the reaction of PpAOS1 with different hydroperoxides from C18- and C20 fatty 
acids. The kinetic parameters were determined by measuring the initial time-dependent substrate 
consumption at 234 nm at different substrate concentrations. For analysis between 20 and 30 data points were 
fitted to the Michaelis-Menten equation. The concentration of PpAOS1 was 0.1 nM except for the 
measurements of 9γ- and 13γ-HPOT (0.05 nM). The values for kcat were calculated by considering heme 









[min-1 M-1 x 106] 
9-HPOD 121 +/- 61 0.98 +/- 0.29 32680 270 
9α-HPOT 39 +/- 14 0.20 +/- 0.03 6706 172 
9γ-HPOT 46 +/- 17 2.35 +/- 0.37 156733 3426 
13-HPOD 83 +/- 42 0.96 +/- 0.27 31856 384 
13α-HPOT 95 +/- 27 0.90 +/- 0.16 30070 316 
13γ-HPOT 107 +/- 57 2.77 +/- 0.88 184500 1731 
12-HPETE 7 +/- 2 0.23 +/- 0.02 7657 1176 
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3.1.6 Site-directed mutagenesis 
To investigate if the site-directed mutagenesis-concept reported before for AtAOS (Lee et al., 2008) 
can be applied to PpAOS and PpHPL different variants were generated. Determinants were chosen 
which were essential for the alteration of the enzyme activity as it was shown for AtAOS. Whereas 
the AtAOS showed specificity for 13-hydroperoxides (Lee et al., 2008), the PpAOS1 and PpHPL were 
unspecific enzymes. 
 
Figure 3.17: Partial multiple sequence alignment of different CYP74-enzymes from different plant species and 
marine invertebrates. Allium sativum (As); Arabidopsis thaliana (At); Branchiostoma floridae (Bf); Lycopersicum 
esculentum (Le); Parthenium argentatum (Pa); Physcomitrella patens (Pp); Solanum tuberosum (St); AtAOS, 
CAA63266; AsDES, AJ867809; AtHPL, AAC69871; BfEAS, EU555186; BfEAS_1, XP2601390; BfEAS_2, XP2602690; 
LeAOS3, AAN76867; LeHPL, AAF67142; PaAOS, CAA55025; PpAOS1,CAC86919; PpAOS2, XP_001759629; PpHPL, 
CAC86920; StDES, CAC28152. The highly conserved residues are in grey brackets. Amino acid positions used for 
site-directed mutagenesis in this study are marked in bold letters. 
Sequence alignments in Figure 3.17 showed that particular amino acid-residues which have been 
shown to be important for the product specificity in AtAOS are also conserved in PpAOS1 and 
PpAOS2. Thus both AOS isozymes contain a strictly conserved phenylalanine (F) at position 93 which 
is an essential residue for the AOS activity (Lee et al., 2008). It is suggested that this F-residue 
stabilizes an intermediately formed carbon-centered substrate radical. The essential residue at this 
position in HPL is a leucine (L), which cannot stabilize reactive product intermediates and leads 
therefore to the formation of an unstable hemiacetal, which decomposes spontaneously to short 
chain aldehydes (Grechkin and Hamberg, 2004). 
Interestingly, sequence alignments showed, that in PpHPL an AOS-specific F-residue instead of that 
for HPL characteristic L can be found at this particular position (F151; PpHPL numbering). To analyze 
the product activity and the importance of this residue the F was substituted by L (PpHPL_F151L) 
(Lee et al., 2008).Additionally the PpAOS1_F93L variant was generated. 
At position 111 a conserved AOS-specific serine (S) in PpAOS1 is located, which was substituted by an 
HPL-specific alanine (A) (PpAOS1_S111A). Additionally in HPL the PpHPL_A169S variant was 
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Figure 3.18: Partial multiple sequence alignment of different CYP74-enzymes from different plant species and 
marine invertebrates. Allium sativum (As); Arabidopsis thaliana (At); Branchiostoma floridae (Bf); Lycopersicum 
esculentum (Le); Parthenium argentatum (Pa); Physcomitrella patens (Pp); Solanum tuberosum (St); AtAOS, 
CAA63266; AsDES, AJ867809; AtHPL, AAC69871; BfEAS, EU555186; BfEAS_1, XP2601390; BfEAS_2, XP2602690; 
LeAOS3, AAN76867; LeHPL, AAF67142; PaAOS, CAA55025; PpAOS1,CAC86919;PpAOS2, XP_001759629; PpHPL, 
CAC86920; StDES, CAC28152. The highly conserved residues are in grey brackets. Amino acid positions used for 
site-directed mutagenesis in this study are marked in bold letters. 
For tomato AOS was reported that there is a further F (LeAOS3_F295) which is strictly conserved in 
AOS and HPL (Toporkova et al., 2008). In PpHPL is at this position an AOS-specific F instead of that 
HPL-specific L (Figure 3.18). Therefore the PpHPL_L336F variant was generated. For LeAOS3 was also 
reported that the variant with substitution of lysine (K) by S (LeAOS3_K302S) has AOS- and 
HPLactivities (Toporkova et al., 2010). In PpAOS1 S is at this position and in PpHPL cysteine (C). In 
both enzymes the residues were substituted by K (PpAOS1_S287K and PpHPL_C343K). 
Site-directed mutagenesis of strictly conserved asparagine (N) by a glutamine (Q) in AtAOS 
(AtAOS_N321Q) showed abolish enzyme activity (Lee et al., 2008). In PpAOS1 and PpHPL these 
residues were substituted (PpAOS1_N281Q and PpHPL_N337Q). 
3.1.6.1 Spectroscopic analysis 
3.1.6.1.1 UV/vis analysis 
In order to investigate if the site-directed mutations effect protein folding and cofactor incubation, 
the purified variants were analyzed via UV/vis and CD spectroscopy (2.3.15). 
In Figure 3.19 the UV/vis spectra of PpHPL variants F151L (A), A169S (B), and F151L, A169S (C) are 
shown. The spectra of the various PpHPL variants were similar to the spectrum of the wild type 
(Figure 3.19 D). PpHPL_F151L (Figure 3.19 A) had absorption maxima at 415 nm (Soret-band), 570 nm 
(α-band), 540 nm (β-), 280 nm (γ-band), and 350 nm (δ-band). The maxima of PpHPL_A169S (Figure 
3.19 B) were at 414 nm (Soret-band), 570 nm (α-band), 531 nm (β-), 278 nm (γ-band), and 350 nm (δ-
band). The Soret-band of the PpHPL double-mutant_F151L, A169S (Figure 3.19 C) was shifted to an 
absorption maximum at 421 nm, the α-band was at 570 nm,β-band at 540 nm, γ-band at279 nm, and 
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Figure 3.19: UV/vis spectra of purified PpHPL_F151L (A), PpHPL_A169S (B), and PpHPL_F151L, A169S (C) in 
comparison to the wild type (D). They were measured in 50 mM sodium phosphate buffer, pH 8.0.The spectra 
are representative for one to three experiments. 
The calculated heme content for the wild type was of 46 %. The heme content of PpHPL_F151L is of 
about 45 % and therefore like the content of wild type. Whereas the heme content of the two other 
variants is slightly lower. PpHPL_A169S has a heme content of 31 % and the double variant 
PpHPL_F151L, A169S of 37 %. 
3.1.6.1.2 CD spectroscopy 
For the analysis of the native protein folding of the variants CD spectra were measured in a range of 
260 nm to 190 nm (Figure 3.20). The spectra of PpHPL_A169S (A) and PpHPL_F151L, A169S (B) were 
similar to that of the wild type (C). Both variants had also the negative peaks at 215 nm and 220 nm 
and the positive peak at 193 nm which are typical for proteins consisting of α-helix (Panagakou et al., 
2012). 
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Figure 3.20: CD sepcra of purified variants from PpHPL in comparison to the wild type. They were measured in 
50 mM sodium phosphate buffer, pH 8.0 on a Chirascan™ CD Spectrometer (Applied Photophysics Ltd., 
Leatherhead, United Kingdom). The spectra were recorded in the range of 260 nm to 190 nm. A: PpHPL_A169S, 
B: PpHPL_F151L, A169S, and C: PpHPL wild type.The figure shows the spectra of oneexperiment. 
Therefore these measurements showed that the single amino acid exchanges had no impact on the 
folding of the proteins. 
3.1.6.2 Analysis of products 
3.1.6.2.1 Radio-HPLC 
Spectroscopic analysis showed that site-directed mutagenesis had no effect on protein folding. To 
analyze if the substitutions of some amino acid residues can alter enzymeactivity product analysis 
were done. The products of the conversions of PpAOS1 variants and PpHPL variants with radio-
labeled 9- and 13-hydroperoxides were analyzed by radio-HPLC. The conversions were performed as 
described in 2.3.13.2. 
In Figure 3.21 the product analysis for the variant PpAOS1_F93L with 9-HPOD is exemplarily shown. 
For comparison the analysis of incubations with PpAOS1 wild type and PpHPL wild type are also 
shown in this chromatogram. Incubations with the PpAOS1_F93L variant led to a strong decrease in 
the classical AOS product, the α-ketol-derivative (RT 7.5 min), whereas an increase of the HPLproduct 
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9-oxo nonanoic acid (RT 2 min) occurred. Incubations with 9α-HPOT showed similar product 
formations for the AOS variant (see appendix Figure 9.2A). 
 
Figure 3.21: Product analysis of PpAOS_F93L with [1-
14
C]-9-HPOD in comparison to the PpAOS1 and PpHPL wild 
types. The purified enzymes as well as only buffer (control) were incubated with the radio-labeled substrate for 
30 min at RT. After extraction with diethyl ether the products were analyzed by RP-HPLC coupled to a radio-
detector.The chromatograms shown are representative for two to three experiments. 
The incubation with 13α-HPOT showed also a strong decrease in the AOSproduct, α-ketol-derivative 
(RT 5.5 min), and a light increase of the HPLproduct (RT 2.5 min) (Figure 3.22). 13-HPOD incubations 
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Figure 3.22: Product analysis of PpAOS_F93L with [1-
14
C]-13α-HPOT in comparison to the PpAOS1 and PpHPL 
wild types. The purified enzymes as well as only buffer (control) were incubated with the radio-labeled 
substrate for 30 min at RT. After extraction with diethyl ether the products were analyzed by RP-HPLC coupled 
to a radio-detector.The chromatograms shown are representative for two to five experiments. 
It seems that the F at position 93 (PpAOS1_F93) is an essential determinant for the dehydration of 
both 9- and 13-hydroperoxides. Therefore an appropriate variant for PpHPL was generated 
(PpHPL_F151L). The product analysis of PpHPL_F151L for all 9α-, 13- and 13α-hydroperoxides 
showed no changes in its product formations and was similar to that of wild type. The generated 
PpHPL_A169S variant in which a conserved HPL-specific alanine (A) was substituted by a AOS-specific 
serine (S), which has been reported to determine AOS activity, also did not showed any alterations in 
its product formations. As well the double variant PpHPL_F151L/A169S showed no changes in its 
specificity. The results for the PpHPL variants and the PpAOS1_F93L variant compared to the wild 
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Table 3.4: Product specificities of different PpHPL and PpAOS1 variants. Affinity purified enzymes were 
incubated with [1-
14
C]-labeled hydroperoxy fatty acids for approx. 30 min at RT. After extraction with diethyl 
ether the isolated products were analyzed by RP-HPLC that was coupled to a radio-detector and quantified by 
integration of the respective peak area. The relative amounts of each product is indicated by the number of 
“+”. 
substrate enzyme-variant 
ω-oxo fatty acids 
(=HPL activity) 
ketols 
(= AOS activity) 
cyclopentenone 
(= AO cyclization) 
9-HPOD HPL ++++ + n. d. 
 AOS1 + ++++ n. d. 
 AOS1_F93L ++++ + n. d. 
9α-HPOT HPL ++++ + n. d. 
 HPL_F151L ++++ + n. d. 
 HPL_A169S ++++ + n. d. 
 HPL_F151L/A169S ++++ + n. d. 
 AOS1 + ++++ n. d. 
 AOS1_F93L ++++ - n. d. 
13-HPOD HPL ++++ + n. d. 
 HPL_F151L ++++ + n. d. 
 HPL_A169S ++++ + n. d. 
 HPL_F151L/A169S ++++ + n. d. 
 AOS1 + ++++ n. d. 
 AOS1_F93L ++++ + n. d. 
13α-HPOT HPL ++++ + n. d. 
 HPL_F151L ++++ + n. d. 
 HPL_A169S ++++ + n. d. 
 HPL_F151L/A169S ++++ + n. d. 
 AOS1 + +++ + 
 AOS1_F93L ++ ++ + 
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3.2 Biochemical characterization of BfEAS 
For comparison of catalysis of the different CYP74-enzymes BfEAS from the lancelet B. floridae was 
characterized. 
3.2.1 Cloning and expression 
Codon optimized DNA encoding for the amino acid sequence of BfEAS with a C-terminal 
hexahistidine peptide and an additional amino acid sequence (MAKKTSS) at the N-terminus was 
synthesized.The amino acids transition between the C-terminal His-tag and the protein is 
DLEHHHHHH and between the additional amino acid sequence at the N-terminus and the protein is 
MAKKTSSM. 
Determination of optimal expression conditions was done in E. coli BL21 Star cells. Therefore various 
expression conditions after the induction with 0.1 M IPTG were tested. BfEAS was either incubated at 
11 °C for 1 d, at 16 °C for 3 d or at 28 °C for 1 d. In order to improve EAS expression δ-amino 
levulinoic acid and ammonium ferric citrate as cofactors was added to the cultures. 
In the following figures the SDS-PAGE analyses of purifications of BfEAS expressed in E. coli BL21 Star 
that were grown under the different expression conditions were shown. The SDS-PAGE analyses 
shown in Figure 3.23 illustrates that the cultivations for 1 d at 11 °C (A) and for 1 d at 28 °C (B) led to 
the production of a similar protein amount. 
 
Figure 3.23: SDS-PAGE analyses of BfEASpurified from different E. coli BL21 Star cultivations (11 °C or at 28 °C 
for 1 d). They were cultivated either at 11 °C for 1 d (A, 10 % gel) or at 28 °C for 1 d (B, 8 % gel).Cells were 
harvested and disrupted by sonification. The cell debris was removed by centrifugation. BfEAS was purified by 
Ni
2+
-affinity chromatography and eluted from the column by a linear gradient with an increasing imidazole 
concentration (15 mM to 300 mM).The figure shows the SDS-PAGEsof one purification. 
The most BfEAS protein was obtained from E. coli BL21 Star that was cultivated at 16 °C for 3 d as 
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Figure 3.24: SDS-PAGE of purified BfEAS expression at 16 °C for 3 d. The enzyme was heterologously expressed 
in BL21 Star. The cells were harvested and disrupted by sonification. The cell debris was removed by 
centrifugation. The protein was purified by Ni
2+
-affinity chromatography and eluted from the column by a 
linear gradient with an increasing imidazole concentration (15 mM to 300 mM). The figure is representative for 
at least five purifications. 
3.2.2 Purification 
BfEAS was purified by an optimized purification protocol that was established in this work (2.3.8.1): 
After membrane preparation (see 2.3.7) the resulting supernatant was loaded onto a 1 ml His-trap 
column. Unspecifically bound proteins were washed from the column with 15 mM imidazole. 
Subsequently, bound BfEAS was eluted with a gradually increasing imidazole concentration of 15 mM 
to 300 mM. Activity tests (2.3.11.1) and SDS-PAGE analysis (2.3.9) were done with collected fractions. 
SDS-PAGE analyses of purifications of BfEAS that was isolated from E. coli BL21 Star grown under 
different expression conditions as shown in Figure 3.23 and Figure 3.24 illustrate clear protein bands 
at 66 kDa for eluted BfEAS. Very high amounts of homogenous protein (approx. 35 mg protein/ml 
expression cultures) were obtained and used for further analysis. 
By size exclusion chromatography a native molecular weight of 60 kDa was determined for BfEAS 
(data not shown). SDS-PAGE showed a molecular weight of approx. 60 kDa and theoretical calculated 
mass was 66 kDa. The molecular mass determined by size exclusion chromatography is thus 
consistent with the theoretical mass of 66 kDa indicating that BfEAS exists as a monomeric protein. 
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3.2.3 Spectroscopic analysis 
3.2.3.1 UV/vis analysis 
Purified BfEAS showed a deep reddish color, which indicated the presence of a heme cofactor. 
Therefore UV/vis spectra were measured and the heme content was determined. The spectrum of 
BfEAS showed an absorption maximum of the Soret-band at 420 nm, whereas the maxima of α-band 
was at 565 nm, β-band at 539 nm, γ-band at 281 nm, and δ-band at 368 nm (Figure 3.25). 
 
Figure 3.25: UV/vis spectrum of purified BfEAS in 50 mM sodium phosphate buffer, pH 8.0. The UV/vis 
spectrum shows absorption maxima at 281 nm (γ) and 420 nm (Soret) and smaller maxima at 36  nm (δ), 
539 nm (β), and 565 nm (α).The figure is representative for three experiments. 
The calculated heme content of BfEAS with a theoretical molar extinction coefficient ε280(BfEAS) ≈ 
89.500 M-1 cm-1 and an excepted molar extinction coefficient for the Soret-band of εsoret≈ 100.000 M
-
1 cm-1, is of approx. 37 %. 
The BfEAS does not show the characteristic high-spin iron-III-complex signal at 630 nm, suggesting 
the presence of a mainly low-spin heme-iron complex. 
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3.2.3.2 CD spectroscopy 
The CD spectrum of BfEAS was measured in 50 mM sodium phosphate buffer, pH 8.0 in a range of 
260 nm to 190 nm (Figure 3.26). 
 
Figure 3.26: CD sepctrum of purified BfEAS. It was measured in 50 mM sodium phosphate buffer, pH 8.0 on a 
Chirascan™ CD Spectrometer (Applied Photophysics Ltd., Leatherhead, United Kingdom). The spectrum was 
recorded in the range of 260 nm to 190 nm.The figure shows the spectrum of oneexperiment. 
The spectrum showed negative peaks at 212 nm and 222 nm, and a positive peak at 194 nm, which 
are typical peaks for proteins with a mainly α-helical fold (Panagakou et al., 2012). 
3.2.4 Analysis of products 
B. floridae contains the ω-3 fatty acid docosahexaenoic acid. Because of its 6 double bonds (Figure 
3.27) upon oxidation formation of twelve different positional isomers is possible of which ten of 
them may be of enzymatic origin. 
 
Figure 3.27: Structure of ω-3 fatty acid docosahexaenoic acid (DHA) and its possible ten positions that may be 
oxidized enzymes. Abbreviations: HPDHA: Hydroperoxy docosahexaenoic acid. 
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To determine which products were formed by the conversions of BfEAS with hydroperoxides derived 
from LA and α-LeA as well as with hydroperoxides derived from DHA product analysis of the different 
reactions were performed. 
3.2.4.1 Radio-HPLC 
Products formed from incubations of purified BfEAS with radio-labeled 9- and 13-hydroperoxides as 
substrates were analyzed by RP-HPLC coupled to a radio-detector (2.3.13.2). 
In Figure 3.28 the RP-HPLC analysis of products formed from incubation of BfEAS with [14C]-9α-HPOT 
as substrate is shown. Besides the main product that eluted after 3.5 min additional products were 
detected. Based on the respective RT and absorption maxima, these products were identified as 9-
oxo nonanoic acid (RT 2 min), an epoxy alcohol derivative (RT 3.5 min) as well as colnelenic acid 
(RT 28 min). Thus, beside the EAS specific epoxy alcohol product also small amounts of the 
characteristic HPL product (9-oxo nonanoic acid) as well as a characteristic DES product (colnelenic 
acid) are formed during catalysis. The peak at about 6 min could not be identified. 
 
Figure 3.28: Product analysis from incubation of BfEAS with [1-
14
C]-9α-HPOT. The purified enzyme was 
incubated with the radio-labeled substrate for 30 min at RT. After extraction with diethyl ether the products 
were analyzed by RP-HPLC coupled to a radio-detector. The insertion shows product analysis of purified StDES 
with [1-
14
C]-9α-HPOT.The figure is representative for five experiments. 
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The conversion of [14C]-9-HPOD with BfEAS gave a similar product pattern as with [14C]-9α-HPOT as 
substrate: an epoxy alcohol derivative, 9-oxo nonanoic acid as well as colneleic acid could be 
detected (see appendix Figure 9.3 A). 
Interestingly, analogous conversions of 13-hydroperoxides derived from LA and α-LeA with BfEAS 
appeared to be more specific. Conversions of 13α-HPOT yielded mainly the respective epoxy alcohol 
derivative (RT 4 min) as product. Divinyl ether derivative could not be detected as side product. The 
only side product that was formed in those incubations was (9Z)-12-oxo-9-dodecenoic acid 
(RT 2.5 min). RP-HPLC analyses of products formed from incubation of 13α-HPOT with BfEAS are 
exemplarily shown in Figure 3.29.Product patterns of conversion of [14C]-13-HPOD with BfEAS were 
similar to that of [14C]-13α-HPOT (see appendix Figure 9.3 B). 
 
Figure 3.29: Product analysis from incubation of BfEAS with [1-
14
C]-13α-HPOT. The purified enzyme was 
incubated with the radio-labeled substrate for 30 min at RT. After extraction with diethyl ether the products 
were analyzed by RP-HPLC coupled to a radio-detector. The figure is representative for five experiments. 
The occurrence of EAS-, HPL- and DES-specific products suggested close interconnection of the 
different enzymatic trajectories in CYP74-catalysis (Lee et al., 2008, Li et al., 2008, Brash, 2009,Cho et 
al., 2011). 
Table 3.5 summarizes the products formed by incubations of BfEAS with the different radio-labeled 
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Table 3.5: Product specificities of BfEAS. Affinity purified enzymes were incubated with [1-
14
C]-labeled 
hydroperoxy fatty acids for approx. 30 min at RT. After extraction with diethyl ether the isolated products were 
analyzed by RP-HPLC that was coupled to a radio-detector and quantified by integration of the respective peak 
area. The relative amounts of each product is indicated by the number of “+”. 
substrate 
ω-oxo fatty acids 
(= HPL activity) 
epoxy alcohols 
(= EAS activity) 
divinyl ether 
(= DES activity) 
other products 
9-HPOD + ++++ + n. d. 
9α-HPOT ++ +++ ++ + 
13-HPOD + +++++ n. d. n. d. 
13α-HPOT + +++++ n. d. - 
 
3.2.4.2 RP-HPLC/MS2 
In order to elucidate the exact structure of the different epoxy alcohol derivatives, the formed 
products were also analyzed by means of RP-HPLC/MS2. Therefore incubations of purified BfEAS with 
9- and 13-hydroperoxides derived from LA and α-LeA were performed as described in (2.3.13). The 
following figures exemplarily show extracted ion chromatograms as well as the respective tandem 
mass spectra with potential fragmentation patterns of the epoxy alcoholsderived from incubations of 
BfEAS with 9α-HPOT (Figure 3.30 and Figure 3.31) and 13α-HPOT (Figure 3.32). 
In Figure 3.30 the extracted m/z 309 ion chromatogram (A) and tandem mass spectrum (B) for the 
conversion of BfEAS with 9α-HPOT is shown. The fragment pattern is similar to that of known pattern 
reported before (Oliw et al., 2006). The m/z 185 and m/z 201 signals suggested that epoxide 
migration from (9S,10S,12Z,15Z)-11-hydroxy-9,10-epoxy-12,15-octadecadienoic acid to (12Z,15Z)-9-
hydroxy-10,11-epoxy-12,15-octadecadienoic acid occurred as it has also been reported before by 




-analysis of products formed by incubation of BfEAS with 9α-HPOT. Shown are the 
extracted ion chromatogram (m/z 309) (A) and the associated tandem mass spectrum of the epoxy alcohol(B). 
RT: 0.00 - 44.99 SM: 7B
























































9a_Wt #468-597 RT: 5.45-6.98 AV: 65 NL: 5.97E6
F: - c ESI d Full ms2 309.22@40.00 [ 75.00-320.00]
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In order to confirm the formation of the divinyl ether derivative detected using radio-HPLC analysis 
and to analyze its chemical structure the respective product was pre-isolated via RP-HPLC/DAD and 
subsequently analyzed by RP-HPLC/MS2. Theextracted m/z 291 ion chromatogram and the associated 
tandem mass spectrum and potential fragment pattern of the collected divinyl ether are shown in 




-analysis of products formed by incubation of BfEAS with 9α-HPOT (divinyl ether). 
Shown are the extracted m/z 291 ion chromatogram (A) and the associated tandem mass spectrum (B) of the 
collected divinyl etherfraction of the RP-HPLC/DAD analysis. 
The extracted m/z 309 ion chromatogram in Figure 3.32 shows the epoxy alcohol for the conversion 
of 13α-HPOT. Its fragment pattern is in agreement with that of known pattern reported before 




-analysis of products formed by incubation of BfEAS with 13α-HPOT. Shown are the 
extracted ion chromatogram (m/z 309) (A)and the associated tandem mass spectrum of the epoxy alcohol (B). 
Various fatty acid hydroperoxide isomers derived from C22 fatty acid DHA may be generated by the 
conversion with different LOXs-isoforms (Figure 3.27).In this study LOXs from soybean (GmLOX1), 
RT: 0.00 - 45.00 SM: 7B


























































20 #1517 RT: 24.87 AV: 1 NL: 8.19E4
F: - c ESI d Full ms2 291.08@40.00 [ 70.00-305.00]
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13a_Wt #543-687 RT: 6.56-8.31 AV: 73 NL: 7.57E6
F - c ESI d Full ms2 309.19@40.00 [ 75.00-320.00]
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moss (PpLOX2), Arabidopsis (AtLOX1) and potato (StLOX), were used in order to produce different 
hydroperoxy isomers as potential substrates for BfEAS. Incubations were performed as described in 
2.3.13 and the products were analyzed by RP-HPLC/MS2 (2.3.13.3). 
In Figure 3.33 extracted ion chromatogram and associated tandem mass spectrum and potential 
fragment pattern of reaction of GmLOX1 with DHA are exemplarily shown. 
Conversion of DHA by GmLOX1 led to the formation of 17-HDHA (Figure 3.33 A and B) and the 




-analysis of products formed by incubation of GmLOX1 with DHA. Shown are the 
extracted ion chromatogram m/z 343 and the associated tandem mass spectrum of 17-HDHA.Abbreviations: 
17-HPDHA: 17-hydroperoxy docosahexaenoic acid. 
In Table 3.6 products formed from reactions of DHA with different LOXs are summarized.Conversions 
of AtLOX1 and StLOX with DHA yielded 10-H(P)DHA, whereas PpLOX led to the formation of 14-
H(P)DHA. 
Table 3.6: Product formation of conversions by various LOXs with DHA. 






The extracted ion chromatograms and associated tandem mass spectra and potential fragment 
patterns of 10-, 14- and 17-HDHA were consistent to known patterns (Hong et al., 2007). 
After identification of possible isomers of conversions of DHA by various LOXs which can be used as 
substrates, analysis of product formations of incubations of the different LOXs with DHA and BfEAS 
were also analyzed. InFigure 3.34exemplarily the analysis of the reaction products from co-
incubation of DHA with GmLOX1 and BfEAS is shown. Extracted ion chromatogram and associated 
tandem mass spectrum and potential fragment pattern indicated formation of epoxy alcohol that 
gmloxDHA #1356-1410 RT: 21.83-22.35 AV: 22 NL: 1.72E6
F: - c ESI d Full ms2 343.12@40.00 [ 80.00-355.00]
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was tentatively assigned as (4Z,7Z,10Z,13Z,19Z)-17-hydroxy-15,16-epoxy-4,7,10,13,19-




-analysis of products formed by incubation of GmLOX1 with DHA and BfEAS. Shown 
are the extracted m/z 359 ion chromatogram (A) and the associated tandem mass spectrum (B). 
Conversions of DHA with AtLOX1, StLOX and PpLOX, respectively, and BfEAS led as well with GmLOX 
to the formation of epoxy alcohols as products. 
Co-incubations of DHA with AtLOX1 and BfEASlead to formation of an epoxy alcohol that was 
tentatively assigned as (4Z,7Z,13Z,16Z,19Z)-10-hydroxy-11,12-epoxy-4,7,13,16,19-docosapentaenoic 
acid. The extracted ion chromatogram and associated tandem mass spectrum and potential fragment 




-analysis of products formed by incubation of AtLOX1 with DHA and BfEAS. Shown 
are the extracted m/z 359 ion chromatogram (A) and the associated tandem mass spectrum (B). 
Like AtLOX1 the StLOX led also to the formation of (4Z,7Z,13Z,16Z,19Z)-10-hydroxy-11,12-epoxy-
4,7,13,16,19-docosapentaenoic acid by co-incubation with BfEAS and DHA.The extracted ion 
chromatogram and associated tandem mass spectrum and potential fragment pattern are shown 
inFigure 3.36. 
RT: 0.00 - 45.00 SM: 7B
























































EASgmLOX #1005-1204 RT: 15.66-18.54 AV: 100 NL: 2.54E5
F: - c ESI d Full ms2 359.16@40.00 [ 85.00-370.00]





























































RT: 0.00 - 44.99 SM: 7B


























































EASatlox1 #1111-1346 RT: 16.10-19.07 AV: 118 NL: 1.01E6
F: - c ESI d Full ms2 359.15@40.00 [ 85.00-370.00]



































































-analysis of products formed by incubation of StLOX with DHA and BfEAS. Shown are 
the extracted m/z 359 ion chromatogram (A) and the associated tandem mass spectrum (B). 
Figure 3.37 shows the extracted ion chromatogram and associated tandem mass spectrum and 
potential fragment pattern of co-incubation of BfEAS with PpLOX and DHA. The formed epoxy alcohol 
was tentatively assigned as (4Z,7Z,10Z,16Z,19Z)-14-hydroxy-12,13-epoxy-4,7,10,16,19-




-analysis of products formed by incubation of PpLOX with DHA and BfEAS. Shown are 
the extracted m/z 359 ion chromatogram (A) and the associated tandem mass spectrum (B). 
3.2.5 Kinetic analysis 
DHA leads to the formation of ten positional isomers which may be used as substrates (Figure 3.27). 
Therefore it is of interest to determine substrate preference of conversions of BfEAS with 
hydroperoxides derived from C18- and C22 fatty acids by spectrometrically approaches (2.3.11.1). 
  
RT: 0.00 - 44.99 SM: 7B



























































EASstLOX #1126-1369 RT: 15.62-18.74 AV: 122 NL: 7.67E5
F - c ESI d Full ms2 359.21@40.00 [ 85.00-370.00]






























































RT: 0.00 - 44.99 SM: 7B





























































EAS_PpLOX #1062-1260 RT: 15.51-18.53 AV: 99 NL: 1.55E5
F: - c ESI d Full ms2 359.15@40.00 [ 85.00-370.00]
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3.2.5.1 pH optimum 
To determine the optimal buffer conditions for measurements of the kinetic parameters first the pH 
optimum of EAS was measured as described in 2.3.14.1. Therefore the initial velocity for the reaction 
of 1 nM BfEAS with30 µM 13-HPOD at 234 nm was measured in different buffers. A citrate-
phosphate buffer was used for the pH range 2.82 to 7.25, phosphate buffer for the pH range 5.5 to 
8.0, Tris buffer for the range 7.31 to 9.22 and a glycine-NaOH buffer for the range from 8.71 to 9.9. 
The optimal pH for the BfEAS was determined to be around pH 6.75, which can be seen in Figure 
3.38. 
 
Figure 3.38: The pH optimum of BfEAS with 13-HPOD. The initial velocity for the conversion of 1 nM BfEAS with 
30 µM 13-HPOD at 234 nm in different buffers at RT was measured. Each data point represents the mean value 
of three measurements. 
3.2.5.2 Kinetic parameters 
To determine the substrate preference of BfEAS kinetic parameters for reactions of BfEAS with 13-
hydroperoxides derived from C18 fatty acids LA and α-LeA, and for reaction of BfEAS with 17-
hydroperoxide derived from C22 fatty acid DHA were measured as described (2.3.11.1). The reaction 
was started by addition of 1 nM BfEAS. 
The kinetic parameters were determined by plotting the derived data points to the Michaelis-
Menten equation. 
The Michaelis-Menten diagrams for the reactionsof BfEAS with 13-HPOD and 13α-HPOT, 
respectively, where the initial time-dependent changes at 234 nm were measured, are shown in 
Figure 3.39. 
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Figure 3.39: Kinetic analyses of BfEAS with 13-HPOD (A) and 13α-HPOT (B). The reactions were performed in 
50 mM sodium phosphate buffer, pH 6.5 at RT and were started by addition of 1 nM BfEAS. The initial time-
dependent changes at 234 nm were measured.For each data point the substrate concentration was measured 
again. 
InFigure 3.40 the Michaelis-Menten diagram derived from measuring the initial time-dependent 
substrate consumption at 234 nm for the reaction of BfEAS with C22 fatty acid derived hydroperoxide 
17-HPDHA is shown. 
 
Figure 3.40: Kinetic analysis of BfEAS with 17-HPDHA.The reaction was performed in 50 mM sodium phosphate 
buffer, pH 6.5 at RT and was started by addition of 1 nM BfEAS. The initial time-dependent changes at 234 nm 
were measured.For each data point the substrate concentration was measured again. 
Table 3.7 summarizes the derived kinetic parameters. The kcat-values were calculated by considering 
heme occupancy of approx.37 %. 
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Table 3.7: Kinetic parameters for the reaction of BfEAS with different hydroperoxides from C18- and C22 fatty 
acids. The kinetic parameters were determinedby measuring the initial time-dependent substrate consumption 
at 234 nm at different substrate concentrations. For analysis between 15 and 25 data points were fitted to the 
Michaelis-Menten equation. The concentration of BfEAS was 1 nM. The values for kcat were calculated by 
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+/- 0.0  
676 68 
 
The values for kcat/KM showed that BfEAS isomerized both 13-hydroperoxides derived from LA and α-
LeA and 17-hydroperoxide derived from DHA with specificity for 13α-HPOT. 
Kinetic measurements of BfEAS with 9-hydroperoxides derived from LA and α-LeA turned out to be 
very difficult since divinyl ethers were also formed in significant amount besides the epoxy alcohol 
derivative (Figure 3.28). As these compounds have relatively broad absorption maxima at 252 nm 
(CA, EA and EnA) to 268 nm (EnA) that overlap with that of the hydroperoxide substrate at 234 nm 
no reasonable data were obtained in this analysis. Measurements of the kinetic parameters with 
other hydroperoxides derived from DHA (10- and 14-HPDHA) were not performed, sinceit was not 
possible to produce enough of these substrates. 
3.2.6 Site-directed mutagenesis 
Sequence alignments (Figure 3.41) showedthat in BfEAS particular amino acid-residues which are 
important for product specificity in AtAOS are also conserved in BfEAS as it has also been reported 
before (Lee et al., 2008). At position 58 BfEAS contains a strictly conserved (F), which is AOS-specific. 
Analysis of products of an analog PpAOS1 variant (PpAOS1_F93L) where this conserved F was 
substituted by L showed that the AOS altered its product activity to HPL activity (see 3.1.6.2.1). To 
analyze product activity and importance of this conservedF in BfEAS it was substituted by the 
essential residue for HPL activity L (BfEAS_F58L). Also, at position 75 BfEAS contains a strictly 
conserved proline (P). This residue was substituted by a HPL-specific A (BfEAS_P75A) and also by an 
AOS-specific S (BfEAS_P75S) (Figure 3.41 A). 
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Figure 3.41:Partial multiple sequence alignment of different CYP74 enzymes from different plant species and 
marine invertebrates. Allium sativum (As); Arabidopsis thaliana (At); Branchiostoma floridae (Bf); Lycopersicum 
esculentum (Le); Parthenium argentatum (Pa); Physcomitrella patens (Pp); Solanum tuberosum (St); AtAOS, 
CAA63266; AsDES, AJ867809; AtHPL, AAC69871; BfEAS, EU555186; BfEAS_1, XP2601390; BfEAS_2, XP2602690; 
LeAOS3, AAN76867; LeHPL, AAF67142; PaAOS, CAA55025; PpAOS1,CAC86919; PpAOS2, XP_001759629; PpHPL, 
CAC86920; StDES, CAC28152. The highly conserved residues are in grey brackets. Amino acid positions used for 
site-directed mutagenesis in this study are marked in bold letters. 
Additionally to the BfEAS_F58L variant a BfEAS_F60L variant was generated. Lee and coworkers (Lee 
et al., 2008) showed in alignments and structures that the particular F which is highly conserved and 
determining enzymeactivity was located at position 60. Sequence alignments in this study showed 
that this special F might be the F located at position 58 (Figure 3.41 A). To determine which F is the 
specific residue variants for both substitutions (F58L and F60L) were generated. 
As reported before for tomato AOS (LeAOS3_F295) (Toporkova et al., 2008) a further F is strictly 
conserved in AOS and HPLs. In DES an isoleucin (I) is located at this position. Substitutions of this 
conserved F by I (BfEAS_F223I) and by PpHPL-specific L (BfEAS_F223L) (Figure 3.41 B) were 
performed (2.3.1.1). 
According to site-directed mutagenesis in AtAOS (AtAOS_N321Q) BfEAS_N224Q variant was 
generated. This substitution should abolish enzyme activity (Lee et al., 2008). 
A very special feature of the CYP74-enzymes is that they contain in contrast to typical P450-enzymes 
an insertion of 9 amino acids in the heme-bindingloop (Lee et al., 2008). In order to analyze the 
molecular function of this unique feature and its impact on catalysis, a truncation variant of BfEAS 
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Figure 3.42:Partial multiple sequence alignment of different CYP74 enzymes from different plant species and 
marine invertebrates. Allium sativum (As); Arabidopsis thaliana (At); Branchiostoma floridae (Bf); Lycopersicum 
esculentum (Le); Parthenium argentatum (Pa); Physcomitrella patens (Pp); Solanum tuberosum (St); AtAOS, 
CAA63266; AsDES, AJ867809; AtHPL, AAC69871; BfEAS, EU555186; BfEAS_1, XP2601390; BfEAS_2, XP2602690; 
LeAOS3, AAN76867; LeHPL, AAF67142; PaAOS, CAA55025; PpAOS1,CAC86919; PpAOS2, XP_001759629; PpHPL, 
CAC86920; StDES, CAC28152. The additional 9 amino acid insertion is in grey brackets. Amino acids removed by 
mutagenesis in this study are marked in bold letters. 
In analogy to the site directed mutagenesis of PpAOS1 and PpHPL described before (3.1.6) BfEAS was 
mutated. Therefore the activity determining amino acid residues in BfEAS were changed or removed 
(Figure 3.41 and Figure 3.42). 
3.2.6.1 Purification 
BfEAS variants were purified as described in 2.3.8.1. The SDS-PAGEanalyses of the different variants 
(data not shown) were similar to that of wild type (Figure 3.24). However, SDS-PAGE analysis of the 
BfEAS_9AS-deletion variant showed multiple smaller bands (Figure 3.43). At 66 kDa the protein band 
of BfEAS is shown. Beside this band there were also strong protein bands at 55 kDa, 57 kDa, and 
60 kDa. It seemed that these bands belong to the eluted BfEAS and weren’t unspecifically bound 
















Results    74 
 
Figure 3.43: SDS-PAGE analysis of purified BfEAS_9AS-deletion. The enzyme was heterologously expressed in 
BL21 Star. The cells were harvested and disrupted by sonification. The cell debris were removed by 
centrifugation. The purification was done by Ni
2+
-affinity chromatography. The column was first washed with 
loading buffer (50 mM sodium phosphate, pH 8.0, 1 M NaCl, 500 mM urea) and then with buffer which 
contains additionally 15 mM imidazole. The protein was eluted from the column by a linear gradient with an 
increasing imidazole concentration (15 mM to 300 mM).Aliquots of collected fractions of the purification were 
loaded on a 10 % SDS-PAGE gel.The figure is representative for two purifications. 
Similar to the purification of wild type enzyme by affinity chromatography, very high amounts of 
homogenous protein were isolated from E. coli expressing the different variant enzymes (about to 
30 mg protein/ml expression culture). The purified proteins were used for further analysis. 
3.2.6.2 Spectroscopic analysis 
To investigate if the above mentioned substitutions of special amino acid residues have an effect on 
the protein folding and cofactor incubation, UV/vis and CD spectroscopy analysis were performed as 
described (2.3.15). 
3.2.6.2.1 UV/vis analysis 
UV/vis spectra ofBfEAS variants which werecompared to that of the wild type enzyme are shown in 
Figure 3.44. BfEAS_F58L (A) had absorption maxima at 420 nm (Soret), 281 nm (γ) and a very small at 
348 nm (δ). Absorption maxima for the α- and β-bands were not measured.The absorption maxima 
of BfEAS_9AS-deletion were at 423 nm (Soret), 280 nm (γ) and at 356 nm (δ) (B). There was a small 
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Figure 3.44: UV/vis spectra of purified BfEAS_F58L (A) and BfEAS_9AS-deletion (B) in comparison to the BfEAS 
wild type (C). The spectra were measured in 50 mM sodium phosphate buffer, pH 6.0.The spectraare 
representative for one to three experiments. 
The difference between mutants and wild type is that the mutants did not show absorption maxima 
for α- and β-bands (BfEAS_F58L) or even very small absorption maximum only for β-band 
(BfEAS_9AS-deletion). Maxima for δ-band were also very small in the variants. Another difference is 
in the heme content. The heme content of BfEAS_F58L is of 16 % and of BfEAS_9AS-deletion of 2 %, 
whereas the content of wild type of 37 % was. Therefore the variants had lower heme contents than 
the wild type especially the 9AS-deletion variant, where the amino acid insertion near the heme-
binding loop was deleted. 
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3.2.6.2.2 CD spectroscopy 
CDspectra of BfEAS_F58L and BfEAS_9AS-deletion were measured to analyze the native protein 
folding of the variants. The spectra were recorded in a range of 260 nm to 190 nm. 
 
Figure 3.45: CD sepcra of purified BfEAS_F58L (A) and BfEAS_9AS-deletion (B) in comparison to BfEAS wild type 
(C). Spectra were measured in50 mM sodium phosphate buffer, pH 8.0 on a Chirascan™ CD Spectrometer 
(Applied Photophysics Ltd., Leatherhead, United Kingdom) in the range of 260 nm to 190 nm.The figure shows 
the spectra of one experiment. 
In Figure 3.45 CD spectra of the variants in comparison to wild type (C) are shown. Like the wild type 
the variants had two negative peaks and one positive peak which are characteristic for proteins 
consisting of α-helix (Panagakou et al., 2012). The negative peaks of BfEAS_F58L (A) were at 210 nm 
and 219 nm and the positive peak at 192 nm, whereas the peaks of BfEAS_9AS-deletion (B) were at 
210 nm, 222 nm and 193 nm. 
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3.2.6.3 Analysis of products 
3.2.6.3.1 Radio-HPLC 
Analysis of products derived from reactions of BfEAS variants with [1-14C]-labeled substrates were 
carried out by radio-HPLC. The reactions were incubated and extracted as described in 2.3.13.2. 
The conversion of 9α-HPOTby the variants BfEAS_F58L and BfEAS_9AS-deletion in comparison to the 
wild type areexemplarily shown in Figure 3.46. The reaction of BfEAS_F58L leads to a decrease in 
epoxy alcohol formation and in a slight increase of 9-oxo nonanoic acid. Colnelenic acid was not 
detected. The products of BfEAS_9AS-deletion variant were similar to the products of the wild type, 
with the exception that epoxy alcohol slightly decreased and only small amounts of divinyl ether CnA 
were detected. The peak at about 11 min could not be identified. 
 
Figure 3.46: Product analysis from incubation of BfEAS, BfEAS_F58L, and BfEAS_9AS-deletion with [1-
14
C]-9α-
HPOT. The purified enzymes were incubated with the radio-labeled substrate for 30 min at RT. After extraction 
with diethyl ether the products were analyzed by RP-HPLC coupled to a radio-detector. The figure is 
representative for two to five experiments. 
Incubation with 9-HPOD showed that with the BfEAS_F58L variant the epoxy alcohol was strongly 
decreased whereas the HPL product was strongly increased (see appendix Figure 9.4 A). By 
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InFigure 3.47 the chromatograms for conversion of 13α-HPOT by BfEAS variants are exemplarily 
shown. Similar to the wild type the variants did not generate any divinyl ether derivative. BfEAS_F58L 
variant showed a strong reduction in formation of epoxy alcohol and a slight increase in formation of 
oxo fatty acid. BfEAS_9AS-deletion variant showed also a decrease in epoxy alcohol formation as well 
as a slightly increase in oxo fatty acid formation. 
 
Figure 3.47: Product analysis from incubation of BfEAS, BfEAS_F58L, and BfEAS_9AS-deletion with [1-
14
C]-13α-
HPOT. The purified enzymes were incubated with the radio-labeled substrate for 30 min at RT. After extraction 
with diethyl ether the products were analyzed by RP-HPLC coupled to a radio-detector.The figure is 
representative for two to five experiments. 
Similarly, conversion of 13-HPOD by both variants (BfEAS_F58L and BfEAS_9AS-deletion) showed 
strong decreases of EASproducts. BfEAS_F58L showed a slight increase of HPLproducts, whereas 
BfEAS_9AS has HPLproduct amounts like the wild type. The F58L variant was more active than the 
9AS-deletion variant. Similar to the wild type DES products were not generated (see appendix Figure 
9.4B). 
In Table 3.8product analysis of BfEAS wild type and various BfEAS variants with radio-labeled 9- and 

































































Results    79 
Table 3.8: Product specificities of BfEAS wild type and various BfEAS variants. Affinity purified enzymes were 
incubated with [1-
14
C]-labeled hydroperoxy fatty acids for approx. 30 min at RT. After extraction with diethyl 
ether the isolated products were analyzed by RP-HPLCthat was coupled to a radio-detector and quantified by 
integration of the respective peak area. The relative amounts of each product is indicated by the number of 
“+”. 
substrate variant 
ω-oxo fatty acids 
(= HPL activity) 
epoxy alcohols 
(= EAS activity) 
divinyl ether 
(= DES activity) 
other products 
9-HPODE Wt + ++++ + n. d. 
 F58L +++ + n. d. + 
 F60L + ++++ - - 
 P75A +++ + n. d. + 
 P75S + + n. d. - 
 F223I ++ ++++ n. d. - 
 F223L + +++++ - - 
 N224Q + ++++ + n. d. 
 9AS-deletion + ++++ - n. d. 
9α-HPOT Wt ++ +++ ++ + 
 F58L ++ + n. d. + 
 F60L ++ ++++ - - 
 P75A ++ + n. d. + 
 P75S ++ + n. d. + 
 F223I ++ ++++ - - 
 F223L ++ ++++ - - 
 N224Q ++ +++ + + 
 9AS-deletion ++ ++ - + 
13-HPOD Wt + ++++ n. d. n. d. 
 F58L ++ + n. d. + 
 F60L ++ ++++ n. d. n. d. 
 P75A ++ + n. d. + 
 P75S + + n. d. n. d. 
 F223I + + n. d. - 
 F223L + +++ n. d. n. d. 
 N224Q + +++ n. d. - 
 9AS-deletion + + n. d. n. d. 
13α-HPOT Wt + +++++ n. d. n. d. 
 F58L ++ + n. d. + 
 F60L ++ +++++ n. d. n. d. 
 P75A ++ + n. d. + 
 P75S + + n. d. - 
 F223I ++ + n. d. + 
 F223L + +++++ n. d. n. d. 
 N224Q + +++ n. d. + 
 9AS-deletion + +++ n. d. n. d. 
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3.2.6.3.2 RP-HPLC/MS2 
Product formations of the various BfEAS variants were also analyzed by RP-HPLC/MS2. Reactions 
were performed as described (2.3.13.2 and 2.3.13.3). After purification the variants were incubated 
with 9- and 13-hydroperoxides derived from LA or α-LeA. 
The extracted ion chromatogram and associated tandem mass spectrum and potential fragment 
pattern for the conversion of 9α-HPOT by BfEAS_F58L is shown in Figure 3.48. The insertion in A 
shows the extracted ion chromatogram of BfEAS wild type. The fragment pattern identified the 




-analysis of products formed by incubation of BfEAS_F58L with 9α-HPOT in 
comparison to the wild type (insertion). Shown are the extracted ion chromatograms (m/z 309) (A)and the 
associated tandem mass spectrum (B). 
The extracted ion chromatograms and associated tandem mass spectra and potential fragment 
patterns of BfEAS_9AS-deletion were similar to that of BfEAS_F58L (data not shown). BfEAS_9AS-
deletion variant was not active as the other two variants, because less amounts of epoxy alcohol 
were detected. 
Figure 3.49 shows the extracted ion chromatogram and the associated tandem mass spectrum and 
potential fragment patterns of the conversion of BfEAS variant F58L with 13α-HPOT in comparison to 
the wild type. The epoxy alcohol (9Z,15Z)-11-hydroxy-12,13-epoxy-9,15-octadecadienoic acid (Figure 
3.49B) was detected. 
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9a_F58L #449-630 RT: 5.20-7.40 AV: 91 NL: 3.41E6
F - c ESI d Full ms2 309.18@40.00 [ 75.00-320.00]




































































-analysis of products formed by incubation of BfEAS_F58L with 13α-HPOT in 
comparison to the wild type (insertion). Shown are the extracted ion chromatogram (m/z 309)(A)and the 
associated tandem mass spectrum (B). 
The RP-HPLC/MS2 analysis of conversions of other BfEAS variants with 9- and 13-hydroperoxides 
derived from LA and α-LeA verified also the formation of epoxy alcohols (data not shown). 
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13a_F58L #551-716 RT: 6.60-8.69 AV: 82 NL: 2.75E6
F - c ESI d Full ms2 309.20@40.00 [ 75.00-320.00]
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4 Discussion 
The aim of the study was the biochemical characterization of the CYP74-enzymes in the moss 
Physcomitrella patens and in the lancelet Branchiostoma floridae. In the first part the biochemical 
properties of PpAOS1 were analyzed and compared with that of previously characterized PpAOS2 
(diploma thesis Scholz, 2009) and PpHPL (Stumpe et al., 2006a). 
For this purpose a purification protocol was established that enabled the generation of high amounts 
of homogenous protein. In addition previously established methods for the isolation of PpAOS2 and 
PpHPL were modified in order to generate high amounts of homogenous protein. With purified 
PpAOS1 different biochemical analysis were performed: the specificity of PpAOS1 against 
hydroperoxides derived from C18 fatty acids LA, α-LeA and γ-LeA and the C20 fatty acid ARA were 
determined. The products from those reactions were analyzed by radio-HPLC and RP-HPLC/MS2. 
Based on bioinformatic data different amino acids possibly involved in catalysis were mutagenized by 
site-directed mutagenesis and the respective enzyme variants were analyzed with respect to their 
biochemical properties and compared to those of the wild type PpAOS1, PpAOS2 and PpHPL. 
In the second part the biochemical parameters of the fourth CYP74-enzyme EAS from B. floridae 
were determined to compare it with AOS, DES and HPL from plants. 
4.1 Biochemical characterization of CYP74-enzymes 
4.1.1 Spectroscopic analysis (UV/vis and CD) 
In plants CYP74-enzymes are targeted to different membranes of the plastid envelope (Froehlich 
et al., 2001) where they bind to the hydrophobic bilayer via a patch of hydrophobic helices (Schaller 
and Stintzi, 2009). As pointed out recently by Schückel and coworkers, the hydrophobic nature of 
these enzymes renders the expression and solubilisation difficult (Schückel et al., 2012). In order to 
improve the solubility of PpHPL an amino acid sequence (MAKKTSS) was added at the N-terminus, 
directly behind the hexahistidine-tag. A similar approach was successfully used by Lee and coworkers 
before for the purification and crystallization of AtAOS (Lee et al., 2008). Initially, purification of 
PpHPL and the AOS isoforms PpAOS1 and PpAOS2 was performed according to previously 
established protocols (diploma thesis Scholz, 2009). As these procedures only led to samples 
containing variable amounts of contaminating proteins (see Figure 3.1 and Figure 3.3 A) the 
purification protocol was optimized. To generate more homogenous protein by IMAC-purification the 
stepwise imidazole gradient (5 % and 100 %) was changed into a linear imidazole gradient (5 % to 
100 % in 20 min), where the unspecifically bound proteins were eluted from the column. This 
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modification led to more homogenous protein (see Figure 3.2 and Figure 3.3 B and C). In some 
experiments a subsequent purification step by using size exclusion chromatography was used. 
However, as this procedure did not led to a significant improvement of the protein purity this 
procedure was only used for analyzing the native molecular weights of the proteins. The molecular 
weight of PpAOS1 and PpAOS2 as determined by SDS-PAGE analysis was approx. 55 kDa and 57 kDa 
for PpHPL. Size exclution chromatography determined for PpAOS1 a molecular weight of 40 kDa, for 
PpAOS2 of 240 kDa and for PpHPL of 113 kDa. These findings indicated that PpAOS1 is a monomeric 
protein complex, while PpAOS2 may form at least under the applied experimental conditions a 
tetrameric or even pentameric complex. PpHPL on the other hand may exist as a homodimeric 
complex. Different oligomeric states have also been reported for other CYP74s: While for AOS of 
Arabidopsis (AtAOS) and for guayule (PaAOS) were found to be monomeres (Li et al., 2008, Hughes 
et al., 2006a), the HPL of pepper (CaHPL) was identified to form a trimeric protein complex (Shibata 
et al., 1995). Recently, it was shown that the oligomeric state of CYP74s might be influenced by 
different molecular factors as for example the presence or absence of detergents. Based on these 
different resulting effects new rules for CYP74-classification were proposed (Hughes et al., 2006b). 
As mentioned above CYP74-enzymes belong to the P450-family and are thus heme containing 
enzymes. A prerequisite of these enzymes is that the heme cofactor is ligated by a cysteine as the 
fifth iron ligand on the proximal site and water as the sixth ligand at the distal site (Lee et al., 2008, Li 
et al., 2008). Consequently, the heme iron in all P450-enzymes (in this resting state) is low spin. In 
order to characterize the heme cofactor and its molecular micro-environment the purified proteins 
were analyzed by means of UV/vis-spectroscopy. Detected UV/vis spectra (see Figure 3.4) for the 
proteins showed the characteristic main absorption maximum at about 410 nm which is 
characteristic for hemeproteins and is known as the Soret-band. Importantly, all spectra lacked an 
absorption maximum at 630 nm which is characteristic for high-spin iron-III-complexes. Therefore the 
UV/vis analysis of PpAOS1, PpAOS2 and PpHPL indicates that all three proteins contain low-spin 
hemeiron complexes. This finding is thus in line with the spin-states reported for all CYP74s so far 
and is characteristic for P450-enzymes (Noordermeer et al., 2001b). 
UV/vis analysis also indicated that PpAOS1 and PpAOS2 had significant differences in their heme 
contents. While PpAOS1 has a content of approx. 30 % the content of PpAOS2 is only 4 %. The heme 
content of PpHPL is higher (46 %) than of both AOS isoforms.  
The analysis of protein folding by CD spectroscopy (see Figure 3.5 and Figure 3.6) showed signals 
typical for proteins with a mainly α-helical fold (Panagakou et al., 2012). Thus this finding goes in line 
with the fact that both characterized AOS-structures are mainly composed of α-helices (Lee et al., 
2008, Li et al., 2008). 
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4.1.2 Analysis of products (radio-HPLC and RP-HPLC/MS2) 
To analyze the different products that were formed by incubations of various CYP74-enzymes (e. g. 
PpAOS1, PpAOS2 and PpHPL) with different 9-and 13-hydroperoxides derived from LA and α-LeA, 
radio-HPLC and RP-HPLC/MS2 analysis were performed. 
Analysis of products formed by conversions of radio-labeled 9-hydroperoxides with PpAOS1 
indicated that mainly typical AOS products, the α- and γ-ketols were formed (Figure 3.7andFigure 9.1 
A). It is well established that these metabolites are formed non-enzymatically by hydrolysis of the 
allene oxide. While the α-ketol represents the main product of this reaction, the γ-ketols are 
normally formed in lower amounts. Interestingly, in addition to these characteristic AOS products the 
HPL-specific ω-oxo fatty acid product was also detected as side product. The occurrence of the 
characteristic HPL product (ω-oxo fatty acid, (Vick and Zimmerman, 1976)) beside the α- and γ-ketols 
(Hamberg, 1987, Brash et al., 1988) suggests that PpAOS possess an inherent HPL activity. This 
finding is in line with previous studies on rice AOS and Arabidopsis AOS (Cho et al., 2011).Conversions 
of radio-labeled 13-hydroperoxides with PpAOS1 gave similar results (Figure 3.8and Figure 9.3 B). 
However, in addition to the ketols and oxo fatty acid a cyclopentenone derivative wasformed, which 
arose from the non-enzymatical cyclization of the intermediary formed allene oxide(Hamberg et al., 
1988). 
On the other hand, incubations of PpHPL with 9-hydroperoxides derived from radio-labeled LA and α-
LeA led not only to the formation of 9-oxo nonanoic acid as main product but yielded α- and γ-ketols 
(Figure 3.7 andFigure 9.1 A). Conversions of radio-labeled 13-hydroperoxides gave similar results 
(Figure 3.8 and Figure 9.1 B).Thus results indicate that also PpHPL exhibits inherent AOSactivity. It 
should be noted at this point, that the α-ketols were formed in lower amounts compared to the γ-
ketols that were formed in higher amounts. This finding was surprising since as mentioned above the 
α-ketol is normally formed in high amounts and the γ-ketol in significantly less amounts (Grechkin et 
al., 1991). The favored formation of the γ-ketol may have occurred because of the acidic pH used in 
the applied buffer systems. As reported by Grechkin and coworkers the trajectory of this unspecific 
reaction is highly pH-dependent; in particular formation of the γ-ketol is favoured at low (acidic) pH-
values (Grechkin et al., 1991). These conditions were used for the product analysis experiments. 
The existence of both enzymatic activities suggests that the catalytic pathways of AOS and HPL are 
close interconnected as has been suggested before (Lee et al., 2008, Brash, 2009,Cho et al., 2011). 
To analyze if this close interconnection of the catalytic pathways also applies to other members of 
the CYP74-family conversions of StDES and AsDES with radio-labeled 9-and 13-hydroperoxides 
derived from α-LeA were performed. The radio-HPLC analysis showed that beside the main 
DESproduct (divinyl ether) also some HPLproduct (ω-oxo fatty acid) can be detected (see Figure 3.9). 
These results led to the hypothesis that the catalytic pathways of DES and HPL were also close 
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interconnected. Unfortunately the handling of both DESisozymes turned out to be difficult, since the 
protein yield after purification was considerably low. Thus we did not follow up the mechanistic 
details of these reactions. 
The products formed by conversion of 13α-HPOT by PpAOS1 and PpHPL were verified by RP-
HPLC/MS2 (see Figure 3.10toFigure 3.13). 
4.1.3 Kinetic analysis (pH optimum and kinetic parameters) 
For determination of the pH optimum the conversion of 13-HPOD to the corresponding products was 
measured by recording the decrease at 234 nm in various buffers. This method gives information 
about the initial velocity in dependence of various pH reaction buffers. Initial velocity can be 
influenced by enzyme concentration and substrate concentration. Therefore the concentrations 
were kept constant at the measurements. 
PpAOS1 showed highest activity at pH 6.5 (see Figure 3.14). A similar pH optimum (pH 6.0) was 
recently reported for PpAOS1 (Bandara et al., 2009). In contrast to the slightly acidic pH of PpAOS1, 
PpAOS2 has a neutral pH optimum at pH 7.0 (diploma thesis Scholz, 2009). 
The slightly acidic pH optimum of PpAOS1 and the neutral pH optimum of PpAOS2 are consistent to 
pH optimum of the corresponding PpLOX isoforms (Anterola et al., 2009). This is important since the 
fatty acid hydroperoxide substrates for AOS activity are provided by LOXs (Wasternack and 
Kombrink, 2010). 
Interestingly, the pH-values optimal for catalytic activity of both AOS isoforms are also in line with 
their sub-cellular localizations. PpAOS2 is localized in the plastid, where, due to the increasing 
concentration of H+ during photosynthesis, the milieu might become slightly acidic (Taiz, 2007). 
PpAOS1 on the other hand is localized in the cytosol at a nearly neutral pH (Scholz et al., 2012). 
Similar pH optima have also been reported for different AOSs from flowering plants that are between 
pH 7.0 and pH 8.0 (Bandara et al., 2009). 
P. patens containC18 fatty acids LA and LeA and C20 fatty acids ARA and EPA (Dembitsky, 1993, Girke 
et al., 1998). As these fatty acids can be used as substrates for oxylipin biosynthesis two different 
biosynthetic pathways have been proposed: the octadecanoid and the eicosanoid pathway (Wichard 
et al., 2005). Thus it was of interest to assign which PpAOS isoform may be involved in which 
pathway. For this purpose the substrate specificity was determined by analyzing the kinetic 
parameters KM and Vmax of PpAOS1 for the different substrates and comparing those results to the 
data obtained for PpAOS2 which were part of a former study (diploma thesis Scholz, 2009). In order 
to compare the kinetic parameters of both AOSisoforms it was essential to take the unequal heme 
occupancy of both proteins into account. Thus, the data for PpAOS2 were re-calculated by 
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considering the respective heme occupancy mentioned above. The data obtained for PpAOS1 were 
analogously modified. 
The kinetic analysis showed that PpAOS1 can use both the 9- and 13-hydroperoxides derived from 
C18 fatty acids LA, α-LeA and γ-LeA and 12-HPETE derived from C20 fatty acid ARA as substrates with a 
similar activity (see Table 3.3) indicating that PpAOS1 might be involved in the octadecanoid as well 
as in the eicosanoid pathway. The kcat-values of PpAOS1 are comparable with those reported for 
other AOS (Hughes et al., 2006a, Lee et al., 2008). 
A re-evaluation of the data derived from the kinetic analysis of the reactions catalyzed by PpAOS2 
(Table 4.1) showed that C18 fatty acid derived hydroperoxides are only very poor substrates, whereas 
C20 fatty acid derived 12-HPETE are converted with a similar high activity as it was shown for PpAOS1. 
Table 4.1:Re-evaluation of the kinetic parameters for the reaction of PpAOS2 with different hydroperoxides 
derived from C18- and C20 fatty acids. The kinetic parameters were measured at a photometer, where the initial 
time-dependent substrate consumption at 234 nm with different substrate concentrations was determined. 
For the analysis between 20 and 30 data points were fitted to the Michaelis-Menten equation. The 
concentration of PpAOS2 was 100 nM except for the measurements of 12-HPETE (1 nM). The values for kcat 









[min-1 M-1 x 106] 
9-HPOD 36 +/- 5 0.02 +/- 0.001 5 0.14 
9α-HPOT 40 +/- 4 0.01 +/- 0.001 2.5 0.06 
9γ-HPOT 28 +/- 4 0.03 +/- 0.002 7.5 0.27 
13-HPOD 27 +/- 3 0.04 +/- 0.002 10 0.37 
13α-HPOT 30 +/- 5 0.02 +/- 0.002 5 0.17 
13γ-HPOT 42 +/- 10 0.02 +/- 0.002 5 0.12 
12-HPETE 10 +/- 5 0.49 +/- 0.057 12250 1228.69 
 
This result indicates that PpAOS2 exhibits in contrast to PpAOS1 a distinct specificity for C20-derived 
hydroperoxy derivatives and thus suggests a distinct involvement in the eicosanoid pathway 
(Wichard et al., 2005). 
The data obtained from the kinetic measurements suggests that the substrate preference of PpAOS1 
is characteristic for unspecific 9/13-AOS. The majorities of biochemically characterized AOS found in 
the literature are substrate specific 13-AOS and are thus members of the subfamily CYP74A. 
Unspecific 9/13-AOS as well as 9-AOS, 9-HPL and 9/13-HPL are part of the CYP74C-family. HPLs and 
DES with a preference for 13-hydroperoxides belong to the CYP74B-family and DES with a preference 
for 9-hydroperoxides to CYP74D (Stumpe and Feussner, 2006, Gogolev et al., 2011). In comparison to 
both AOS isoforms for PpHPL was reported that it can accept C18- as well as C20-derived 
hydroperoxides as substrates (Stumpe et al., 2006a) and that it prefers 9-hydroperoxides derived 
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from C18fatty acids. The phylogenetic analysis in Figure 1.3shows that the division in the different 
subfamily groups applies to CYP74s from higher plants but not for CYP74-enzymes AOS1, AOS2 and 
HPL from non-flowering plants like the moss Physcomitrella. 
4.1.4 Mutagenesis 
For AOS from Arabidopsis it is known that the catalytic activity can be altered by mutating specific 
determinants that connect the AOS and HPL activities (Lee et al., 2008, Cho et al., 2011). However, 
the AOS used in these experiments has a distinct specificity for 13-hydroperoxides as substrates 
(Hughes et al., 2006a). Thus it was of interest to investigate whether the respective amino acids are 
also triggering the catalytic activity of unspecific 9-/13-AOS. For this purpose in the present work site-
directed mutagenesis of these particular determinants was performed on PpHPL and PpAOS1 which 
have preferences for 9-and 13-hydroperoxides as substrates (Stumpe et al., 2006a). It was 
hypothesized that a conserved F is an essential residue in the active site of AOS and plays a central 
role in the catalysis by stabilizing an intermediary formed carbon centered substrate radical. The 
replacement of the F by L, converts the AOS into a HPL (Lee et al., 2008, Cho et al., 2011). In order to 
analyze if this concept can also be applied on AOS with a broad substrate range, the respective 
PpAOS1 variant (PpAOS1_F93L) was generated. In HPL at this particular position is a conserved L 
located. However, PpHPL contains at this position the F which is characteristic for AOS-enzymes. In 
order to analyze the function of this amino acid on HPL-catalysis the PpHPL_F151L variant was 
generated. Additionally PpHPL_A169S was generated, in which a HPL-specific A was substituted by an 
AOS-specific S. 
As reported for tomato AOS (LeAOS3) at position 295 is a further F which is strictly conserved in all 
known AOS and HPLs and can alter enzyme activity by substitution (Toporkova et al., 2008). PpHPL 
has at this particular position a conserved L instead of the F. Thus PpHPL_F336L variant was 
generated to analyze the function of this residue in HPL-catalysis. It was also reported for LeAOS3 
that it has AOS- and HPLactivities by substitution of lysine (K) by S (LeAOS3_K302S) (Toporkova et al., 
2010). PpAOS1 has S and PpHPL a C at this position. These residues were substituted by K 
(PpAOS1_S287K and PpHPL_C343K). 
Beside the F (AtAOS_F320, LeAOS3_F295) is a conserved N which substitution by a Q should abolish 
enzyme activity (Lee et al., 2008). Therefore PpAOS1_N281Q and PpHPL_N337Q were generated. 
With the generated variants of PpAOS1 and PpHPL spectroscopic analysis and product analysis were 
performed. 
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4.1.4.1 Spectroscopic analysis (UV/vis and CD) 
UV/vis spectra of PpHPL variants showed no significant changes (see Figure 3.19). They looked similar 
to the spectra of the wild type enzyme. Like the wild typeenzyme the different HPL variants appeared 
to contain low-spin-heme iron as it is characteristic for P450-enzymes (Noordermeer et al., 2001b). 
The heme content of PpHPL_F151L (45 %) is very similar to that of PpHPL wild type (46 %). 
PpHPL_A169S (31 %) and PpHPL_F151L, A169S (37 %) has light decreases in the heme content. 
CD spectra showed that the variants had a similar protein folding like the wild type (see Figure 3.20). 
As the CD spectrum of the wild type the CD spectra of the variants showed the typical peaks for 
proteins with a mainly α-helical fold (Panagakou et al., 2012). Thus these results showed that site-
directed mutagenesis had no effects on protein folding. 
4.1.4.2 Analysis of products (radio-HPLC) 
To analyze the influence of the single amino acid exchanges on enzyme activity products formed by 
the different PpAOS1 and PpHPL variants were analyzed by radio-HPLC. 
Incubations of the PpAOS1 variant in which the respective F was substituted by L (PpAOS1_F93L) 
showed that the product activity was altered from AOS- to HPLactivity paralleling the results 
obtained for substrate specific AtAOS. This effect on the activity was also observed for incubations 
with all 9- and 13-hydroperoxides as substrates (see Figure 3.21, Figure 3.22andFigure 9.2).This has 
before only been reported for AtAOS which has a preference for 13-hydroperoxides (Lee et al., 2008, 
Cho et al., 2011,Hughes et al., 2006a). Thus, the mutational studies of PpAOS1 of this work showed 
for the first time, that the AOS activity of an unspecific enzyme can also be converted to HPLactivity. 
It may be considered that site-directed mutagenesis of the AOS-specific F in PpHPL would increase 
the HPLactivity and decrease the inherent AOSactivity that was found in wild type. Radio-
HPLCanalysis showed that the product pattern of the variant, where the conserved AOS-specific F 
was substituted by HPL-specific L, was similar to that of wild type. Lee as well as Schaller have 
proposed reaction mechanisms for AOS and HPL with a common radical intermediate (epoxy allylic 
radical) and that product formation takes place by the property of stabilization of the radical by AOS-
specific F or not by HPL-specific L (Lee et al., 2008, Schaller and Stintzi, 2009). Brash also proposed 
that the enzymes have common intermediates and that they can be synthesized either through ionic 
or radical routes and that the unstable hemiacetal is possible through both routes (Brash, 2009). 
In other HPLs this proposed mechanisms may be possible. In case of HPL of Physcomitrella it could be 
that the occurrence of the AOS-specific F in the PpHPL-sequence instead of HPL-specific L is 
responsible for the inherent AOS activity. For HPL activity may other determinants be responsible. 
Substitution of HPL-specific A by AOS-specific S (PpHPL_A169S) showed also similar product pattern 
as the wild type. Also the double variant (PpHPL_F151L, A169S) did not show any alteration in its 
Discussion    89 
 
product pattern. These results suggest that determinants essential for AOS-catalysis are not essential 
for the activity in PpHPL. Therefore in PpHPL other determinants seem to be relevant for enzyme 
specificity. These findings are similar to those reported before for HPL of tomato (Lee et al., 2008), 
where the analogous double variant LeHPL_L101F, A119S exhibited only 5 % AOS activity. 
Generation of PpAOS1_S111A, PpAOS1_S287K, PpHPL_L336F and PpHPL_C343K were not successful. 
Additionally to the site-directed mutagenesis analysis of AOS and HPL a set of different StDES 
variants were generated for product analysis. The problem was that the expression of the mutants 
was too low to perform product analysis. Thus expression conditions have to be improved.  
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4.2 Biochemical characterization of BfEAS 
Recently EAS was beside AOS, DES and HPL reported as fourth member of the CYP74-enzymes (Lee 
et al., 2008). Until now the enzymes of EAS pathway were not detected in plants, only EAS products 
have been found in potato and rice (Hamberg, 1999, Feussner and Wasternack, 2002,Ohta et al., 
1990).However, EAS activity was very recently also observed in the rice pathogen Magnaporthe 
salvinii (Wennman and Oliw, 2012). Along these lines it has been discussed that EAS seems to be 
involved in pathogen defense (Feussner and Wasternack, 2002, Blée, 1998b). Therefore it is of 
interest to characterize the biochemical properties of this enzyme and to compare it with other 
CYP74-enzymes which have been found in plants. In this study EAS of the lancelet B. floridae was 
purified and used for kinetic and spectroscopic analysis. Product analysis was performed by radio-
HPLC and RP-HPLC/MS2. For further analysis site-directed mutagenesis were carried out. 
4.2.1 Spectroscopic analysis (UV/vis and CD) 
First a purification protocol was established that enabled the isolation of highly homogenous protein 
(see Figure 3.24). Analysis by size exclution chromatography determined a native molecular weight of 
60 kDa for BfEAS. Therefore BfEAS is like PpAOS1 a monomeric protein. 
With the purified enzyme further analysis were performed. Absorption profiles obtained by UV/vis 
analysis and CD analysis of BfEAS were similar to the analysis of PpAOS and PpHPL. The UV/vis 
spectrum confirmed the presence of the heme cofactor in BfEAS, because the spectrum showed 
characteristic absorption maximum at 420 nm. As the two AOS and the HPL of P. patens the EAS of 
B. floridae also seem to contain a low-spin heme-iron-III-complex, because high-spin-iron-III-complex 
characteristic maximum at 630 nm was not detected (see Figure 3.25). 
The heme content of BfEAS is about 37 % and almost similar to PpAOS1 (30 %) and PpHPL (46 %). 
The measured CD spectrum (see Figure 3.26) showed like PpAOS1 and PpHPL typical peaks for 
proteins with a mainly α-helical fold (Panagakou et al., 2012) and thus suggests that EAS might 
exhibit a similar over-all structure as AtAOS (Lee et al., 2008). 
4.2.2 Analysis of products (radio-HPLC and RP-HPLC/MS2) 
Analyses of products formed by incubations of BfEAS with hydroperoxides were analyzed by radio-
HPLC and RP-HPLC/MS2. 
Analysis of products by incubations with radio-labeled 9-and 13-hydroperoxides from LA and α-LeA 
showed different product patterns by radio-HPLC analysis. Exemplarily with 9-hydroperoxide derived 
from α-LeA as substrate the respective epoxyalcohol-derivative (12Z,15Z)-9-hydroxy-10,11-epoxy-
12,15-octadecadienoic acid was detected as the main product (see Figure 3.28 and Figure 3.30). In 
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addition formation of small amounts of the HPL product (9-oxo nonanoic acid) as well as the 
DESproduct (colnelenic acid) was detected (see Figure 3.28 and Figure 3.31). On the other hand 
incubations of BfEAS with 13-hydroperoxide derived from α-LeA mainly led to formation of the epoxy 
alcohol derivative (9Z,15Z)-11-hydroxy-12,13-epoxy-9,15-octadecadienoic acid as main product (see 
Figure 3.29 and Figure 3.32)and (9Z)-12-oxo-9-dodecenoic acid as the only side product (see Figure 
3.29). 
These findings suggest that conversions of 13-hydroperoxides from LA and α-LeA were more specific 
than conversions of 9-hydroperoxides from LA and α-LeA. The finding that during catalysis the 
characteristic products of EAS, DES and HPL arise reflects the close interconnection of the different 
enzymatic trajectories in catalysis of CYP74-enzymes and thus indicates that EAS, DES and HPL may 
have the same intermediate, an epoxy allylic radical, in catalysis (Brash, 2009). 
Since the C18 fatty acids LA and α-LeA are not the most abundant fatty acids in Branchiostoma it is 
questionable if the tested 9-and 13-hydroperoxides derived from LA and α-LeA are the natural 
substrates of BfEAS. The C22 fatty acid DHA is one of the most abundant fatty acids in B. floridae(Lee 
et al., 2008). Therefore by incubations of DHA with different LOXsisoforms various hydroperoxide 
isomers can be generated and used as substrates for BfEAS. In this study the products formed from 
incubations DHA with different LOXisoforms from soybean (GmLOX1), moss (PpLOX2), Arabidopsis 
(AtLOX1) and potato (StLOX) were analyzed by RP-HPLC/MS2 to identify the possible hydroperoxide 
isomers that may be used for EAS analysis. Extracted ion chromatograms, associated tandem mass 
spectra and potential fragment patterns were consistent to known patterns (Hong et al., 2007). 
Conversion of DHA by GmLOX1 led to the formation of 17-hydroperoxide (see Figure 3.33), whereas 
conversions of DHA by AtLXO1 and StLOX led to the formation of 10-hydroperoxide (see Figure 3.35 
and Figure 3.36), and by PpLOX the 14-hydroperoxide was generated (Figure 3.37). 
After the identification of various hydroperoxide isomers derived from DHA, conversions of BfEAS 
with this hydroperoxides were analyzed and indeed incubations of BfEAS with hydroperoxides 
derived from C22 fatty acid led to the formation of the corresponding epoxy alcohols (see Figure 
3.34and Figure 9.7 to Figure 9.9), where the hydroxygroup stays at its position and the epoxy group is 
at the adjacent double bond of the DHA-derived fatty acid hydroperoxide. 
4.2.3 Kinetic analysis (pH optimum and kinetic parameters) 
The determined pH optimum of BfEAS is similar to that of other CYP74-enzymes. BfEAS showed the 
highest activity at pH 6.75 (see Figure 3.38). This optimum is between the optima of both AOS 
isoforms of P. patens (PpAOS1 pH 6.5 and PpAOS2 pH 7.0 (Scholz et al., 2012). 
In B. floridae various fatty acids were the potential precursors of EAS substrates. As mentioned 
before B. floridae contains inter alia the C18 fatty acids LA and α-LeA as well as the C22 fatty acid DHA. 
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For determination of substrate preference the kinetic parameters KM and Vmax of BfEAS for 
conversions of 13-hydroperoxides derived from the C18 fatty acids and 17-hydroperoxide derived 
from the C22 fatty acid were measured. 
Kinetic analysis showed that BfEAS can use both 13-hydroperoxides derived from LA and α-LeA (see 
Figure 3.39) as well as 17-HPDHA derived from DHA (see Figure 3.40) as substrates. The kcat-values 
were calculated by considering heme occupancy of 37 % and showed that BfEAS has a preference for 
13α-HPOT as substrate. The kcat/KM-values of BfEAS for 13α-HPOT were similar to that of PpAOS1. 
The results of the first kinetic measurements and product analysis suggest that BfEAS can convert 
different hydroperoxy-substrates (9- and 13-hydroperoxides from LA and α-LeA as well as 10-, 14- 
and 17-hydroperoxides derived from DHA) to a large variety of different products. Products of 
incubations with 9- and 13-hydroperoxides are shown in Table 4.2. 
Table 4.2: Products formed by conversions of 9-and 13-hydroperoxides derived from C18 fatty acids LA and α-
LeA by BfEAS. 



























colneleic acid (CA) colnelenic acid (CnA) - - 
 
In Table 4.3 the products from incubations with 10-, 14- and 17-hydroperoxides are shown. 
Table 4.3: Products formed by conversions of 10-, 14-, and 17-hydroperoxides derived from C22 fatty acid DHA 
by BfEAS. 
















Thus, one may conclude that BfEAS is an unspecific enzyme like PpAOS1. However, in order to 
confirm this hypothesis it is essential to determine the substrate preference of BfEAS by analyzing 
the kinetic parameters for 9-hydroperoxides derived from LA and α-LeA as well as for 10- and 14-
hydroperoxides derived from DHA. Unfortunately measurements with 10- and 14-HPDHA as 
substrates could not be performed in frame of this thesis due to the limited amount of substrates 
available. Also, measurements of initial time-dependent consumptions of 9-hydroperoxides 
appeared to be difficult, because BfEAS has a broad product spectrum. As mentioned above beside 
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EAS products (epoxy alcohols) also HPL products (ω-oxo fatty acids) as well as DES products (divinyl 
ether) were detected. Therefore it is very difficult to get reasonable data for kcat, because the broad 
absorption maxima (252 nm to 268 nm) of the divinyl ethers that overlaps with those of the 
hydroperoxide substrates (234 nm). 
4.2.4 Mutagenesis 
In analogy to the mutagenesis analysis of PpAOS1, PpHPL, (StDES) and AtAOS essential residues in 
BfEAS were substituted to analyze if site-directed mutagenesis have an effect on the product 
formation. 
Sequence alignments showed that specific amino acid residues important for product specificity in 
AtAOS as mentioned above (Lee et al., 2008), were also conserved in BfEAS (see Figure 3.17). To 
analyze the importance of these residues in BfEAS site-directed mutagenesis were performed. BfEAS 
contains the AOS-specific F, that is thought be essential for AOS activity by stabilizing intermediary 
formed substrate radicals (Lee et al., 2008). This residue was substituted by the HPL-specific L 
(BfEAS_F58L). In addition an in EAS conserved P located at position 75 in BfEAS was substituted by a 
HPL-specific A (BfEAS_P75A) and the AOS-specific S (BfEAS_P75S). 
Lee and coworkers proposed that the conserved F, which is essential for AOSactivity, is located at 
position 60 in the BfEAS-sequence (AtAOS_F137) (Lee et al., 2008). This contradicts the alignments in 
this study where this particular F was located at position 58 in BfEAS. In order to investigate the 
molecular function of this amino acid in addition to that of the F58 a F60L variant was generated. 
Toporkova and coworkers determined another strictly conserved F in tomato AOS (LeAOS_F295) 
(Toporkova et al., 2008). This F is also strictly conserved in AOS and in HPLs except in PpHPL where L 
is at this position. DES have a conserved I at this position. To analyze the importance of this F 
BfEAS_F223I and BfEAS_F223L variants were generated. 
At position 224 an N-residue is located in BfEAS. This N is highly conserved in all CYP74-enzymes and 
kinetic analyzes of AtAOS_N321Q showed that enzyme activity was abolished (Lee et al., 2008). 
Therefore the N224 in BfEAS was substituted by Q (BfEAS_N224Q). 
Additionally to the site-directed mutagenesis of the activity determining amino acids residues a 
truncation variant was generated. CYP74-enzymes contain in contrast to classical P450-enzymes an 
insertion of 9AS in the near of the heme-binding loop. To analyze the molecular function of this 
insertion the BfEAS_9AS-deletion variant was generated and analyzed. 
The generated BfEAS variants were purified and then analyzed by spectroscopic analysis and product 
analysis. 
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4.2.4.1 Spectroscopic anaylsis (UV/vis and CD) 
Spectroscopic analysis of BfEAS variants were performed to get information about the influence of 
site-directed mutagenesis on the proteinfolding and the cofactor binding. 
UV/vis spectra of both variants (BfEAS_F58L and BfEAS_9AS-deletion) show absorption maxima for 
Soret-band and γ-band. In comparison to wild type the maxima for δ-band in both variants are 
considerably low. Unlike the wild type BfEAS_F58L shows no absorption maxima for α- and β-bands 
and BfEAS_9AS-deletion only small absorption maxima for β-band (see Figure 3.44). This data might 
indicate that the amino acid exchanges resulted in an altered micro-environment of the heme 
cofactor. However, the enzyme variants apparently contain hemeiron in its low-spin state, because 
signals at 630 nm, which were characteristic for high-spin iron-III-complexes were not detected. 
The heme content of BfEAS_F58L is 16 % and of BfEAS_9AS-deletion 2 %. Therefore the heme 
contents of the variants are lower than the content of wild type (37 %). The strong decrease of the 
heme content in BfEAS_9AS-deletion variant suggest that the deletion of the CYP74 9AS-insert, which 
is near the heme-binding loop, seem to have a significantly influence on proteinfolding. 
Like the wild type the CD spectra of the variants (see Figure 3.45) showed characteristics for proteins 
with a mainly α-helical fold (Panagakou et al., 2012). 
4.2.4.2 Analysis of products (radio-HPLC and RP-HPLC/MS2) 
The products formed by incubations of BfEAS variants with 9- and 13-hydroperoxides derived from 
LA and α-LeA was analyzed by radio-HPLC and RP-HPLC/MS2. 
The decrease of EAS activity in BfEAS_F58L variant by incubations with C18 fatty acid derived 
hydroperoxides indicates that the F at position 58 is essential for enzyme activity as it was also 
reported for AtAOS_F137L (Lee et al., 2008). The F is reported to stabilize the intermediately formed 
carbon-centered substrate radicals. Substitution of the aromatic F with HPL characteristic aliphatic L 
yielded a protein that cannot stabilize the substrate radical and therefore forms an unstable 
hemiacetal, which decomposes to short chain aldehydes (Grechkin and Hamberg, 2004). It was 
expected that mutagenesis of the EAS-specific F to L (BfEAS_F58L) might lead to an increase of the 
inherent HPL- or DESactivity which was found as sideactivity in BfEAS wild type. However, radio-HPLC 
analysis of products formed from incubations with 9-and 13-hydroperoxides with this variant showed 
no significant increase of ω-oxo fatty acids or divinyl ethers (see Figure 3.48, Figure 3.49 and Figure 
9.4).Nevertheless substitution of F at position 58 by L does not lead to an inactive protein since a 
decrease of the respective hydroperoxide substrates was observed. Incubations of BfEAS_P75A 
variant with 9- and 13-hydroperoxides showed similar product patterns like BfEAS_F58L. For 
substitution of EAS-specific P by HPL-specific A it was expected that EASactivity decreases and 
HPLactivity increases. However, the analyses showed that inherent HPLactivity showed no 
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significantly increases and that the product patterns were like that of BfEAS_F58L.The F58 and the 
P75 seem to be essential determinants for the formation of epoxy alcohols in BfEAS. Substitution of 
these determinants influenced the reaction mechanism in that way that EAS-route is disturbed and 
that the inherent activities (DES and HPL) appear to be unaffected. 
Analysis of BfEAS_9AS-deletion variant showed surprisingly that this enzyme variant still exhibits 
catalytic activity (see Figure 3.48, Figure 3.49and Figure 9.4). The product pattern was similar to wild 
type, but the deletion-variant formed the products in lower amounts than the wild type does 
indicating that the activity was highly impaired. BfEAS_9AS-deletion showed with hydroperoxides 
derived from LA strong decreases of the epoxy alcohol, whereas with hydroperoxides derived from α-
LeA only slight decreases of epoxy alcohol were detected. Kinetic analysis of the deletion variant 
could verify the lower activity of BfEAS_9AS-deletion variant. 
Radio-HPLC analyses of other generated variants (see Table 3.8) showed product patterns which 
were similar to that of wild type. Lee and coworkers reported for AtAOS that the substitution of N by 
Q (AtAOS_N321Q) abolish > 95 % activity (Lee et al., 2008). Radio-HPLC and RP-HPLC/MS2 analyses 
indicated that the BfEAS_N224Q variant exhibits a similar catalytic activity as the wild type. Thus 
these results suggest that the postulated concept for N/Q-substitution may not be applicable to all 
CYP74-enzymes. To investigate this aspect in more detail, additionally steady state kinetic analysis of 
BfEAS_N224Q is essential. Lee showed that the respective F for enzyme activity alteration is in BfEAS 
at position 60(Lee et al., 2008). Incubations of BfEAS_F60L with 9- and 13-hydroperoxides showed 
similar product patterns like wild type. The results of the product analysis performed in this work 
suggest that the respective F is at position 58 (BfEAS_F58L) and not at position 60. 
As shown in Table 3.8 the amount of products formed from hydroperoxides derived from LA was 
lower compared to that formed from LeA-analogous. This indicates that this enzyme variant might 
have a substrate preference for LeA-derived hydroperoxides. 
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5 Summary 
In this study recombinant CYP74-enzymes AOS1, AOS2 and HPL from the moss P. patens, DES from 
S. tuberosum and EAS from the lancelet B. floridae were expressed in E. coli and purified for further 
analysis. PpAOS1 and BfEAS were biochemically characterized. Substrate specificities against 
hydroperoxides derived from C18 fatty acids LA and α-LeA (PpAOS1 and BfEAS), C20 fatty acid ARA 
(PpAOS1) as well as C22 fatty acid DHA (BfEAS) and pH optima were determined. Both enzymes 
showed slightly acidic pH (PpAOS1 6.5 and BfEAS 6.75). UV/vis and CD spectroscopy analysis were 
performed to characterize the heme content and structure of the enzymes. 
Analysis of products of AOS, DES, EAS and HPL wild types showed that these enzymes have inherent 
side activities of the other enzymes beside their main enzyme activity. Thus PpHPL has inherent 
AOSactivity, PpAOS1 as well as StDES have inherent HPLactivity, whereas BfEAS has inherent HPL- 
and DESactivity. 
Site-directed mutagenesis was performed in order to identify amino acid residues essential for 
catalytic activity. Analysis of products of conversions of PpAOS1 with 9-and 13-hydroperoxides 
derived from LA and α-LeA showed that enzyme activity can be altered from AOS to HPL by 
substitution of an essential determinant (PpAOS1_F93L). This mutagenesis concept was reported 
before for an AOS from Arabidopsis (AtAOS) with specificity for 13-hydroperoxides (Lee et al., 2008). 
In the present study this concept has been extended to AOS with specificity for 9-and 13-
hydroperoxide. The results showed that this concept works for both specific and unspecific enzymes. 
For PpHPL this concept was not applicable suggesting that for the alteration of HPL activity other 
determinants were essential. 
Site-directed mutagenesis of StDES for product analysis generated mutants that had very low or no 
activity to perform the product analysis. 
All purified variants of BfEAS were catalytically active. Product analysis showed that the mutational 
concept of AtAOS (Lee et al., 2008) can also be applied to BfEAS. It was observed that EASactivity 
decreased by mutating the conserved F (BfEAS_F58L) and the conserved P (BfEAS_P75A). But unlike 
in AtAOS or in PpAOS1 no significant increase of HPLactivity was detected, because in comparison to 
the other formed products the amount of oxo fatty acids was nearly the same. DESactivity like in the 
wild type was not detected in the variants. The results suggest like in PpAOS1 that the concept can 
be applied to unspecific enzymes. BfEAS is like PpAOS1 and unspecific enzyme. 
The deletion of the 9AS-insert, which is characteristic for CYP74-enzyme, had no influence on 
enzymeactivity. The BfEAS_9AS-deletion variant was still active. 
Product analysis by RP-HPLC/MS2 confirmed the formation of epoxy alcohols by conversions of BfEAS 
with 9- and 13-hydroperoxides derived from LA and α-LeA. The detected fragment patterns were 
similar to that of wild type (Cristea and Oliw, 2006, Oliw et al., 2006). 
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Product analysis showed that the catalytic trajectories of PpAOS1 and PpHPL as well as BfEAS, DES 
and HPL are closely interconnected and can be interconverted by exchanges of special single amino 
acids. 
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6 Outlook 
In order to get further insights into the CYP74-catalysis different biochemical and biophysical 
experiments might be performed: On the one hand different heme intermediates formed during 
catalysis might be analyzed by performing time resolved UV/vis spectroscopy employing the stopped 
flow technique. Data derived from those experiments might further analyzed by performing freeze-
quench EPR-spectroscopy. In similar experiments on the other hand different substrate 
intermediates might be identified. Here it will be of special interest to investigate whether the 
different catalytic trajectories occur by a pure radical pathway or if also cationic intermediates might 
be formed as proposed recently (Brash, 2009). 
Additionally, X-ray crystallography might be used to determine the 3D-structure of other CYP74, 
because only AOS-structures have been solved in the field of the CYP74-enzymes (AtAOS and PaAOS) 
(Lee et al., 2008, Li et al., 2008). 
To get a further inside into the physiological role of the fourth CYP74-enzyme EAS was transferred 
into A. thaliana. As it is known that EAS derived oxylipins are thought to be involved in pathogen 
defense reactions (Feussner and Wasternack, 2002, Blée, 1998b). Thus it will be of interest to 
investigate if the recombinant plants are more resistant compared to wild type plants. 
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9.2 Alignment 
AtAOS           -------------------------------------------MASISTPFPISLHPKTV 17 
PaAOS           ------------------------------------------------------------ 
LeAOS3          ------------------------------------------------------------ 
PpAOS1          ------------------------------------------------------------ 
PpAOS2          ------------------------------------------------------------ 
AtHPL           ------------------------------------------------------------ 
LeHPL           ------------------------------------------------------------ 
PpHPL           ----------------------------MDRTLVLTCTTTCSHSAFRQSALPSNTSISVR 32 
StDES           ------------------------------------------------------------ 
AsDes           ------------------------------------------------------------ 
BfEAS           ------------------------------------------------------------ 
BfEAS_1         ------------------------------------------------------------ 
BfEAS_2         MGAGSVVGFDLTSCNIALDLIPVVEGLISKRKRNPFWYVWDDKGSEIFEKIATTSATYTL 60 
 
AtAOS           RSKPLKFRVLTRPIKASGSETPDLTVATRTGSKDLPIRNIPGNYGLPIVGPIKDRWDYFY 77 
PaAOS           ---------------------------MDPSSK--PLREIPGSYGIPFFQPIKDRLEYFY 31 
LeAOS3          ------------MANTKDSYHIITMDTKESSIPSLPMKEIPGDYGVPFFGAIKDRYDFHY 48 
PpAOS1          ---------------------------MAVPSSKLPLKAIPGDYGVPYFGAIKDRLDYFW 33 
PpAOS2          ---------------------------MAVPVSNLPLRAIPGGYGISYLGAIKDRLDYFW 33 
AtHPL           ------------------------------------------------------------ 
LeHPL           ---------------------MNSAPLSTPAPVTLPVRSIPGSYGLPLVGPIADRLDYFW 39 
PpHPL           LGTCSVRTQKRRTVVASLGNIETTSTSTVGQESNLPLREIPGSYGIPYLSQLLDRWTFFY 92 
StDES           ------------------------MSS-YSELSNLPIREIPGDYGFPIISAIKDRYDYFY 35 
AsDes           ----------------------MSTSNGSTENIQKPLRKIPDITGTPILTAIKDRLDFFY 38 
BfEAS           ------------------------------------------------------------ 
BfEAS_1         ------------------------------------------------------------ 
BfEAS_2         WKREFTLLQRKCNEIASKTTSPTILVELGSGASSKTRLIIEAMLKQHGSLTFVPVDIAKG 120 
 
AtAOS           DQG-AEEFFKSRIRKYNSTVYRVNMPP--GAFIAENPQVVALLDGKSFPVLFDVDKVEKK 134 
PaAOS           GTGGRDEYFRSRMQKYQSTVFRANMPP--GPFVSSNPKVIVLLDAKSFPILFDVSKVEKK 89 
LeAOS3          NQG-ADEFFRSRMKKYDSTVFRTNVPP--GPFNARNSKVVVLVDAVSYPILFDNSQVDKE 105 
PpAOS1          LQG-EEQFYRSRMAKYNSTVFRVNMPP--GPPISEHPQVICLLDQKSFPILFDVSKVEKK 90 
PpAOS2          IQG-EEEFYRSRVEKYNSTVFRVSMPP--GPPIAKDARVICVLDQKSFPILFDVNKCEKR 90 
AtHPL           -----------------------------------------------------MDLVDKR 7 
LeHPL           FQK-PENFFTKRMEKHKSTVFRTNVPPCFPFFGSVNPNVVAVLDVKSFSHLFDMEIVEKA 98 
PpHPL           REG-EPQFWQSRMAKYGSTVIRSNMPP--GWFWT-DSRCIMLLDQKSYPTVFDYDKVDKY 148 
StDES           NQG-EDAWFHNKAEKYKSTVVKINMAP--GPFTSNDYKLVAFLDANSFVCMFDNSLIDKT 92 
AsDes           NQG-QYEYFQSRVKKNNSTILRMNMIP--GPFAS-NPKIVALCDAASFPTLFDPSKVSKV 94 
BfEAS           ---MGNQVGTARLLGWGNQTLKPNREEDFVEKNIGFPCRVVTGNKAVQSVFD--IELFKK 55 
BfEAS_1         ---MGSVLGTLQLLGWNNQMLKPNREEDFVEKNIGFPCRVVTGNKTVQSVFD--IDLFKK 55 
BfEAS_2         RIIMGNALGYLKWLKSNNQAFAPDRHEDFVETNIGFPCRVVTGNKAVQSVFD--VDLFRK 178 
 
AtAOS           DLFTGTYMPSTELTGGYRILSYLDPSEPKHEKLKNLLFFLLKSSRNRIFPEFQATYSE-L 193 
PaAOS           DLFTGTYMPSTKLTGAYRVLSYLDPSEPRHAQLKNLLFFMLKNSSNRVIPQFETTYTE-L 148 
LeAOS3          NYFEGTFMSSPSFNGGYKVCGFLGTSDPKHTTLKGLFLSTLTRLHDKFIPIFTTSITS-M 164 
PpAOS1          DVFTGTYMPSVSFTSGYRVCSYLDPSEERHTKLKQWCFEVIAMNGRNFLPEFHKSIEE-S 149 
PpAOS2          DLFLGTYMPDLSYTSGHRVLSYLDPSEVRHEKLKQWCFDLIARNGRKFLPEFHTAMEE-S 149 
AtHPL           DVLIGDFRPSLGFYGGVRVGVYLDTTEPKHAKIKGFAMETLKRSSKVWLQELRSNLNI-F 66 
LeHPL           NVLVGDFMPSVVYTGDMRVCAYLDTSEPKHAQIKNFSQDILKRGSKTWVPTLLKELDT-M 157 
PpHPL           KAFAGTIMPSTEYNGGYEVCAYLDASDKKHEQLKGYCFELLKFSSSKWAREFHTAISE-T 207 
StDES           DTLGGTFKPGKEYYSGYRPVAFIDTKDPNHAALKGYILSAFAKRHNLFIPLFRNSLSDHL 152 
AsDes           NSLTGNYMPALSFTGGYRVCAYLDPSEPTHTKIKQVFFNAQAAKKDTFIPTFVSTFNS-M 153 
BfEAS           EEFCFGVA-EVRRDFTEGICPSVSSNGKIHEKNKGFLMEVIAKAGEGIPSSTASSVLS-- 112 
BfEAS_1         EEFCFGVVGEVRKDFTEGVCPCILSNGKIHEKNKGFLMEVIAKAGEDIPPSTALSVLS-- 113 
BfEAS_2         EEFYFGPI-EVRKDFTEGVCPSITSNGKIHERNKALMMDIIAEAYKEIPTSTANAVLS-- 235 
 
AtAOS           FDSLEKELSLKGKADFGGSSDGTAFNFLARAFYG---TNPADTKLKADAPGLITKWVLFN 250 
PaAOS           FEGLEAELAKNGKAAFNDVGEQAAFRFLGRAYFN---SNPEETKLGTSAPTLISSWVLFN 205 
LeAOS3          FTSLEKELSEKGTSYFNPIGDNLSFEFLFRLFCEG--KNPIDTSVGPNGPKIVDKWVFLQ 222 
PpAOS1          MVLWETSLAKGEKTSVSDEVKQFAFNFLMRAVCHHDPAAPGEYSLGRNGGPYATAWANPQ 209 
PpAOS2          FAVWEEAMEKGENANLSEEVQQFAFNFLVRAVLHHDPVAPGEASLGKNGGPYASAWHGPQ 209 
AtHPL           WGTIESEISKNGAASYIFPLQRCIFSFLCASLAG--VDASVSPDIAENGWKTINTWLALQ 124 
LeHPL           FTTFEADLSKSNTASLLPALQKFLFNFFSLTILG--ADPSVSPEIANSGYIFLDSWLAIQ 215 
PpHPL           FNQWEGKLAQKTPALINPTLPESLFSFVINALTTARFDDSSIPDAEKPVCGDLQKWAGFQ 267 
StDES           FNNLEKQVTEQGKSDFNALLPTMTFNFIFRLLCDQ--TNPSDTVLGAQGPEHLRKWLFPQ 210 
AsDes           FDKMDAEVESKKKAEFTKFNEAAVFEFVGLALVG---PKPAREVFDS-----AKKSVFFQ 205 
BfEAS           --NISKWGSTAMSDFESKLLAVAADTVLPNIFGESSSFNAEDIRLYIIGATEVRSCIVKA 170 
BfEAS_1         --NISKWGSTPMSDFESKLTDVAADAFLPNIFGESTHFHGEEIRLYRSGAIAVRLSIVKA 171 
BfEAS_2         --NIARWGRRPV-DFESKLFAVSAGALLPTIFGKTTHFNAEEIELYISGSTELRPDILAA 292 
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AtAOS           LHP--LLSIG-LPRVIEEPLIHTFSLPPALVKSDYQRLYEFFLESAGEILVEADK-LGIS 306 
PaAOS           LAP--TLDLG-LPWFLQEPLLHTFRLPAFLIKSTYNKLYDYFQSVATPVMEQAEK-LGVP 261 
LeAOS3          LAPLISLGLKFVPNFLEDLVLHTFPLPYILVKRDHQKLYNAFYNSMKDILDEAEK-LGVK 281 
PpAOS1          LAP--IAGQTGLPHVVEELVLHTVPLPSALVKKNYDALYNFIKNYATEALDRAEA-MGIE 266 
PpAOS2          LAP--IAGQTGLPHAVEEL-LHTIRLPSSVVKEQYDALYNFFKTYGGEELDRAVA-LGIK 265 
AtHPL           VIP--TAKLGVVPQPLEEILLHTWPYPSLLIAGNYKKLYNFIDENAGDCLRLGQEEFGLT 182 
LeHPL           LAP--TVSIGVL-QPLEEILVHSFAYPFFLVKGNYEKLVQFVKNEAKEVLSRAQTGFQLT 272 
PpHPL           LMP---VIRTGAPIYIEEM-LHVAPIPASLTKGGYDKMVVFLQKYAAETLSIAEK-FGLS 322 
StDES           LIP--SLSAKKLPNIIEDTLFHNFLIPFGFIKSDYNKLVDAFSKSAVSILDEAEK-LGIK 267 
AsDes           FHP--FITAG-LPALVEELAFHMFPFPSFVAKSSYKILYEYFSTGGSWILDNAEE-IGLS 261 
BfEAS           LT---------SKNLDEERQAMRSIIGKIKTSERYQQLMDLGHAYG------------LG 209 
BfEAS_1         LT---------GRNLDEERRAMTSILEKIKTSERYQQLLDLGKSYG------------LG 210 
BfEAS_2         LLE--------GKDLAEGRPAMAYVLEKMKTSERYHQLIDLGKSHG------------FG 332 
 
AtAOS           REEATHNLLFATCFNTWGGMKILFPNMV-KRIGRAGHQVHNRLAEEIRSVIKSNG-GELT 364 
PaAOS           KDEAVHNILFAVCFNTFGGVKILFPNTL-KWIGVAGENLHTQLAEEIRGAIKSYGDGNVT 320 
LeAOS3          RDEACHNFVFLAGFNSYGGLKVFFPSLI-KWIGTSGPSLHARLVKEIRTAVKEAG-G-VT 338 
PpAOS1          RNDATANLLFFLCFNAYGGFSIFFPLIT-ILISSCGPELMHDLHDEVTKAVAATD-GKVT 324 
PpAOS2          RDDAIANLLFLLGFNAYGGFNFFFPQLT-GHIAQCGPELMHELHEEVVAAVQATE-GKVT 323 
AtHPL           RDEAIQNLLFVLGFNAYGGFSVFLPSLIGRITGD-NSGLQERIRTEVRRVCGSGS-D-LN 239 
LeHPL           EQEAIHNLLFILGFNAFGGFSIFLPTLLGNLGDEKNADMQEKLRKEVRDKVGVNP-ENLS 331 
PpHPL           QDEAVHNLIFFLILNAHGGFCRFLPVIL-REVAKNG-QLQADLREEVRAAVKASGSDQVT 380 
StDES           REEAVQNILFLVGINMFAGLNAFSPHLF-RFVGEAGASLHTQLAKEIRTVIKEEG-GAIT 325 
AsDes           REEAIHHLIFTWAINAYLGIRTCLMRLF-KWIVASGPDLQEKLAREVRSVVRSEE-GKIT 319 
BfEAS           EAETTAQLLLPVFFNGVAGIRANLVSSF-ARLDTISAEDREELREEALAALKKHG--GLT 266 
BfEAS_1         EKEATAQLLFPVFINGAYGLAAHLVCTF-ACLDTISAEDREELREEALAALKNHR--GLT 267 
BfEAS_2         EKETTGQLLFSIMFNGVGGMAVNLVPSF-AHLDTISAEDREELREEALAALKKHG--GLT 389 
 
AtAOS           MGAIEK-MELTKS-----VVYECLRFEPPVTAQYG-----RAKKDLVIESHDAA------ 407 
PaAOS           LEAIEQ-MPLTKS-----VVYESLRIEPPVPPQYG-----KAKSNFTIESHDAT------ 363 
LeAOS3          LSAIDK-MPLVKS-----VVYETLRMDPPVPFQTV-----KARKNIIITNHESS------ 381 
PpAOS1          LQSIEN-MPLVKS-----VVYEAFRFKPPVPYQYG-----KAKFDFTIENHENS------ 367 
PpAOS2          PKSLEN-MPLLSS-----VVYEGFRMKPPVPYQYA-----RAKTDFLIESHENS------ 366 
AtHPL           FKTVNE-MELVKS-----VVYETLRFSPPVPLQFA-----RARKDFQISSHDAV------ 282 
LeHPL           FESVKE-MELVQS-----FVYETLRLSPPVPSQYA-----RARKDFKLSSHDSV------ 374 
PpHPL           MKAVMNDMPLVAS-----TVFEALRFDPPVPFQYA-----RAKKDFIIESHDAR------ 424 
StDES           LSAINK-MSLVKS-----VVYETLRLRPPVPLQYG-----KAKKDFMVQSHDAS------ 368 
AsDes           FAGIEK-MELVKS-----VAYESFRFDPPVQVQYG-----TAKSDLIIESHDGK------ 362 
BfEAS           RESLEE-MPKMES-----FVLEVLRACPSPMFWST-IATRPTTVEYTTDSGEHA------ 313 
BfEAS_1         RESLEE-MPKIES-----FVLEVLRFCPNPVFWST-IATCPTTVEYTTDSGEHT------ 314 
BfEAS_2         REALAE-MPKIES-----FVLEVLRACPAPDFWST-IATRPTTVKYSTESGPQE------ 436 
 
AtAOS           FKVKAGEMLYGYQPLATRDPKIFD-RADEFVPERFVGEEGEKLLRHVLWSNGPETETPTV 466 
PaAOS           FEVKKGEMLFGYQPFATKDPKVFD-RPEEFVPDRFVGD-GEALLKYVWWSNGPETESPTV 421 
LeAOS3          FLIKKDELIFGYQPLATKDSKVFK-NAEEFNPDRFVGG-GEKLLKYVYWSNGKEIDNPSV 439 
PpAOS1          FEVKKGEMLYGYQPIVMHDPKVFS-DPDQFLPRRFMGPDGEKLIKYIFWSNGYETDEPTT 426 
PpAOS2          FEVKKGEMLYGFQPYVMHDPNVFE-NPDKFLPRRFMGPEGEALLGNVFWSNGRETDDPTV 425 
AtHPL           FEVKKGELLCGYQPLVMRDANVFD-EPEEFKPDRYVGETGSELLNYLYWSNGPQTGTPSA 341 
LeHPL           YEIKKGELLCGYQPLVMKDPKVFD-EPEKFVLERFTKEKGKELLNYLFWSNGPQTGRPTE 433 
PpHPL           YQIKTGDFLGGVNYMVSRDPKVFTDRPNEFNARRFMGPEGDKLLAHLVWSNGRQTDETTV 484 
StDES           YKINKGQFVVGYQPMASRDPKIFA-NPDEFVPDRFMND-GEKMLKHVLWSNGRETENPAP 426 
AsDes           YQVKKGEMLCGFQPMATRDPKVFD-RADEFVPDRFMGD-GKKLVKHVLWANGYGTDAPKA 420 
BfEAS           LKIKEGERVYASSYWALRDPAVFD-KPEDFMWRRFLGPEGDARRKHHVIFHGRLTDTPAV 372 
BfEAS_1         LKIEEGERVYASSYWALRDPAVFD-KPEDFMWRRFLGPEGDALRKHHVTFHGRLTDTPAV 373 
BfEAS_2         VEIKEGERVYASSYWALRDPAVFD-KPDNFMWRRFLGPEDKARREHHVTFHGRLIDTPAT 495 
 
AtAOS           GNKQCAGK--DFVVLVARLFVIEIFRRYDSFDIEVGTSPLGSSVNFSSLRKASF------ 518 
PaAOS           ENKQCAGK--DFVVLITRLFVIELFRRYDSFEIELGESPLGAAVTLTFLKRASI------ 473 
LeAOS3          NDKQCPGK--DLIVLMGRLLVVEFFMRYDTFEVEFGKLLLGSKVTFKSLTKATS------ 491 
PpAOS1          ANKQCAGK--DLVVTMARAFVAEMFLRYKEYTLTMEGAGNATKVFFSDLKK--------- 475 
PpAOS2          HDKQCAGK--DLAVTISRAYVAEMFLRYKEFTLEVQGSGVQTTLLFSALQKA-------- 475 
AtHPL           SNKQCAAK--DIVTLTASLLVADLFLRYDTITGDSG--------SIKAVVKAK------- 384 
LeHPL           SNKQCAAK--DMVTLTASLIVAYIFQKYDSVSFSSG--------SLTSVKKAS------- 476 
PpHPL           YTKQCAGK--EIVPLTGRLLLAELFMRFDSFNIEG----LEMEATFTSLTPRSD------ 532 
StDES           DNKQCPGK--DLVHLLGRLILVEFFMRYDTFTVEITPLFRAPNVAFKTLTKASK------ 478 
AsDes           DDKICAGK--DLGVLVGRLLIAVMFLRYDKIGGVVGKTMEEVDVIVNELTKVAV------ 472 
BfEAS           NNHMCPGRDVSLSALKGSIAIFNTFFGWELQEPPVWTGTKMTRGSQPDYEVKIKSFWVQH 432 
BfEAS_1         NNHMCPGKDVSLSALKGSIAIFNTFFGWELQEPPFWTGKKLSRGSLPDNEVKIKSFWVQH 433 
BfEAS_2         NNHMCPGKDVGLSVIKGSIALLNTFFGWELEEPPVWTGTKAARLGQPDNEVNINTFWLQH 555 
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AtAOS           ------------------------------------------------------------ 
PaAOS           ------------------------------------------------------------ 
LeAOS3          ------------------------------------------------------------ 
PpAOS1          ------------------------------------------------------------ 
PpAOS2          ------------------------------------------------------------ 
AtHPL           ------------------------------------------------------------ 
LeHPL           ------------------------------------------------------------ 
PpHPL           ------------------------------------------------------------ 
StDES           ------------------------------------------------------------ 
AsDes           ------------------------------------------------------------ 
BfEAS           PEDLKEIFPSHFRDIID------------------------------EADDVDDIDVLVK 462 
BfEAS_1         PEDLKEIFPSHFQDIVN------------------------------EVDDVGDIDVLVK 463 
BfEAS_2         PNDLKAVFPSYFDDIIDGLNKNP------------------------EDSDVAGIDVLVK 591 
 
AtAOS           ------------------------------------------------------------ 
PaAOS           ------------------------------------------------------------ 
LeAOS3          ------------------------------------------------------------ 
PpAOS1          ------------------------------------------------------------ 
PpAOS2          ------------------------------------------------------------ 
AtHPL           ------------------------------------------------------------ 
LeHPL           ------------------------------------------------------------ 
PpHPL           ------------------------------------------------------------ 
StDES           ------------------------------------------------------------ 
AsDes           ------------------------------------------------------------ 
BfEAS           TKTGTYSGSGTNSNVYIRLFDDKGHQSRELQLDVWWKNDFEKGQEGQYKLKDVKVAA--- 519 
BfEAS_1         TKTGKYSGSGTNSNVYIRLFDDKGHQSRELQLDVWWKDDFEKGQEGQYKLKDIKVAA--- 520 
BfEAS_2         TKTGKYRGSGTNSNVYIRLYDDKGHQSRELKLDVWWKNDFERGQKGQYKLKDVKVAA--- 648 
 
AtAOS           ------------------------------------------------------------ 
PaAOS           ------------------------------------------------------------ 
LeAOS3          ------------------------------------------------------------ 
PpAOS1          ------------------------------------------------------------ 
PpAOS2          ------------------------------------------------------------ 
AtHPL           ------------------------------------------------------------ 
LeHPL           ------------------------------------------------------------ 
PpHPL           ------------------------------------------------------------ 
StDES           ------------------------------------------------------------ 
AsDes           ------------------------------------------------------------ 
BfEAS           ----PIVKIELFRDGCQPDDDWYCESVSVQLNPDNSGPTYDFSV------NRWIRQNDHV 569 
BfEAS_1         ----PIVKIELFRDGCHPDDDWYCESVSVQLNPDNNGPTYDFPV------NRWIRQNDHV 570 
BfEAS_2         ----PIVKIELFRDGCHPDDDWYCESVSVQLNPDKKGPTYDFPV------NRWIRQNDHV 698 
 
AtAOS           ----------------------------- 
PaAOS           ----------------------------- 
LeAOS3          ----------------------------- 
PpAOS1          ----------------------------- 
PpAOS2          ----------------------------- 
AtHPL           ----------------------------- 
LeHPL           ----------------------------- 
PpHPL           ----------------------------- 
StDES           ----------------------------- 
AsDes           ----------------------------- 
BfEAS           WLCPGGCEGPQDDVNPKDD---------- 588 
BfEAS_1         WLSPGGGEPPKDDVNPIDD---------- 589 
BfEAS_2         WLSAGGCEPTKDDMKPKDG---------- 717 
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9.3 Primer 



















































Appendix    116 
 
9.4 Additional Figures 
9.4.1 Biochemical characterization of CYP74-enzymes from P. patens 
9.4.1.1 Analysis of products(wild types) 
 
Figure 9.1: Product analyses from incubation of PpAOS1 and PpHPL with [1-
14
C]-9α-HPOT (A) andwith [1-
14
C]-
13-HPOD (B). The purified enzymes as well as only buffer (control) were incubated with the radio-labeled 
substrate for approx. 30 min at RT. After extraction with diethyl ether the products were analyzed by RP-HPLC 
coupled to a radio-detector. The chromatograms shown are representative for three to four(A) and three to 
five (B) experiments. 
9.4.1.2 Analysis of products (site-directed mutagenesis) 
 
Figure 9.2: Product analyses of PpAOS_F93L with [1-
14
C]-9α-HPOT (A) andwith [1-
14
C]-13-HPOD (B) in 
comparison to the PpAOS1 and PpHPL wild types. The purified enzymes as well as only buffer (control) were 
incubated with the radio-labeled substrate for approx. 30 min at RT. After extraction with diethyl ether the 
products were analyzed by RP-HPLC coupled to a radio-detector. The chromatograms shown are representative 
for two to four(A) and two to five (B) experiments. 
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9.4.2 Biochemical characterization of BfEAS 
9.4.2.1 Analysis of products (wild type) 
 
Figure 9.3: Product analyses from incubation of BfEAS with [1-
14
C]-9-HPOD (A) and with [1-
14
C]-13-HPOD (B). 
The purified enzyme was incubated with the radio-labeled substrate for approx. 30 min at RT. After extraction 
with diethyl ether the products were analyzed by RP-HPLC coupled to a radio-detector. The chromatograms 
shown are representative for three (A) and for five (B) experiments. 
9.4.2.2 Analysis of products (site-directed mutagenesis) 
 





C]-13-HPOD (B) in comparison to BfEAS wild type. The purified enzymes were incubated with the 
radio-labeled substrate for approx. 30 min at RT. After extraction with diethyl ether the products were 
analyzed by RP-HPLC coupled to a radio-detector. The chromatograms shown are representative for two to 
three (A) and two to five (B) experiments. 









































































































































































































-analysis of products formed by incubation of BfEAS with 9-HPOD. Shown are the 





-analysis of products formed by incubation of BfEAS with 13-HPOD. Shown are the 





-analysis of products formed by incubation of AtLOX1 with DHA. Shown are the 
extracted ion chromatograms m/z 343 and the associated tandem mass spectrum of 10-HDHA. 
9_Wt #565-757 RT: 6.66-8.92 AV: 97 NL: 6.57E6
F: - c ESI d Full ms2 311.16@40.00 [ 75.00-325.00]
























































RT: 0.00 - 44.99 SM: 7B

























































RT: 0.00 - 45.00 SM: 7B


























































13_Wt #647-835 RT: 8.16-10.38 AV: 95 NL: 6.73E6
F: - c ESI d Full ms2 311.39@40.00 [ 75.00-325.00]





























































RT: 0.00 - 45.00 SM: 7B





















































atlox1DHA #1511-1604 RT: 22.27-23.45 AV: 47 NL: 2.82E6
F: - c ESI d Full ms2 343.16@40.00 [ 80.00-355.00]

























































-analysis of products formed by incubation of StLOX with DHA. Shown are the 





-analysis of products formed by incubation of PpLOX with DHA. Shown are the 




RT: 0.00 - 45.00 SM: 7B





















































stloxDHA #1551-1634 RT: 22.02-23.01 AV: 42 NL: 5.15E6
F: - c ESI d Full ms2 343.16@40.00 [ 80.00-355.00]





















































RT: 0.00 - 44.98 SM: 7B










































































PpLOX_DHA #1365-1373 RT: 20.74-20.88 AV: 3 NL: 3.76E4
F - c ESI d Full ms2 343.18@40.00 [ 80.00-355.00]
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10 List of abbreviations 
°C     Degree Celsius 
®     Registered trademark 
™     Trademark 
ADH     Alcohol dehydrogenase 
AOC     Allene oxide cyclase 
AOS     Allene oxide synthase 
approx.     approximately 
APS     Ammonium persulfate 
ARA     Arachidonic acid 
CA     Colneleic acid 
CD     Circular Dichroism 
cDNA complementary deoxyribonucleic acid 
cm Centimeter 
CnA     Colnelenic acid 
C-terminal    Carboxy terminal 
CYP     Cytochrome P 
d     Day 
DAD     Diode array detector 
ddH2O     Double distilled water 
DES     Divinylether synthase 
DHA     Docosahexaenoic acid 
DNA     Deoxyribonucleic acid 
dNTP  Deoxynucleotidetriphosphate 
DTT  Dithiothreitol 
E     trans configuration 
e. g.     exempli gratia (for example) 
EA     Etheroleic acid 
EAS     Epoxyalcohole synthase 
E. coli     Escherichia coli 
EDTA     Ethylenediaminetetraacetic acid 
EnA     Etherolenic acid 
12,13S-EOT (9Z,11E,13S,15Z)-12,13-epoxy-9,11,15-octadecatrienoic acid 
EPA     Eicosapentaenoic acid 
ESI     Electro spray ionization 
et al.     et alii, et aliae; and others 
EtOH     Ethanol 
g     gravitation acceleration 
g     Gram 
h     Hour 
HCl     Hydrochloric acid 









9-H(P)OD (9S,10E,12Z)-9-hydro(pero)xy-10,12-octadecadienoic acid 











HPL Hydroperoxide lyase 
HPLC High Performance Liquid Chromatography 
IMAC Immobilized Metal Affinity Chromatography 
inter alia among other things 
IPTG Isopropyl β-D-thiogalactopyranoside 
JA     Jasmonic acid 
KAc     Calium acetate 
kb     Kilobasepair 
kcat     turnover number 
kDa     Kilo Dalton 
KM     Michaelis constant 
KOD     Ketodiene/Keto octadecadienoic acid 
KOT     Ketotriene/Keto octadecatrienoic acid 
kV     Kilovolt 
L     Liter 
LA     Linoleic acid 
LB     Luria-Bertani 
α-LeA     Alpha-linolenic acid 
γ-LeA     Gamma-linolenic acid 
log     Decadic logarithm 
LOX     Lipoxygenase 
M     Molar (mole per liter) 
mA     Milliampere 
mg     Milligram 
MgAc     Magnesium acetate 
MgCl2     Magnesium chloride 
min     Minute 
ml     Milliliter 
mM     Millimol per liter 
MS     Mass spectrometry 
m/z     Ratio of mass to charge 
µ     Micro 
µg     Microgram 
µL     Microliter 
µm     Micrometer 
µM     Micromol pro Liter 
µmol     Micromol 
NaAc     Sodium acetate 
NaCl     Sodium chloride 
NAD(P)H    Nicotinamide adenine dinucleotide phosphate 
n. d.     Not detected 
ng     Nanogram 
nm     Nanometer 
nM     Nanomol 
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N-terminal    Amino-terminus 
ODx     Optical density at a wavelenght of X nm 
12-OPDA    (10Z,15Z)-12-oxo-10,15-phytodienoic acid 
OPR3     12-oxo-phytodienoic acid-reductase isoform 3 
PAGE     PolyAcrylamide GelElektrophoresis 
PCR Polymerase Chain Reaction 
pH Negative decadic logarithm of hydrogen ion activity 
pmol pico Mol 
PMSF Phenylmethanesulfonyl fluoride 
P. patens    Physcomitrella patens 
PUFA PolyUnsaturated Fatty Acids 
PXG Peroxygenase 
RP     Reversed Phase 
rpm     rotations per minute 
RT     Room temperature 
s     Second 
SDS     Sodium DodecylSulfate 
SP     Straight Phase 
TAE     Tris-acetate-EDTA 
TEMED N,N,N,N-tetramethylenediamine 
TFA     Trifluoroacetic acid 
Tris     2-Amino-2-hydroxymethyl-propane-1,3diol 
UV     Ultra Violette 
v     reaction rate 
V     Volt 
Vol     Volume 
vis     visible 
Vmax     Maximum reaction rate 
v/v     Volume per volume 
w/v     Weight per volume 
Wt     Wild type 
YT     Yeast Extract Tryptone 




List of figures    123 
 
11 List of figures 
Figure 1.1: Synthesis of hydroperoxides derived from LA by 9-LOX or 13-LOX (adapted from (Stumpe 
and Feussner, 2006)). .............................................................................................................................. 2 
 
Figure 1.2: Formation of oxylipins in plants (adapted from (Göbel et al., 2001)). .................................. 3 
 
Figure 1.3: Phylogenetic analysis of different CYP74 enzymes from different plant species (taken from 
(Scholz et al., 2012)). ............................................................................................................................... 5 
 
Figure 1.4: AOS pathway for the conversion of 13-HPOT (adapted from (Stumpe and Feussner, 
2006)). ..................................................................................................................................................... 7 
 
Figure 1.5: HPL pathway for the conversion of α-LeA (adapted from (Stumpe and Feussner, 2006)). .. 8 
 
Figure 1.6: DES pathway for the conversion of α-LeA (adapted from (Hamberg, 2004)). ...................... 9 
 
Figure 1.7: EAS pathway for the conversion of α-LeA. .......................................................................... 10 
 
Figure 1.8: Proposed reaction mechanisms for CYP74-enzymes (adapted from (Schaller and Stintzi, 
2009)). ................................................................................................................................................... 12 
 
Figure 1.9: Proposed potential intermediates in radical and ionic pathways to CYP74 products 
(adapted from (Brash, 2009)). ............................................................................................................... 13 
 
Figure 3.1: SDS-PAGE analysis of PpAOS1 purification by stepwise elution. ........................................ 35 
 
Figure 3.2: SDS-PAGE analysis of PpAOS1 purification by gradual elution.. ......................................... 36 
 
Figure 3.3: SDS-PAGE analysis of PpHPL (A, B) and PpAOS2 (C) purification. ....................................... 37 
 
Figure 3.4: UV/vis spectra of purified PpAOS1 (A), PpAOS2 (B) and PpHPL (C). ................................... 39 
 
Figure 3.5: CD spectrum of purified PpHPL. .......................................................................................... 40 
 
Figure 3.6: CD spectrum of purified PpAOS1. ....................................................................................... 40 
 
Figure 3.7: Product analysis of PpAOS1 and PpHPL with [1-14C]-9-HPOD. ............................................ 42 
 
Figure 3.8: Product analysis of PpAOS1 and PpHPL with [1-14C]-13α-HPOT. ........................................ 43 
 
Figure 3.9: Product analysis of StDES with [1-14C]-9α-HPOT. ................................................................ 44 
 
List of figures    124 
 
Figure 3.10: RP-HPLC/MS2-analysis of products formed by incubation of PpAOS1 with 13α-HPOT (γ-
ketol)...................................................................................................................................................... 45 
 
Figure 3.11: RP-HPLC/MS2-analysis of products formed by incubation of PpAOS1 with 13α-HPOT (α-
ketol)...................................................................................................................................................... 45 
 
Figure 3.12: RP-HPLC/MS2-analysis of products formed by incubation of PpAOS1 with 13α-HPOT 
(cyclopentenone).. ................................................................................................................................ 46 
 
Figure 3.13: RP-HPLC/MS2-analysis of products formed by incubation of PpHPL with 13α-HPOT (α- 
and γ-ketol)............................................................................................................................................ 47 
 
Figure 3.14: The pH optimum of PpAOS1 with 13-HPOD. ..................................................................... 47 
 
Figure 3.15: Kinetic analyses of PpAOS1 with different hydroperoxides from C18 fatty acids as 
substrates. ............................................................................................................................................. 49 
 
Figure 3.16: Kinetic analysis of PpAOS1 with 12-HPETE. ....................................................................... 50 
 
Figure 3.17: Partial multiple sequence alignment of different CYP74-enzymes from different plant 
species and marine invertebrates. ........................................................................................................ 51 
 
Figure 3.18: Partial multiple sequence alignment of different CYP74-enzymes from different plant 
species and marine invertebrates. ........................................................................................................ 52 
 
Figure 3.19: UV/vis spectra of purified PpHPL_F151L (A), PpHPL_A169S (B), and PpHPL_F151L, A169S 
(C) in comparison to the wild type (D). ................................................................................................. 53 
 
Figure 3.20: CD sepcra of purified variants from PpHPL in comparison to the wild type. .................... 54 
 
Figure 3.21: Product analysis of PpAOS_F93L with [1-14C]-9-HPOD in comparison to the PpAOS1 and 
PpHPL wild types. .................................................................................................................................. 55 
 
Figure 3.22: Product analysis of PpAOS_F93L with [1-14C]-13α-HPOT in comparison to the PpAOS1 
and PpHPL wild types. ........................................................................................................................... 56 
 
Figure 3.23: SDS-PAGE analyses of BfEAS purified from different E. coli BL21 Star cultivations (11 °C or 
at 28 °C for 1 d). ..................................................................................................................................... 58 
 
Figure 3.24: SDS-PAGE of purified BfEAS expression at 16 °C for 3 d. .................................................. 59 
 
Figure 3.25: UV/vis spectrum of purified BfEAS in 50 mM sodium phosphate buffer, pH 8.0. ............ 60 
 
Figure 3.26: CD sepctrum of purified BfEAS. ......................................................................................... 61 
List of figures    125 
 
 
Figure 3.27: Structure of ω-3 fatty acid docosahexaenoic acid (DHA) and its possible ten positions 
that may be oxidized enzymes. ............................................................................................................. 61 
 
Figure 3.28: Product analysis from incubation of BfEAS with [1-14C]-9α-HPOT.. .................................. 62 
 
Figure 3.29: Product analysis from incubation of BfEAS with [1-14C]-13α-HPOT. ................................. 63 
 
Figure 3.30: RP-HPLC/MS2-analysis of products formed by incubation of BfEAS with 9α-HPOT. ......... 64 
 
Figure 3.31: RP-HPLC/MS2-analysis of products formed by incubation of BfEAS with 9α-HPOT (divinyl 
ether). .................................................................................................................................................... 65 
 
Figure 3.32: RP-HPLC/MS2-analysis of products formed by incubation of BfEAS with 13α-HPOT. ....... 65 
 
Figure 3.33: RP-HPLC/MS2-analysis of products formed by incubation of GmLOX1 with DHA. ........... 66 
 
Figure 3.34: RP-HPLC/MS2-analysis of products formed by incubation of GmLOX1 with DHA and 
BfEAS. .................................................................................................................................................... 67 
 
Figure 3.35: RP-HPLC/MS2-analysis of products formed by incubation of AtLOX1 with DHA and BfEAS.
 ............................................................................................................................................................... 67 
 
Figure 3.36: RP-HPLC/MS2-analysis of products formed by incubation of StLOX with DHA and BfEAS.
 ............................................................................................................................................................... 68 
 
Figure 3.37: RP-HPLC/MS2-analysis of products formed by incubation of PpLOX with DHA and BfEAS.
 ............................................................................................................................................................... 68 
 
Figure 3.38: The pH optimum of BfEAS with 13-HPOD. ........................................................................ 69 
 
Figure 3.39: Kinetic analyses of BfEAS with 13-HPOD (A) and 13α-HPOT (B). ...................................... 70 
 
Figure 3.40: Kinetic analysis of BfEAS with 17-HPDHA. ......................................................................... 70 
 
Figure 3.41: Partial multiple sequence alignment of different CYP74 enzymes from different plant 
species and marine invertebrates. ........................................................................................................ 72 
 
Figure 3.42: Partial multiple sequence alignment of different CYP74 enzymes from different plant 
species and marine invertebrates. ........................................................................................................ 73 
 
Figure 3.43: SDS-PAGE analysis of purified BfEAS_9AS-deletion. ......................................................... 74 
 
List of figures    126 
 
Figure 3.44: UV/vis spectra of purified BfEAS_F58L (A) and BfEAS_9AS-deletion (B) in comparison to 
the BfEAS wild type (C). ......................................................................................................................... 75 
 
Figure 3.45: CD sepcra of purified BfEAS_F58L (A) and BfEAS_9AS-deletion (B) in comparison to BfEAS 
wild type (C)........................................................................................................................................... 76 
 
Figure 3.46: Product analysis from incubation of BfEAS, BfEAS_F58L, and BfEAS_9AS-deletion with [1-
14C]-9α-HPOT. ........................................................................................................................................ 77 
 
Figure 3.47: Product analysis from incubation of BfEAS, BfEAS_F58L, and BfEAS_9AS-deletion with [1-
14C]-13α-HPOT. ...................................................................................................................................... 78 
 
Figure 3.48: RP-HPLC/MS2-analysis of products formed by incubation of BfEAS_F58L with 9α-HPOT in 
comparison to the wild type (insertion). ............................................................................................... 80 
 
Figure 3.49: RP-HPLC/MS2-analysis of products formed by incubation of BfEAS_F58L with 13α-HPOT 
in comparison to the wild type (insertion). ........................................................................................... 81 
 
Figure 9.1: Product analyses from incubation of PpAOS1 and PpHPL with [1-14C]-9α-HPOT (A) and 
with [1-14C]-13-HPOD (B). .................................................................................................................... 116 
 
Figure 9.2: Product analyses of PpAOS_F93L with [1-14C]-9α-HPOT (A) and with [1-14C]-13-HPOD (B) in 
comparison to the PpAOS1 and PpHPL wild types. ............................................................................. 116 
 
Figure 9.3: Product analyses from incubation of BfEAS with [1-14C]-9-HPOD (A) and with [1-14C]-13-
HPOD (B). ............................................................................................................................................. 117 
 
Figure 9.4: Product analyses from incubation of BfEAS_F58L and BfEAS_9AS-deletion with [1-14C]-9-
HPOD (A) and with [1-14C]-13-HPOD (B) in comparison to BfEAS wild type. ...................................... 117 
 
Figure 9.5: RP-HPLC/MS2-analysis of products formed by incubation of BfEAS with 9-HPOD. .......... 118 
 
Figure 9.6: RP-HPLC/MS2-analysis of products formed by incubation of BfEAS with 13-HPOD. ........ 118 
 
Figure 9.7: RP-HPLC/MS2-analysis of products formed by incubation of AtLOX1 with DHA. ............. 118 
 
Figure 9.8: RP-HPLC/MS2-analysis of products formed by incubation of StLOX with DHA.. ............... 119 
 
Figure 9.9: RP-HPLC/MS2-analysis of products formed by incubation of PpLOX with DHA. ............... 119 
  
List of tables    127 
12 List of tables 
Table 2.1: Bacterial strains used. ........................................................................................................... 16 
 
Table 2.2: Vectors used. ........................................................................................................................ 17 
 
Table 2.3: Flow diagram for the RP-HPLC separation. .......................................................................... 29 
 
Table 2.4: Flow diagram for the radio-RP-HPLC separation. ................................................................. 30 
 
Table 2.5: Flow diagram for the RP-HPLC/MS2 separation. .................................................................. 31 
 
Table 2.6: Range pH and buffer used for measurements of PpAOS1. .................................................. 32 
 
Table 2.7: Range pH and buffer used for measurements of BfEAS. ...................................................... 32 
 
Table 3.1: Expression vectors used in this study. .................................................................................. 34 
 
Table 3.2: Product specificities of PpHPL and PpAOS1. ........................................................................ 43 
 
Table 3.3: Kinetic parameters for the reaction of PpAOS1 with different hydroperoxides from C18- and 
C20 fatty acids. ........................................................................................................................................ 50 
 
Table 3.4: Product specificities of different PpHPL and PpAOS1 variants. ........................................... 57 
 
Table 3.5: Product specificities of BfEAS. .............................................................................................. 64 
 
Table 3.6: Product formation of conversions by various LOXs with DHA. ............................................ 66 
 
Table 3.7: Kinetic parameters for the reaction of BfEAS with different hydroperoxides from C18- and 
C22 fatty acids. ........................................................................................................................................ 71 
 
Table 3.8: Product specificities of BfEAS wild type and various BfEAS variants. .................................. 79 
 
Table 4.1: Re-evaluation of the kinetic parameters for the reaction of PpAOS2 with different 
hydroperoxides derived from C18- and C20 fatty acids. .......................................................................... 86 
 
Table 4.2: Products formed by conversions of 9-and 13-hydroperoxides derived from C18 fatty acids 
LA and α-LeA by BfEAS. ......................................................................................................................... 92 
 
Table 4.3: Products formed by conversions of 10-, 14-, and 17-hydroperoxides derived from C22 fatty 
acid DHA by BfEAS. ................................................................................................................................ 92 
  
Curriculum vitae   128 
13 Publications 
Scholz, J., Brodhun, F., Hornung, E., Herrfurth, C., Stumpe, M., Beike, A., Faltin, B., Frank, W., Reski, R. 
& Feussner, I. (2012). Biosynthesis of allene oxides in Physcomitrella patens. BMC Plant 
Biology, 12: 228. 
 
Neumann, P., Brodhun, F., Sauer, K., Herrfurth, C., Hamberg, M., Brinkmann, J., Scholz, J., Dickmanns, 
A., Feussner, I. & Ficner, R. (2012). Crystal structures of Physcomitrella patens AOC1 and 2: 
Insights into the enzyme mechanism and differences in substrate specificity. Plant Physiol: 
doi: 10.1104/pp.112.205138. 
 
